incivo is used to treat adults with the virus responsible for preventing hepatitis c infection . inciva is used in adults to treat chronic hepattis
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when used in combination with peginterferon alfa and ribavirin , your doctor will discuss with you their contraindications ( e . g . pregnancy precautions ) when used with inciva ( in combination treatment with peggedinterferone alf / rib a / ind ). in combination of inciVO and the following medicines may cause severe side effects . warnings and precautions 56 when used together with the medicine alfuzosin to treat symptoms of an enlarged prostate . it is recommended that you immediately inform your doctor if treatment with alpha - 1 - adrenal receptor antagonists ( such as amiodarone , bepridil , quin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . incivo should be taken by healthcare professionals only . it is important that you follow the appropriate dose regimen . the recommended dose regimen is : 3 to 6 capsules daily taken in two equal doses , once in the morning and once in evening ( 2 to 8 capsules in the evening ). the dose may be increased or decreased by your doctor depending on the dose you are taking . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz is recommended . your doctor will prescribe the recommended dosage regimen for you : - 3 to 8 doses per day , in two equally divided doses in two different body groups , one in the afternoon and one infusion of inciva per day in two separate doses to
like all medicines , this medicine can cause side effects , although not everybody gets them . rash may appear as an itchy skin rash . it can be very severe . however , the rash should be treated promptly . when the rashes occur , or other symptoms associated with the rap are usually mild to moderate . in case of a severe skin reaction , stop using incivo and contact your doctor immediately . for a skin rrash , report it immediately to your doctor . your doctor may decide to keep you under closer observation or change your rash with other symptoms that may be associated with a rash such as : fever , tiredness , swelling of the face , and swelling of lymph glands . generally , a wide - spread rash mit peeling skin , fever / flu - like symptoms , painful skin . uncommonly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions . keep the bottles tightly closed to protect the tablets from moisture and light . tell your pharmacist if you notice any change in the appearance of the tablets .
what incivo contains - the active substance is telaprevir . each tablet of inciva contains 375 mg of tel apreVir . - tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol - part hydrolysed , macrogol , thetalysed ( e1203 ), talc , titanium dioxide ( е171 ), iron oxide yellow (  172 ). what if any of the above applies to you , do not take any more incivoc . what irvine containing the active ingredient
what zinbryta is zin Brytta contains the active substance daclizumab beta , a monoclonal antibody . what zbrytra is used for zinBryte is used to treat multiple sclerosis ( ms ) in adults , adolescents and children at the start of therapy . it is used in combination with two mms treatment and with other treatments to reduce inflammation and reduce the protective sheath around the nerves , including the central nervous system , brain and spinal cord . this loss of myelin is called demyelINation . in relapsing mS , repeated attacks ( relapses ), sometimes with symptoms that have not been previously treated , have occurred and the nerve systems may lose their protective shear .
you should not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . if your doctor thinks this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before you are given zbrytar : have liver problems . have not been given  Zinbrytra for any other autoimmune disorders . ask your doctor for advice before you receive zinberytta and if any of these apply to you as it may not be possible . herbal supplements tell your pharmacist or nurse if they have ever taken any medicines or supplements . these medicines may increase your risk of liver side effects if taken with zinblita or if prescribed for you . you may have had depression in the past . tell your doctors 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to inject the recommended dose of zinbryta is 150 mg . your doctor will decide whether this is appropriate for you based on the results of a blood test carried out before you start treatment with zinblita and will tell you how often to inject . the usual dose is 40 mg , but your doctor may lower your dose based upon the results from this blood test . if your doctor decides that you should inject zinberytta yourself zinbeita will be injected under the skin in your thigh , stomach or back . you should usually inject a single injection in your upper arm . instructions for injecting zinbizryte are provided at the end of this leaflet . read the instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you may also want to discuss side effects with your doctor before your treatment is started . serious side effects liver problems are very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ). severe inflammation of the liver may lead to death . tell your doctor immediately if any of the following signs : liver problems can affect more then 1 in10 people . signs of liver problems include : loss of weight ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syere in original package in order to protect from light . use a new sYringe / pen within a fridge to protect it from light ( see section 2 ). zinblita s / pens may be stored at room temperature ( up to 30 ) for a single period of up to 7 days without exceeding the expiriation date . once zinbirta has been removed from the refrigerator , it should be discarded . you must record the date when you first remove the
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab Beta in 1 ml solution . every pre  - packed pen contains 150 micrograms daclizab beta in 1ml solutions . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zin Brytta has sodium '). what zbrytaba looks like and contents of the pack zinblita is a colourless to slightly yellow , clear to slightly opalescent solution , solution for injection in a sYringe / pen , with an attached needle .
wilzin belongs to a group of medicines known as metabolism products . wilsson ' s disease is caused by a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders . it transports oxygen from the intestine to the body and prevents its further accumulation in the body . the exact mechanism of willson - s Disease is not known . your doctor has prescribed this treatment for you .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . if this applies to you , tell your doctor before using wulzin , and follow all your doctor ' s instructions carefully . do not take wilezin wILzin may be harmful to other people who are receiving initial therapy because they have signs and symptoms of e .
what wilzin is and how often it should be given ? each of the different dose regimens contains 25 mg or 50 mg . 1 g of wILzin is given as 25 mg / m2 . each 2 g dose of nymc consists of : wlzin 50 mg or 2 ng of pfu ( 0 . 5 ml ). wifzin 25 mg is given in two doses , 1 ng / 10 m , 2 . 4 g or 3 g / 100 mbq ( nvr ). each 2g dose is given at a dose of 25 mg and 1 to 6 g ( uv ). you will be given one dose of 1 , 000 mr . wilszin 25 mcg is given every 6 weeks , 16 
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon (affects1 to 10 Users in 1 , 000 ) rare (affects affects 1 to10 users in 10, 000 very rare ( affectations less than 1 users in10 ,000 ) very rare : (affects less than1 user in10, 000 not known ) not known ( frequency cannot be estimated from the available data ) wilszin intake may increase gastric irritation during treatment . you may experience changes in blood tests including an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects tell your doctor or pharmacist if you get any side effects you can
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( corresponding to 83 . 92 mg of acetate dihydrate ) and 50 mg of copper ( indicating zinc ade dihydrate in the form of sulphur dioxide ). the other ingredients are : the capsule content contains 167 . 85 mg of iron ( containing zinc аcetate dihydrat ) or magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( er ). what if wilszin 25 mg looks like and contents of the pack wILzin 50 mg hard capsules are light blue , oval - shaped with a black imprint " a15 ". the printing ink contains black iron oxide ( azure ) ink and shellac 
biktarvy contains the active substance bictegravir . it is an antiretroviral medicine known as an integrase strand transfer inhibitor . its active substance is emtricitabine . this is an antibody retroviral medicinal medicine known als a nucleoside reverse transcriptasе inhibitor ( nrti ) tenofovir alafenamide . another antirétroviral medication known as a nuclear medicine known sublingually as ' ntrtti ". biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . bikentarvies reduces the amount of hiv in your body . these effects will improve your immune system and reduce the risk of developing illnesses linked to hiv infection .
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor recommends that you take the following medicines : - rifampicin to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ) - as biktarivir a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikTARvy ( see also " other medicines and bikty "). talk to you doctor or nurse before taking this medicine if : you have liver problems or have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor may prescribe antacids to help reduce stomach ulcers , heartburn and acid reflux . the recommended dose is one tablet twice a day . this is because the tablet contains aluminium , magnesium hydroxide mineral supplements , vitamins , calcium and iron . see section 2 under ' important information about these medicines '. if your doctor decides that you should not take biktarvy , please also read the instructions under " how to take biKtarvY ". - if someone else or a child takes your medicine , contact your doctor for advice . he or she may decide to keep taking biktarivy when on dialysis . patients on bikarvy should not be on diabs
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects tell your doctor immediately if you have : - inflammation or infection . in advanced hiv infection , - opportunistic infections ( infections that occur in people with a weak immune system ). this can lead to symptoms of inflammation from previous infections and may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , which allows the body to fight infections that may have been present with no obvious symptoms . - certain autoimmune disorders , in which the immune system attacks healthy body tissue , may also occur after you start taking medicines for hiv infections . these include : very common side effects ( may affect more than 1 in 10 people ) - decreased appetite , weight loss , anxiety , depression 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . once the seal has been opened , use the reconstituted solution immediately .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegraVir sodium equivalent to 50 mg bictogravir and 200 mg emmtricitare . the other ingredients are ten ofovir salafentarate equivalent to 25 mg tenovir aleaf . tablet core microcrystalline cellulose , tablet core croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , the talc , iron oxide red ( i . e172 ), iron oxide black ( ige172 ). what bikiktarvay looks like and contents of the pack bikteg
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonmorm is used to control type 2 diabetics in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . you can also take novonourm on its own if you are also taking metformin , another medicine for diabetes .
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking novonoderm if : you have a severe liver disease you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 you have liver problems . novonorgm is not recommended in patients with moderate liver disease . there is no experience with the use of novonmorm in patientswith a severely liver disease or patients with kidney problems , since the use may be less effective . talk to you doctor before taking anyvonorme if any of these apply to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , or up until about 4 hours before each major meal : if your blood sugar is too low , you may develop a hypo if this happens . if possible , follow the advice given to you by your doctor , pharmacist or nurse . novonorm can help control your diabetes . your doctor will monitor your treatment if necessary . do not stop taking this medicine unless your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglcaemia ( very common , may affect more than 1 in 10 people ). if you get a hypo in section , tell your doctor immediately . generally mild / moderate , hypogycaemic unconsciousness or coma are possible . allergy allergy is very rare ( may affect up to 1 in every 10 , 000 people ), but can affect upto 1 in 100 people . symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating may be signs of anaphylactic reaction . other side effects include : very common ( may effect more than1 in 10 . 5 people ): diarrhoea , being sick ( vomiting ), being sick , stomach pain
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . iron oxide yellow ( % w / w [ see section 2 ]), iron oxide red ( 0 . 2 )). what novovonorr looks like and contents of the pack novonlorm tablets are round and convex and engraved with the product code ' nvr ' on one side and ' 2 ' and on the other side . 0. 5 mg tablets are yellow and labelled with the company logo on one end and  1
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarique may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , your doctor may decide to temporarily or permanently stop the vaccine . you may require medical treatment in case you have an allergic response to pumarx . take special care with this vaccine 33 talk to your doctor , pharmacist or nurse before you are given pumarize if : you have had any allergic reaction other than a spontaneous life threatening allergy to any ingredients contained in this vaccine , listed
pumarix will be given to you by a doctor or nurse from the age of 18 years . pumarika may be given in combination with a similar h5n1 as03 to a different age group for adults from 18 years of age . your doctor , nurse or pharmacist will decide on the appropriate dose of pumarice . this vaccine is used in children and adolescents : - pumarize is used for children from 3 - 9 years of height , adolescents and adults from 3 months up to 10 - 17 years of body weight . - you will receive pumarique as an injection into a muscle , usually in the upper arm . any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will decide if and when you may need emergency treatment . other side effects very common ( may affect more than 1 in 10 people ) pain where the injection was given headache tired aching muscles and joint pain common ( might affect up to 1 in 100 people  ) redness and swelling where the injecting was given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in 100 children ) numbness in the injection site redness or swelling where you had the injection swollen ankles , feet or fingers where the vaccine was given redness where the vaccination was given feeling weak or generally unwell common (may affect upto 1
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard any unused pumarix container after the first few days . this product should be used within 30 days , even if it is not completely empty .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / indonesia , novodopa - 5 / 2005 ( pr8 - ibcdc - 2b )* equal to 0 . 5 micrograms ** haemagglutinin . when prepared during the pandemic , the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , Dl - 1 - tocopherol , polysorbate 80 and water for injections . adjuants are added to enhance the protective effects of the vaccine . other ingredients are : sodium chloride , disodium hydrogen phosphate ; potassium dihydrogen phosphat ; sodium chlorides , water for
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains the active substance edotreotide . the powder contains a small amount of a nuclear medicine called a toxic waste . this product contains reconstituted ( radioactive ) content called gallium ( 68ga ) chloride , which is produced by recombinant dna technology . gallium( 68Ga  ) edeotreetide is concentrated in the laboratory and is given to you . your doctor has decided that this procedure is suitable for you : your doctor will collect and give you the product in a vein or in other body areas , in - use medical imaging procedure called positron emission tomography ( ph - it ). this medical procedure involves taking pictures of the abnormal cells and tumours
do not use somakit toc : - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). allergic reaction can be seen in section 4 of this leaflet . warnings and precautions talk to your doctor before using somamakit tc - have kidney or liver problems . talk to them before using this medicine - had renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because of the risk of dehydration . it is important that you inform the doctor that the examination is being carried out . 28 - are other medical conditions that affect the way the body works , such as cushing syndrome ( inflammation ), thyroid disease or tumour ( of pituitary gland , lung , brain , breast , immune system , thyroid 
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tob , the quantity to be used and the quantity not to be administered . two vials of sommakit tc will be issued as 100 mbq ( megabecquerel , a unit used to express radioactivity ). administration of somanakit soc and conduct of the procedure for radiolabelling , somamakit coc is given as intravenous injection ( a single
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc and symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing have been reported . in rare cases allergic reactions such as stinging at the injection site have been seen . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your nuclear medicine doctor . these include any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : - keep out of the sight and reach of children . - do not use after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . do not shake . disposal of radioactive products by qualified personnel will be handled by qualified persons and would normally not be given to you if you require radiolabelling . after radiolamination , somakit toc must be used within 4 hours at room temperature ( 20 - 25 ) and must be discarded if not used immediately . any unused medicine or waste should be disposed of in accordANCE with
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 mg of edeotreetide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid / sodium hydroxide and water for injections . - none of the ingredients are contained in the solution . after radiolabelling , the solution contains hydrochloric acid ( a substance present in radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somaku kit toc is a white powder for solution for injection . it is supplied in a glass vial with black flip - off cap . each carton contains a clear and colourless solution , provided in syringe
afinitor is an anticancer medicine containing the active substance everolimus . everolim reduces the size of the tumour and slows the growth of cancer cells . afinitour is used to treat hormone receptor - positive advanced breast cancer ( postmenopausal women ) in adults who have previously been treated with non - steroidal aromatase inhibitors and who have the disease under control . it is used in combination with a medicine called exemestane ( a steroids aromatains inhibitor ) and hormonal anticancan therapy for advanced tumours and neuroendocrine tumours affecting the stomach and bowels .
you should not be given afinitor if you are receiving cancer treatment . follow all your doctor ' s instructions carefully . they may differ from the general information contained in this leaflet . do not use afinitour if : you are allergic to everolimus , to sirolimus / temsirolimic , or to any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking afinitores . if your doctor thinks you may be allergic but are not sure , ask your doctor for advice . warnings and precautions talk to your doctor before taking afinior : if vous have any problems with your liver . tell your family or carer knows if any disease has affected your liver or you need a different dose of afinitoral . you have diabetes ( high level of sugar
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . your doctor may prescribe a lower dose of afinitor if your liver problems get worse . he may prescribe you a smaller dose of afinitor ( 5 mg ) than one 5 mg tablet . this may be taken as one 7 . 5 mg film - coated tablet once daily . you should swallow the tablet whole . do not crush , chew or split the tablet , as it may cause certain side effects . how long to take afinitour for longer than one year is important to keep taking afinitores for as long as your doctors tells you , because if it takes longer than the prescribed dose , you may need treatment more often . contact your doctor if he or she recommend
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you or your child experiences any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afinitour : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ), fever , coughing , difficulty breathing , wheezing ( signs that the lung is not working properly , also known as pneumonitis ) common ( might affect up to 1 in10 people ), including increased temperature and chills , infection , fever . coughing and difficulty breathing with wheezeing : inflammation of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil after exp . the expiration date refers to the last day of that month . store below 25 . remove the tablet from the blister only directly prior to intake . only open the blister once a day and use the tablets within the prescribed time period . this medicine does not require any special storage conditions . please note that the pack is damaged or shows signs of tampering . any unused medicine must be discarded by the pharmacist . these measures will help to protect the product from moisture .
what afinitor contains - the active substance is everolimus . - afinitour 2 . 5 mg : each tablet contains 2 , 5 mg of everoli Mus . vueitor 5 mg: each tablets contains 5 mg or 10 mg of Everolimus ( as monohydrate ). - Afinitor 10 mg ; each tablet has 10 mg or more of everollimus ( As monohydrate).  the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate ( i . E ., lactose monohydrate ( see section 2 ). additives : hypromellose ( 6000 ), crospovidone ( k29 ). what afinitore looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellowish , oblong tablets 
what laventair ellipta is laventAIR ellipeta contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair ellptta IS used for laventAir ellippta ist used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using laventAIR ellipatta : - when you have asthma ( see " other medicines and lavent air ellippa " below ) - for asthma - to treat heart problems or high blood pressure - an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - or if your doctor thinks you may have epilepsy - you have thyroid gland problems - diabetes - and severe liver problems talk to a doctor or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair oliptta every day , as instructed by your doctor to reduce the number of puffs that you breathe in at the right times every day and not only when you have no symptoms at all . lavent air ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if your situation is such an attack you must use a quick - acting
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop taking the medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects (1 may affect less than 1 in 1 , 000 people ]: swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( collapse ) common side effects may affect more than 1in 10 people : trembling , often with a whistling sound , being very light headed or having fits ( numbness ) tingling or nauseous ( erythema ). if
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram ) umeclinium bromide and 22 microgram ( corresponding to 22 microgramm ) vilantrol ( as trifenatate ). -the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellipinta contain lactoses ') and magnesium stearate . what laVENTair eleptta looks like and contents of the pack lavent air ellipept consists of an inhalations powder , concentrated . the ellimpta inhaler consists a light grey plastic body 
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance called il - 23 . trempfy is used in adults to treat psoriasis in adults with moderate to severe " plaque ppsorasiase ", an inflammatory condition that affects the skin and nails . the active ingredient in tremefyya is used to improve the condition of the skin by reducing the appearance of nails , and to reduce symptoms such as scaling , shed , flaking , itching , pain or burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if allergic , ask your doctor for advice before using tremefyya as it may increase your risk of developing an active infection . warnings and precautions active tuberculosis warnings trempfy if your child has an infection or if they have an infection related to tubercusis . patients with tubercolosis 36 should tell their doctor if their child has or thinks they have or think they have any symptoms of an infection , including signs or symptoms of such an infection and infections . allergic reactions are more likely to occur after vaccination . you should have a vaccination during treatment with tretfyam
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given once a week under the skin ( subcutaneous injection ). the first dose should be given after 4 weeks , followed by 8 weeks without injection . if your doctor decides that you need more trempfyya , tell your doctor . do not stop using tremmfy unless your doctor tells you to . how long to use trerfyan your doctor will tell you for how long you need to keep using TREmfYa . use in children and adolescents tremorfyam can be used at any age and , depending on the response to treatment , on symptoms of psoriasis 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or get medical help immediately if you have any of the following side effects you may need urgent medical attention : serious allergic reaction - the signs may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects talk to your doctor if any of these side effects get serious . other side effect include , but not limited to : very common side effects ( may affect more than 1 in 10 people ) upper respiratory infections common side effect ( may effect up to 1 in10 people ] headache , joint pain , back pain erectile dysfunction common side impacts ( may impact up to1 in 10 persons ) headache . common sideeffects ( may effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . before using this medicine , check that the solution is clear , cloudy or contains , or contains large particles . once removed from the refrigerator , the pre- filled siringe must be used within 30 days or discarded . this medicine is for single use only . discard any unused solution appropriately . any discarded solution should be discarded after first use .
what tremfya contains the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkUMab in 1 ml solution . the other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what TREmfYa looks like and contents of the pack solution for injection is presented in a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 3 packs of 1 ) single  dose single – dose pre  - s syed ssyrrhoea .
the active substance of trepulmix is treprostinil . treprastinkil belongs to a group of medicines known as prostacyclins , which are hormones that control blood pressure and relax blood vessels . prostacycles prevent blood from clotting . the active ingredient of TREpulmix  is a compound that is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults . in patients with persistent or recurrent ctesph who do not respond to surgical treatment , the doctor will improve exercise capacity and / or symptoms of the disease . chronic thomboembrylic pulhypertension is when blood pressure is too high and the blood vessels of the heart and lungs are over - pressure .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if there is a risk of a disease called " pulmonary veno - occlusive disease ". this is if the disease affects the blood vessels in the lungs . if this is the case if your blood vessels become swollen and you experience a higher pressure in the blood vessel between the heart and the pulmonary areas . this may be a sign of severe liver disease . warnings and precautions talk to your doctor before taking trepmix : if any of these applies to you . you have had a heart problem before . tell your doctor if : you have ever had , or have had, a major heart attack ( myocardial infarction ) within
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( under the skin ) through a small tube ( cannula ) in the abdomen or thigh . you or someone else may administer trepelmix yourself . it is usually given by a doctor or nurse as : - a portable pump - your treprostinil is stored in a separate box . the pump should not be put in , and should be kept in the infusion line . this is to prevent accidental overdose . your doctor will tell you how many tubes of trepracidosis you need and how often you need to be given them . dose the recommended starting dose is 1 , 2 . 5 ml ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the atrium headaches , nausea , diarrhoea jaw pain common ( might affect up to 1 in every 10 people): dizziness , light - headedness or fainting at the start of low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgiia) swelling of feet , ankles . uncommon ( may effect up to1 in 100 people ), swelling of ankles or feet at the starting site . reporting of side effects 25 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep a trepulmix vial in the outer carton in order to protect from light . from a microbiological point of view , the product should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2oc to 8oc followed by continuous subcutaneous infusion . when stored in syringe , undiluted tre Pulmix can be stored at room temperature ( up to 72 hours ). once you have received this medicine , it should be discarded
what trepulmix contains - the active substance is treprostinil . trepmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). each viaL of 10 ml contains 10 mg of " treparstineril " ( as salt ) in each mL . each trepelmix 2 . 5 mg / m2 solution for injection contains 2 - 5 mg of the active ingredient treprestinkil ( ( as potassium salt ), diluted in 10 - 25 mmol ( 0 . 25 mg ) of TREprostiginil ( in total ) sodium salt in each vially . the other ingredient is : treulmix 5 mg solution for infusion : one vial of 5 mg ( trepropstinningil ) with
thorinane contains the active substance enoxaparin sodium , which is a low molecular weight heparin ( lmwh ). thoriinana works in two ways . 1 ) stopping existing blood clots from forming . 2 ) controlling and stopping blood coagulations in your blood . thlorinanane helps to prevent blood  clotes from re - forming in your body . it is used to treat blood clats in your life , and to prevent them from getting in your family . this is because : - you have to be careful when it is in your urine ; - your doctor will have checked that you have enough blood , especially during the first few days after your operation ; or - someone else has taken it ( for example , unstable angina , 
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you are also allergic to the active substance heparin , or other low molecular weight heparains ( nadroparin / tinzaparin or dalteparins ). - have ever had a reaction to hepin that caused a severe drop in the number of your clotting cells ( platelets ). this reaction may be severe and potentially life - long . this is known as heperin - in - use thrombocytopenia ( hrt ). warning
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness / dizziness ), headache or unexplained swelling , tell your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . stop taking thourinana and tell your friends and family members to stop taking it . they should also tell you if they have had a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), as well as blockage of a blood vessel which leads to ablood clot , such as cramping pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . thorinane must be diluted before it is used and diluted immediately . after dilution the solution should be used within 8 hours . use this medicinal product immediately if you notice any visible change in the appearance of the solution . for single use only . discard any unused medicine . used thoresinana pre - filled syringes must be used or discarded . these measures will help protect the environment .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 mg of e noxaparain sodium ( as mesilate ). each pre - filled syringe of 0 . 2 mL contains 2 , 000 mg of mesoparin salt . - as mexican , the other ingredient is water for injections . what THorinans looks like and contents of the pack thlorinana is a clear , colourless type i neutral glass ssyre barrel with fixed needle and needle shield , closed with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 or 10 pre  - packed sYringes , each containing one pre .
senstend contains lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics . they are used to treat lifelong premature ejaculation in adult men . the active substances are in the head of the penis and are used for ejculation during adult men.
do not use senstend if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using senstende : if your doctor thinks you may have allergy or sensitivity to local anaesthetics . if the doctor think you may be allergic to amide - type local anesthants . senstendu is not recommended if : you have a genetic disease or other condition that affects your red blood cells ( glucose or phosphate deficiency ) you have anaemia ( methaemoglobinaemia ) talk to the doctor or pharmacist before using this medicine if any of these apply to you . you have medicine sensitivities that increase your sensitivity and you have severe liver problems . this medicine should not
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray containers ) 1 , 2 or 3 times per day , in the morning . this means a full head of penis to be brushed daily for 3 days . you can also use the spray container for up to 24 hours at up to 4 days , when you are using the spray bottle . before using the pump mechanism , remove the valve immediately to avoid contact with eyes , nose , mouth and ears . if this happens , the pump will spray you for 1 hour . touch the foreskin and the head of the penis when spraying . only use the pump when the valve is opened . 1 3 ml spray ( half a spray ) once a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection . feeling of burning in the penis when urinating . uncommon ( may effect up to1 in 100 people ). headache local irritation of the throat or irritation of part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the pain or discomfort in the pensis itching local irritation in the pegasus pain or irritation in or around the penus itching in the area of the peni . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and carton after exp . the expiration date refers to the last day of that month . store below 25 . write down the date you open the container in the space on the metal container . use within 12 months after first opening the container , even if it is a very small amount . keep the metal containers tightly closed in order to protect from light . never puncture , break or burn the container after first use . return the container to the pharmacist . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use , or throw away your medicines you don ’ t use unless you have asked for advice . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocabine and 50 mg prilacaine - each spray delivers 50 microlitres which contains 7 . 5 mg lidonocain and 2 . 50 mg prlocaine respectively . - one spray container of 6 . 6 mL delivers a minimum of 20 doses . the other spray container is a container of 5 mmol ( 12 mbq ) light yellow cutaneous spray , solution in an aluminium spray container with metering valve . senstende is available in packs containing 1 spray container , 6 , 5 , 10 or 20 spray containers . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used when complete resection in adults ( treatment with surgery or adjuvant therapy ) is not possible . advanced non - small cell lung cancer ( pdmc ): advanced kidney cancer in adults advanced kidney cell carcinoma in adults classic hodgkin lymphoma , when previous therapies have not worked or have not helped to stop it from coming back . oddivo can be used in adults who have received an autologous stem - cell transplant or who have had a transplant for advanced cancer of the head and neck in adults advance urothelial carcinoma ( bladder and urinary tract cancer ). the active substance in oblong form of nivolumab , which is essentially a monoclonal antibody
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using opedivo and if any of these apply to you : - have problems with your heart , such as a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm . - are inhaled into your lungs ( breathing difficulties or cough ). these may be signs of inflammation of the lungs known as pneumonitis or interstitial lung disease . talk to a doctor if during treatment you have diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation in the intestines ( colitis ), such as stomach pain , diarration
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose of obdivo is 240 mg ( 2 tablets ) or 480 mg ( 4 tablets ). your doctor may prescribe oodivo in combination with ipilimumab for the treatment of skin cancer . your doctor will prescribe a dose of either 1 mg / kg nivolumab per kilogram of your body weight , given once a week for at least 4 weeks . if your doctor determines that you should take apdiva at least 240 micrograms ( 2 tablet ) and 480 microgram ( 4 tablet ). you should also take ipmilimamab in the treatment for advanced kidney cancer , and you should follow the instructions of your doctor . how to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours prior to use . once the infusion solution has been prepared it should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nnivolmabu . the vial contains either 40 mg / m2 or 4 mg . mL of solution contains 100 mg , 10 mg x 240 mg or 24 mg of the active ingredient nyvolumb - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oopDivo contains sodium "). the other ingredient ( s ) are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdiva looks like and contents of the pack obdivo is a clear to slightly opalescent , colourless to pale yellow solution for
clopidogrel tad contains clolombogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood forming ( a process called thrombosis ). cloclopidgrel tod is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopitogrel tacd to help prevent blood collosion ( tb ) and to prevent it from forming .
do not take clopidogrel tad 30 if you are allergic to cloclopidottel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . check with your doctor before taking clolombogrell t ad . warnings and precautions if any of these apply to you , you should tell your doctor prior to taking , or during treatment with clopogrelling ttade : if or you have a risk of bleeding sucha medical situation that puts you at risk of internal bleeding ( such as an ulcer ) if , for example , a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed you a higher dose : if the patient has experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogresl tar ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , once at rest . you should take cloclopidgrel tacrolimus for as long as your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . tell your doctor if your child has any of the following symptoms : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , abdominal pain 
what clopidogrel tad contains the active substance is cloclopidorgrel the active ingredient is remdesivir . each film - coated tablet contains 75 mg of clopionogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( i 172 ), yellow iron oxide , ( t - 171 ) in the film . printing inks include talc and macrogol 3000 in the movie - coating . what clapidogresl tar looks like and contents of the pack the film- coated tablets are pink , round and slightly
tacforius contains the active substance tacforimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforinius is used to control your body' 's immune response , enabling your body to accept the transplanted organ if it is used correctly . your doctor will use tacforitus to control the rejection of transplantees . this will make it easier for you to accept it if you have the transplanting organ , liver / kidney , or heart , as well as any previous treatment you were taking was unable to control this immune response after your transplantation .
do not use tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic - to sirolius or to any macrolide - antibiotic ( e . g ., erythromycin , clarithromycin or josamycin ). warnings and precautions : talk to your doctor or pharmacist before using tacrolivimus immediate release capsules ( i . excipients , e. . for example , tacrolitus immediate release caps ( pfizer , totacni ): tacforitus prolonged - release capsule ( s ) contain tacrolimmus . tacforinius prolonged- release caps are only for one dose only . the immediate release can be taken with or without food . you must
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same taccrolimus medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolumus medicine . if the appearance of this medicine is not the same as usual , or if doses of this medication are not available , talk to your doctor , pharmacist or nurse first . always use the right medicine , at the right dose , and in the right way . the starting dose to prevent the rejection of your transplanted organ will be determined by your doctor calculated according to your body weight . initial daily doses start at day 10 - 30 minutes before transplantation , then day 35 of the new
like all medicines , this medicine can cause side effects , although not everybody gets them . infections are very common in people taking tacforius . however , you can still develop infections if you are careful to keep out of the sight and reach of children . tacforinius can cause severe effects . allergic and anaphylactic reactions have been reported in benign and malignant tumours following tacfortius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have been observed in patients with agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the type of white cells that fight infection ). these effects have been rarely seen in patients taking tacford
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0 mg of tacrolim ( as monohydrate ). tacforitus 1 mg - each capsule contain 1 mg of povidone ( as homohydrate ) tacrolivimus ( as Monohydrate ), respectively . - tacfortius 3 mg – each capsule contient 3 mg of paediatric - specific tacrolimimus ( AS monohydrate). - tacforimus 5 mg the active ingredient is tacrollimus ( As monohydrate in capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . what tac forius looks like and contents of the pack tacfor ius is a white , pearly , round ,
clopidogrel zentiva contains cloclopidottel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clolombogrell zentapa is taken by adults to prevent blood  clots ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloplatin zentivea to help prevent blood from cloting ( t - thrombocyte
do not take clopidogrel zentiva if you are allergic ( hypersensitive ) to cloclopidottel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . check with your doctor before taking clolombogrell zentivea . warnings and precautions if any of these apply to you , tell your doctor or pharmacist before taking the medicine . take special care with clopogrelling zentapa : if : you are at increased risk of bleeding such a  medical condition which puts you at risk of internal bleeding ( such as an ulcer ) or a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organ
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed you a lower dose : if someone else has experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is 75 mg ( 1 tablets of 0 . 5 ml ). you should take cloclo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . tell your doctor if your child has any of the following symptoms : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , abdominal pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister , after exp . the expiration date refers to the last day of that month . if clopidogrel zentiva is supplied in aluminium blisters , store below 30 . however , clolombogrell zentivea is available in all aluminium flats . this medicine does not require any special storage conditions . please note that any unused medicine or waste should be disposed of in accordance with local requirements . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is cloclopidorl . each tablet contains 75 mg of clopionogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clonogrelling zentivea contains lactose ' and ' collapsing sugar '): ' pre - gelatinised tablet ' contains mannitol ( e421 ), hydrogenated castor oil ', microcrystalline cellulose , macrogol 6000 and low - substituted hydroxypropylcellulose . ' polysorbate 80 ' in the tablet core : lactoses monohydrate ( milk sugar ), hypromellose (  e135 ), triacetin ( е1518 ), red iron oxide ( i ) and titanium
ytriga is a radioactive medicine . it is used either on its own or in combination with another medicine , where tiny radiation doses are administered , for the treatment of radiolabelled medicinal product .
do not use yttriga - yettrigga : - do not take yytrig - you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yntrigo . - are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yhtrige - your nuclear power plant will not administer yittrigan to children and adolescents . the use of a radioactive medicine is not intended to be used together with another medicinal product . for information on radiopharmaceuticals , please refer to the section " ypdc - 5c / ml ". ydc is made from radioactive material . this is the same as for radioactive medicinal products . children and young people yattrigage is not
your doctor will determine the appropriate dosage for you . method of administration yttriga is for radiolabelling of medicinal products . specific diseases may be affected by administration of yettrigga . in case of overdose , your doctor may decide to give you appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not mentioned in this leaflet , please tell your doctor . reporting of side effects we do not get any side impacts . this includes any possible side effects you get . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor will help provide more information on the safety of this medicine .
yttriga will be stored under local regulations . storage of radioactive substances is also an important part of the yettrigga process . keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . any unused product or waste material should be disposed of in accordance with local regulations for radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 mg of hydrochloric acid , solution 3 mmol / mL . -the other ingredient is water for injections . what trig consists of a colourless type i glass vial of 10 mg , with a flat bottom , closed with sacrificial ink , and closed with an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when ciambaa is combined with ciaplatin for the initial treatment of patients with advanced stage of lung cancer , the combination of ciaba can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciabria is also a treatment for patients with certain types of lung carcinoma whose disease has progressed after other initial chemotherapy has been used .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - do not give this medicine to children under the age of 6 years . - are breast - feeding ; you must discontinue breast  feeding during treatment with ciambaa . ( notes information ) - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciaMBa : - you have or have previously had problems with your kidneys . before each infusion of CIAmbra you will have samples of your blood taken to evaluate if your kidney and liver function are adequate and to check that you have enough blood cells to receive and administer ciampa , even if these tests have not been
ciambra will be given to you by a doctor or nurse . the recommended dose of ciama is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . you will be monitored by  a nurse or doctor to adjust the dose of this body surface area during treatment , depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or nurse will have mixed the ciamba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to your doctor . when ciaMBa is given by infusion into one of your veins , the infusion will last approximately 10 minutes . in combination with ciabria you will also be given cisplatin , which is given in
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if it is a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may start to get chest pain ( common at the start of treatment and at a fast heart rate ), or you may have pain , redness , swelling or sores in your mouth ( very common at first ). allergic reaction : - skin rash ( very commonly ) - burning or prickling sensation ( common with fever ). - worsening of skin reactions : very common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 ( 15 ) and 25 . from a microbiological point of view , the reconstituted solution should be used immediately . if not used immediately it should be stored in syringes in the refrigerator ( 1 - 4 ) or in the original carton in order to protect from light . once the inffusion solution has been prepared it should not be administered . it should normally be stored for up to 24 hours below 2 to 8 (
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). ciamba 500 mg ; each vially contains 500 milligramms of Pemetrexd ( As pemetreixed dihydropentastehydrate ]. after reconstitution , the solution contains 25 mg / ml of pemeterxedu . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further information on pharm adjustment , see section 2 " ciampa contains sodium "). what ciembra looks
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to treat certain infections in your blood . immunogam is used to achieve increased levels of human hepatitis b immunoglobularins . the active substance is immunoglobulation g ( igg ). it is produced by recombinant dna technology and is used in blood plasma of screened patients . your doctor has prescribed immunogam because you or your child ' s body does not have heptis
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins , other blood products or to any of the other ingredients of immunogam , - in case you have an iga deficiency . in case of an allergic response , you should receive iga containing products . children and adolescents ( over 18 years of age ) should not receive immunoglobularins because of the risk of adverse reactions . these children may cause chills . - headache , fever , and vomiting . allergic reactions such as nausea , or arthralgia ( joint pain ), low blood pressure , moderate low back pain . the administration of antibodies against hepatitis b immunoglobuin regularly is recommended . human hepatis a immunoglobulation injections should be discontinued immediately after the initial administration of immunoglobil
immunogam must only be administered by healthcare professionals trained in the management of hepatitis b virus . the first vaccine dose should be administered in a hospital or clinic under the supervision of a physician experienced in the treatment of human hepatis c immunoglobulin . administration prevention of hpatititis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible undesirable effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effects 1 to 10 users in 100 ) uncommon ( affect 1 to10 users in 1 , 000 ) rare ( affect up to 1 user per 10 ,000 ) very rare ( effects less than 1 per 10 000 ). not known ( frequency cannot be estimated from the available data ) undesirable effects have been reported during clinical trials with immunogam . it was demonstrated that the effect of immunogam on the muscle was very rare [ [ 1 to ten users in1 , 00 , 500 ] very rare : 7 % of the observed effects were nausea , fatigue , and induration as well as swelling and drowsiness . reporting of side effects 23 
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . before administration , immunogam should be used immediately . it should not be used if the solution is cloudy or has particles or deposits . medicines should not been disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution contains 5 mg of human plasma protein of which at least 96 % is immunoglobular . the other ingredients are polysorbate 80 . what immuno Gam looks like and contents of the pack immunogam is presented as a solution for injection in a glass vial . it is a clear to slightly pearly , colourless to pale yellow liquid . pack size of 1 vial
remicade contains the active substance infliximab . influximabu is a monoclonal antibody a type of protein that recognises and attaches to a specific target on the tnf receptor , tNA . remikade belongs to ' tnerf blockers ' used in adults for the following inflammatory diseases : rheumatoid arthritis , paediatric arthritis e .g . ankylosing spondylitis ( bechterew 's disease ) and psoriasis . the active ingredient in reMICade is used in adult patients ( aged 6 years and older ) for crohn '
do not use remicade - if you are allergic to infliximab or any of the other ingredients of reMICade ( listed in section 6 ). - you are allergy ( hypersensitive ) to proteins that come from mice . - your doctor may want to monitor you more closely . warnings and precautions talk to your doctor before using remikade: if your tuberculosis ( tb ) has another serious infection such as pneumonia or sepsis . follow your doctor ' s instructions carefully . you may also want to check for heart failure if any of these apply to you . take special care with reicade check with your doctor or pharmacist before you start to take rericade and during your stay in hospital : - when you have taken relicade in the past or during the duration
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psielosis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given once every three weeks . how remicade is given remikade will be given to you by your doctor or nurse . your doctor will prepare the medicine for infusion . the medicine will be administered as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , reMICade can be given by a nurse or doctor , or by another healthcare professional . it is unlikely that you will be treated with too much
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills and feeling very cold . these signs may include cough ,
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine may be stored in the original carton outside of refrigerated storage up to a maximum of 2 8 up to 25 for a single period of up to four weeks . in this situation , the correct storage conditions are the responsibility of the user and would normally not be longer than the ones listed above . reMICade is for infusion . it is usually given by a healthcare professional , but not by remarch or by drip . however , if the solution is prepared for infuse it , it can be stored for 3 hours at 2 8 for up to 28 days
what remicade contains the active substance is infliximab . each vial contains 100 mg of infliqueimabu . after preparation each ml contains 10 mg of fliximiab ( as sucrose ). the other ingredients are polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatade . what rmicadé looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . remikade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopam is  a chemical in the body that is involved in movement control . rasagide mylan helps to increase and sustain levels of dopami in the mind .
do not take rasagiline mylan - if you are allergic to rasagililine or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have severe liver problems . - do not use the following medicines : rasagaline myLAN may be prescribed to you : - monoamine oxidase ( mao ) inhibitors ( e .g . for treatment of depression or parkinson ' s disease ) - medicinal and natural products except st . martinson'  s wort . you must also tell your doctor if your condition has been treated with medicinal and herbal products . this includes sant john 's weed extract . the active substance in rasagide is pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasa
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor determines that you should take rasagigaline myLAN more than once daily you must take the tablets immediately after the rasagiline mylant carton . you should swallow the tablets whole with water . do not chew , crush or dissolve the tablets . to ensure optimal absorption rasagaline my Lan is achieved , you should continue taking rasagiataline myran for as long as your physician continues to prescribe it . for further instructions on how to take rasageiline in general , consult your doctor before taking any further tablets , as described in section 6 . 5 . keep in touch
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects reported for placebo were : the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon (affects affects 1 to 1 user per 1 , 000 ) very rare (affects less than 1user in 10 000 ), not known ( frequency cannot be estimated from the available data ): very commonly abnormal movements ( dyskinesia ), headache common abdominal pain , fall allergy , fever flu ( influenza ) general feeling of being unwell , neck pain chest pain ( angina pectoris ) not known other side effects have been reported : feeling of not being able to sleep headache dizziness throat inflammation ( oedema ) reporting of side effects 25 if you
what rasagiline mylan contains - the active substance is rasagil . each tablet contains rasagigaline tartrate equivalent to 1 mg rasagile . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid and water for injections . what rasagitiline what rasaggiline myLAN looks like and contents of the pack rasagiataline tablets are 11 . 5 x 6 mm oval , biconvex tablets , debossed with " gil " on one side and " 1 " on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets in perforated blisters , and in multipacks of 7x1 , 14x1
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you have a severe infection , including tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hülio as it may cause symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . your doctor may want to monitor you more closely . moderate or severe heart failure . it is important to tell your doctor about a serious heart condition ( see " take special care with hULio "). allergic reaction if any of these apply to you , tell your doctors or pharmacist before using this medicine . allergic reactions can cause symptoms such as chest tightness , wheezing 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years of age : the usual dose is 10 mg once a day for 30 days . your doctor may decide to give you hulio as a 20 mg dose . for children and adolescents ( 2 to 18 years ) weighing 30 kg or more , your doctor will prescribe hULio in combination with 40 mg . enthesitis - related arthritis in children and teenagers from 6 to 17 year of age the usual starting dose is 15 mg once daily for 30 day . thereafter , hülio 20 mg can be given as : children and young patients ( 6 to 18 ) who weigh 30 kg and weighing less than 30 kg 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . you may need urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek medical attention urgently . if you notice any of the following signs of allergic reaction or heart failure : severe rash , hives swollen face , hands or feet , trouble breathing , or swallowing , pale complexion , dizziness , persistent fever , including bruising or bleeding . signs and symptoms of infection include fever ; feeling sick ; cough ; respiratory tract infection ; pneumonia ; skin infection . tell your doctor as soon as possible if your symptoms of rash start to look like tar . the frequency of some side effects is similar to those observed with hUL
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection in a sterile solution is supplied as 40 mg aad alimlumab in 0 . 8 ml clear to slightly opalescent , colourless to slightly pearly solution in syringe with a rubber stopper . hülio is available in packs containing 1 or 2 vials with 1 steril injection sYringe , 1 steile needle , 2 sterility vial adapter 
yellox contains bromfenac , which belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . yellx is used to reduce the risk of eye inflammation after cataract surgery in adults .
do not use yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yellax if : you have asthma , skin allergy or intense inflammation in your nose you are taking other nsaids . you may be prescribed other said substances . these include acetylsalicylic acid , ibuprofen , ketoprofened , diclofenocide . this medicine can be used together with topical steroids such as cortisone which can cause unwanted side effects . yellx may cause bleeding problems in patients with haemophilia in the past . other medicines may increase bleeding time . ask your doctor or pharmacist if any of these apply to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye ( s ) twice a day at the same time each day . your doctor will decide on the correct dose for you based on your eye ( (  ss ). yellox can be used for 2 days , but you can use the drops at the exact time the day before , during or after your cataract surgery . method of administration yellax is for oral use . it is for use in adults and children . wash your hands before you use the eye drops . twist off the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a finger , just before a slight increase
what yellox contains - the active substance is bromfenac . each ml of solution contains bromfed ( as sodium sesquihydrate ). each vial contains 33 mg bromfienac -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , theolysaccharide , and tyloxapol . - components of the concentrate are povidone ( k30 ), disodium edetate and sodium hydroxide . these ingredients are used to maintain acidity levels . what Yellox looks like and contents of the pack yyellow solution for injection is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil . this belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - when you have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzveo and if any of these apply to you . d Zuveo may affect your breathing ( such as asthma , wheezing , or shortness of breath ). you must tell your doctor if dzoneo affects your breathing . your doctor may need to adjust your dose or stop treatment if necessary . talk to you doctor before and during treatment : ( see also section 4 ); if your doctor has told you that you have or have had a head injury or brain tumour . ( see section 4 of this leaflet ); or if it has been noticed that some
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose is calculated by the doctor using the single - dose administration device . you should not administer this medicine more than once a day . dzuveo must not be used together with strong painkillers ( such as sufentanil ) within 30 minutes of a meal . to take the sublingual tablet , you can use the removable single  dose applicator provided in the box . attach the applicators to the tongue . once the tablets dissolve under the tongue it should be immediately injected for pain relief . it should take at least 10 minutes for the entire day and the maximum daily dose should not exceed 720 mg . when you first start using dzveo , your doctor will tell you how long you should continue your treatment with düve
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you get any of the following side effects you may need medical attention : severe breathing problems , slow and shallow breathing . if any of these side effects occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side impacts ( may effect up to 1 in10 people ), include : inability or difficulty breathing , fast or slow breathing if this happens , stop taking dzuveo and contact your doctor or nurse immediately , if it happens . other side effects include , but are not limited to : very common effects ( can affect more then 1 in every 10 people in 100 people ). nausea ( being sickness ), nausea (
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . any unused medicine must be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ). -the other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn ' s disease ( e464 ), croscarmellose sodium , indigo carmine ( k90 ), and stearic acid / magnesium steatrate . the tablets are white , round edges , debossed with " dz30 " on one side and " nvr " on the other side . what azuveou looks like and contents of the pack dZveo is a tablet . it is available in a pack containing 3 single - dose applicator ( labelled [ sublingual tablet 
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body and cannot be treated with surgical treatments . erleda is used in adult men to treat sensitive prostate cancer which has spread to areas outside the body or cannot be removed by surgical treatment . the active ingredient in erlesadda , testosterone , is found in high levels in male patients with resistant prostate cancer . how er leada works er leady blocks the action of androgens in the cancer , by blocking the action androgents . apalutamidie stops prostate cancer cells from growing .
do not take erleada : if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if : you are pregnant , think you may be pregnant . ( it is also better to avoid erlesamide in early pregnancy see contraception section if any of these apply to you as er leadá is taking this medicine . you should not take this medicine and tell your healthcare provider if at any time you have taken this medicine to prevent fits or prevent fits . warnings and precautions talk to your doctor before taking this product : your doctor will check you for any signs of seizures . your doctor may also check you : are taking any medicines to prevent blood clots ( e .g . warfarin or acenoco
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg taken once daily . your doctor may increase your dose to a maximum of 60 mg once daily ( see section " taking erleada "). taking this medicine take this tablet by mouth and with food . take er leadá at the same time each day and take it with or without food , preferably at the end of the day . taking  Erleadra with other medicines may be more suitable for you , but you should not take more er leada than your doctor tells you to . if your doctor decides to reduce your dose of erleda , you should contact your doctor . you may take a higher dose of this medicine when you take it by mouth . this will help you to remember to take
like all medicines , this medicine can cause side effects , although not everybody gets them . patients treated with erleada may experience the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also include fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects other side effects may include fit and seizure . this is uncommon ( may affect up to 1 in 100 people ) when erleda is taken alone . you should contact your doctor if you experience any of the following side effects while taking er leada : very common : affects more than 1 in 10 people - fit -
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutadite . - other ingredients in the tablet core are colloidal anhydrous silica , croscarmellose sodium , ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , and silicified microcrystalline cellulose . the film  coating contains iron oxide black ( 8000 ), iron oxide yellow ( 6000 ), macrogol , polyvinyl alcohol , water , zinc , titanium dioxide ( i . E171 ). what erada looks like and contents of the pack erleda film  - coating tablets are pinkish , oval , biconvex , approximately 8 . 7 
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine and is used to help your doctor prepare the medicine for scan . it is given to adults who have had a pet scan previously and who are undergoing treatment for prostate cancer . after other tests , your doctor will determine whether a specific antigen ( psa ) can be detected and screened for the cancer , using an aXumin pet scan , depending on the type of the cancer and the results of the scan ; your doctor may decide to give you another test . the use of azumin does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceual outweighs the risk of being exposed to radiation .
do not take axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking aXumin you have kidney problems you are on a low sodium diet you should not take more than one dose of azumin once a day . you should have the aqumin scan at least 4 hours before you go to bed . after the scan you will take your usual medicines and wait at least 60 minutes after the apollotine and drink the opportunistic drink . if in doubt , you should call your doctor straight away and ask him or her for advice . the scan will be taken in the presence of your doctor . children and adolescents aaxUMin is not recommended for use in children and teenagers under 18 years
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used by you . the quantity to be administered is 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of remuneration of ph - aplombin and conduct of the procedure auxumin is injected into a vein ( intravenously ) with a flush of sodium chloride solution . duration of the administration your nuclear
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) at the site of injection . most of the side effects disappeared after administration of the medicine . the following side effects have been reported for axumin : common ( may effect up to1 in 100 users ): pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if you get any side effects talk to your nuclear medicine doctor .this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( 1600 mg to 16000 mg ). aaxUMin 3200 mg . each tablet provides 3200 iu of froluciclovin ( 3200 to 32000 ius ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide . see section 2 " aXumin has been prepared and is used in adults only ". what ? auxumin is available as 1600 mg tablets in multidose vials containing 1 to 10 vial , each containing 1600 iii or 16000 iuka . the strength of azumin 3 200 iubi / ml solution is essentially sodium free .
azopt contains brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors , used to reduce pressure within the eye . aziopt eye drops are used to lower high pressure in the eye in adults . this pressure can lead to an illness called glaucoma . too much pressure in one eye can damage your sight .
do not take azopt : if you have severe kidney problems . if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if the doctor think you may also be allergic , to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor before taking arizopt . you should tell your doctor if : you have the same allergy but with a higher dose of too much acidity in your blood ( hyperchloraemic acidosis ) while taking , or think you might be allergic again . talk to you doctor before you take , while taking and injecting aezopt , if any of these apply to you . warnings : talk to a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes ( ocular use ). the recommended dose is 1 drop in the affected eye or eyes once a day in the evening . use if your doctor told you to use , wait at least 5 minutes between using aezopt and the other eye drops . aziopt should only be used in your eyes . instructions for use - use the instructions for opening the bottle : 1 , 2 and 3 before using the azyopt bottle . wash your hands . twist off the cap . after you remove the cap from the bottle to release the snap collar . hold the bottle and hold the container , pointing down , between your thumb and finger . tilt your head back . pull down your lower eye
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been seen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision - eye irritation - cloudy eye - cataract - clear , colourless eyes - ringing in the ears - double vision if you get any of these effects : eye irritation common side effect ( may effect up to1 in 100 people ), effects in your eye , including blurred or clouded vision , eye irritation and eye pain - corneal discharge - itchy eye ; dry eye  abnormal eye sensation ; redness of the eye some side effects are more severe and are related to bad taste . uncommon side effects (8 may affect more than 1 in 100 persons )- effects at the back of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzola . - other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , and mannitol ( e421 ), purified water , sodium chloride and tyloxapol . the active substances are hydrochloric acid and sodium hydroxide . these substances help to keep acidity levels ( ph levels ) normal . what - azyopt looks like and contents of the pack azaropt is a milky liquid ( a suspension ) supplied in a 5 mL plastic ( droptainer ) bottle with 10 mg of suspension and with a screw - off cap .
forxiga contains dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adult patients ( aged 18 years and older ). forxuga is used to treat the following types of diabetes in adults : - type 1 diabetes in which your body does not make any insulin , and - if you are not able to take the medicine as your doctor has told you . - this is called " long - term " diabetes , in which the body does NOT make any diabetes - and forxigan can help prevent this type of diabetes : in patients who are overweight ( obese ) and in patients with type 2 diabetes in whom your body doesn ' t make enough insulin . the
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxika . - contact your doctor immediately if : - you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruit or metallic taste in your mouth , an odour to your urine or sweat , rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a serious complication of diabetes due to increased levels of " ketone bodies " in your urine and blood , seen in tests , and may be life - long . these are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for use in adults with type 2 diabetes . the usual dose is one 10 mg tablet once a day . your doctor may prescribe a lower dose to a maximum of 5 mg once if your liver problem is not controlling your condition . in this case , your doctor will prescribe  a higher dose of forxika . if there is a problem with your liver , you should continue with the recommended dose of one 5 mg tablet . taking this medicine swallow the tablet whole with half a glass of water . you can take the tablets with or without food . it is important that you take forxigan every day until your doctor tells you otherwise . this will help get the best results for your health . diet and exercise can help your body use its blood sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). angioediaedia may be severe and may lead to swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis , observed in patients with type 1 diabetes ( may effect up to1 in 10 people ) and type 2 diabetes ( seen rarely ) or rare ( may impact up to one in 1 ,000 people ), diabetic ketoacodialysis may occur in patients who have increased levels of " ketone bodies " in your urine . these include a higher risk of developing ketoacaemia . your
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapagilifloniol propanediole monohydrate equivalent to 5 mg dapaglingiflouzin - - other ingredients : - tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 ' forxika contains lactoses '), crospovidone ( i )), silicon dioxide (  e551 ), magnesium stearate ( ergonovine ) ( encapsulated ) - film  - coating : polyvinyl alcohol ( containing titanium dioxide ), macrogol 3350 ( 6000 ), yellow iron oxide ( е172 ). what forixiga looks like and contents of the pack
mepact contains the active substance mefamurtide which stops the growth of certain bacteria that affect the immune system . mepacting is used to treat osteosarcoma ( bone cancer ) in adults between 2 and 30 years of age , when surgery to remove the tumour is not possible . it is also used in adults when chemotherapy destroys cancer cells and brings cancer cells back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing ciclosporin and other calcineurin inhibitors ( nsaids ), as this may increase the risk of your heart or blood vessels being damaged , which may result in blood clots (thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor before taking mepactation . some patients have experienced long - lasting or worsening symptoms after mepacting treatment . talk to you doctor before using mepacted if : you have asthma or other breathing disorders . your asthma suffers from inflammatory or autoimmune disease , and you are treated
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepactation is 2 vials of mifamurtide given twice a day . this is every 12 to 24 hours . you will usually receive your mepacting treatments at the same time each day , but different times of the day ; however , your doctor may change your chemotherapy schedule . if your chemotherapy is delayed or delayed , you will receive 36 weeks of treatment with mepacT . your doctor will monitor you during this time period . mepacted may be interrupted by an interruption in the freeze - dried powder and transformed into a liquid suspension before it is mixed with the filter . after it has been mixed with me
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mepactation , but transient use of paracetamol may be more effective to reduce fever during treatment with mepacted . stomach problems ( such as nausea , vomiting , and loss of appetite ) have been rarely reported during chemotherapy . tell your doctor immediately if you have continuing fever or chills and get medical help immediately . you should stay in hospital for at least 8 hours after you have received mepacting . talk to your doctor if : you have an infection or rash you have any problems breathing or wheezing . these are very common in people taking mepactic . if they do get worse , tell your healthcare provider . they will be monitored for signs of infection such as coughing , coughing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the viall in outer carton in order to protect from light . reconstituted suspension should be used immediately after preparation . chemical and physical in - use stability of mepact with sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection has been demonstrated for 6 hours after reconstitution . this medicine is for single use only . any unused suspension must be discarded after the completion of reconstitution and dilution . does not require any special temperature storage conditions . once removed from the refrigerator , the product must be used within the manufacturer ' s approval and the date of 
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamurmurtides . after reconstitution , one ml of suspension contains 0 . 08 mg of Mifa Murtide ( 18 mg / mmol ). -the other ingredients are 1 - palmitoyl - 2 - oleoyll -sn - gastro - 3 - polycholine ( choline ) ( 2 , 3 , 4 - dioleayl- sn- glycero - 3- phospho- l , sodium salt ( 19 mg )) ( see section 2 " mepacting with sodium "). what me Pact looks like and contents of the pack mepactation is a white homogeneous cake for concentrate
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists , which are used to treat redness on the skin of the face . it is used to reduce the amount of redness caused by rosacea , and to reduce redness of the facial area . rosacesa is caused by high levels of blood flow in the facial skin , as well as enlargement ( dilation ) of the small blood vessels of the skin . mirvasa acts by reducing the number of blood vessels and thereby reducing their size , leading to redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvass . - children and adolescents mirvas is not to be used in children less than 2 years of age because of possible side effects . the medicine should only be injected under the skin ( subcutaneous use ). - this is the same as with certain medicines used to treat depression ( parkinson ' s disease ). these include : monoamine oxidase ( mao ) inhibitors ( e . excipients such as selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin ) and mir
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is for use on the skin only . this means that it should only be applied to the face . you should only apply this medicine to the inside of your body . it should not be applied on the body surfaces other than your eyes , mouth , nose or vagina . how to use mirvass mirvasto is for injection under the skin ( subcutaneous use ). your doctor will decide which area of the treatment you should use . your doctor may ask you to use a small amount of gel ( a pea - sized amount ) once a day , until your symptoms improve . the maximum daily dose of 1gram ( 5 pea size amounts ) should be given to you , once - daily , to the faces and to your hands .
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include severe skin irritation or inflammation , skin rash , and skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are worsening of rosacea . the treatment should be stopped immediately . see also symptoms in section 2 for signs of contact allergy . allergic reaction : rash is rare in rare angioedema ( a serious allergic reaction that causes skin pain and discomfort ). uncommon side effect is skin irritability . it is uncommon in patients who develop it . if you notice any of the following side effects you should contact your doctor immediately : allergic reaction with rash and / or rare angina ( if there is a severe allergic reaction at the site of injection 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . mirvaso is for single use only . discard any vial that is damaged or shows signs of tampering .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimoniidine , corresponding to 5 mg / m2 of  Brimonidine tartrate . - other ingredients are : carbomer , 2 - methylparahydroxybenzoate , 5 - propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasa contains methyl parahydroxybenzone and propyl glycol "). what mirvao looks like and contents of the pack mirvass is a clear , opaque gel , supplied in 2 mL , 10 m , or 30 mbq of gel . unit dose vial with airless pump system .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumablich binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , where they provide the tumour with nutrients and oxygen . once bevacimab is bound to vegan, tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and the oxygen it provides the tumour . mvai is essentially a medicine used for the treatment of adult patients with advanced cancer in the large bowel , i .e
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) - you are allergy ( hyper sensitive ) ( allergic )) to chinese hamster ovary ( cho ) cell products - your doctor will check this if it is possible for you to become pregnant . warnings and precautions talk to your doctor before using mvasi . mvai may increase your risk of developing holes in the gut wall . this is a common complication of inflammation inside the abdomen , such as diverticulitis , stomach ulcers , colitis associated with chemotherapy . talk to the doctor if any of these apply to you . before receiving mbusi , tell your doctor . there is , therefore , an abnormal connection or
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of 1 mg / kg of body weight . you will be treated with mvai once every 2 or 3 weeks . if you have been treated for several weeks , you may be given infusions once a week . treatment with this medicine will continue for as long as you are benefiting from mbusi , even if there is no evidence of your tumour growing . frequency of use mviii should be used only to treat a specific type of cancer . how and when to use avasi mvici is given to you by a doctor or nurse . it is given by in
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . these side effects were mostly mild to moderate and short - term . however , they could be more serious if mvai was used together with other medicines . allergic reactions if any of the following happens , tell your doctor or nurse straight away . signs of an allergic reaction may include difficulty in breathing or chest pain , redness and flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). you should get medical help immediately if your doctor notices any of these serious side effects and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless the infusion systems have been prepared in  a sterile environment . for dlution in ' asterile milieu ', a maximum of 35 minutes is expected after thawing and then diluted . storage times after diluted solution are the
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacimizumac , corresponding to 1 . 4 to 16 . 5 mg / m2 when diluted as recommended . one vial of 4 mL contains 100 mg of Bevacizuab in 1 , 4 - 8 mpouring volumes , equivalent to 16 mg , or 400 mg of BEvaciumab at 16 , 5 . 6 mg . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what vvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . it is essentially a clear to slightly opalescent , colourless to slightly yellow liquid in
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in association with other medicines to treat refractory mantles cell lymphopenia ( when the cells are made from your own white blood cells called autologous anti - cd19 - reduced cc3+ cells ). mantLE cell lymphhoma is - an attack on a cancer that affects part of the immune system ( the body ' s own b - lymphocytes ). in mantled cell lymphodyma , b- lymph cells have an uncontrolled way to enter the lymph tissue , bone marrow or blood . tecARTus works by allowing the white blood cell in your blood to multiply and the cancer cells can then be passed on to other parts of your body . the medicine works by encouraging the immune systems to attack and destroy the cancer
do not take tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if allergic to any of these ingredients , tell your doctor before taking the medicine . warnings and precautions tecARTus may reduce the number of white blood cells in your blood ( lymphodepleting chemotherapy ) by at least 3 % . if white blood cell counts are not collected for autologous use , your doctor will perform tests and checks to make sure that you have enough tecArtus . tests and check your lungs , heart , kidney and blood pressure . talk to your doctor if any of those conditions apply to you . signs of infection or inflammation of your cancer ( graft - against - host disease ) may occur after a transplant on your body . symptoms may include rash and nausea .
tecartus is made specially for you by a doctor who has been specially trained in the use of its own white blood cells . your cells will be collected by recombinant technology . these will be stored in your blood by dna technology ( a procedure call leukapheresis ). your white blood cell count will be monitored while you are being given your medicine . if your blood is frozen , it will be returned to your vein . this will take 3 to 6 hours . when your whiteblood cells are collected it will take 2 to 3 days to collect them . medicines used during tecarus treatment ( also called lymphodepleting chemotherapy ) are given to make sure that the modified white blood can be safely injected into your body . the recommended dose is 30 to 60 minutes . you may be given other medicines to reduce infusion reactions and fever . some of these
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will monitor you for side effects and will explain the potential risks and benefits of taking tecartus . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical attention . the following side effects were reported during the tecARTus infusion in very common : may affect more than 1 in 10 people - fever , chills , reduced blood pressure , symptoms ( dizziness , lightheadedness ) - fluid in the lungs , all symptoms of a condition called cytokine release syndrome . - loss of consciousness , decreased level of consciousness which may be accompanied by confusion and memory loss .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and infusion bag . store frozen in vapour phase of liquid nitrogen less than 150 . this medicine contains genetically modified human blood cells and human - derived material . the product is for single use only . discard 36 any unused medicine after first use .
what tecartus contains - the active substance is autologous anti - cd19 - reduced ccd3+ cells , each patient - specific single infusion bag containing a dispersion of anti  - cad19 car t cells in approximately 68 ml for a target dose of 2 x 106 anti . -the other ingredients are : sodium chloride , human albumin ( see section 2 " tecARTus contains sodium "). what Tecartus looks like and contents of the pack tecArtus is a clear to opaque , colourless to yellow dispersed solution for infusion , supplied in an infusion bags individually packed in a metal cassette . each single infration bag contains approximately 67 mbq of cell dispertion .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic type a . the active ingredient in this medicine is metformin , sulphonylureas , or glitazones that you will take to lower blood sugar for your diabetes . these are all used to treat type 2 Diabetes .
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - in case of inflammation of the pancreas ( pancreatictitis ): warnings and precautions talk to your doctor before taking janugavia ( see section 4 ). in case you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid . janusvia is not recommended if your family has a disease of the Pancreases ( such as pancreattitis in children and adolescents ). it is important to tell your doctor if any of these apply to you . talk to you doctor before and during treatment with janualvia if : you have gallstones , alcohol dependence or very high levels of triglycerides
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks this is too strong or not suitable , or if someone else has kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor will tell you if this medicine is suitable for you , depending on how your body uses it to lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if , for any reason , you have to take a different dose each day , as a result of taking more jan
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). if this happens , tell your doctor and do not take the next dose until it is safe to do so . a serious allergic reaction ( frequency not known ), which may include rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , may occur while taking this medicine . you should not stop taking this product
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate , equivalent to 25 mg of sitaglictin in each film- coated sachet . - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphating , croscarmellose sodium , magnesium stearate ( е470b ), and sodium stearyl fumarate . the tablet film coating contains : poly ( vinyl alcohol ), macrogol 3350 , the talc ( ctab ), titanium dioxide ( i171 ), red iron oxide (  e172 ), yellow iron oxide . what junuvia looks like and contents of the pack pink film  opaque blisters . pack sizes of one blister each 
what xultophy is xULtophy belongs to a group of medicines called ' oral medicines ' used to treat diabetes xültophy works by replacing the insulin produced by your body which is thought to be too high to be harmful to your health . how xcultophy work xkultophy has a long and steady blood sugar - lowering action . what is type 2 diabetes mellitus ? diabetes occurs when your body does not make enough insulin or is not able to use the insulin it produces properly . this leads to lowering of blood sugar over a longer period . your doctor may prescribe insulin degludec ( along - acting basal insulin ) to help control your blood sugar levels . it can also be given with liraglutide or glp - 1 ( for patients who need insulin during meals ). xulation
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking xULtophy: if your child is taking a sulfonylurea ( e . g ., glimepiride , or glibenclamide ), consult your doctor as your sULfonyera dose may need to be adjusted . your doctor may need you to change your dietary and lifestyle advice on how to act when your blood sugar levels are controlled with xpultophy and will regularly check your blood glucose levels . talk to a doctor if any of these apply to you . warnings about some of the conditions mentioned below , before taking the medicine
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your doctor thinks you are blind or have poor eyesight or cannot read the dose counter on the pen , do not use this indicator until it is time to check your blood sugar level . the recommended dose of xultophy is 41 one pen in the morning and one in the evening . you can use xpultophy up to 8 hours after you last used xULtophy . how to use XultoPhy - xelephy is supplied in a pre - filled dial - as - dose pen . each pen contains 1 dose of insulin degludec , 0 . 036 mg liraglutide . your doctor may tell you to increase or decrease the dose over a period of time . use
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar . very common ( may affect more than 1 in 10 people ): if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood zahăr , it is important to check your blood glucose level before you take xultophy . to help prevent this , you must first check your : blood sugar niveau and act quickly if necessary . this is called hypoglacy . see the box at the end of this section for more information . possible serious allergic reaction ( anaphylactic reaction ) not known ( frequency cannot be estimated from the available data ) if a serious allergic response occurs , your doctor will check the frequency and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening the viall may be stored at room temperature ( up to 30 ) for up to 8 weeks and not beyond 21 days ( upto 21 ). store in the original package in order for it to protect it from light and moisture .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg liliraglutede , 3 times per m2 of solution , corresponding to 300 units of insulin degglude C , 10 . 8 mg / mL of ligalutide the other ingredients are glycerol , Phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy contain sodium ". what Xultopsy looks like and contents of the pack xültophy is a clear , colourless solution for injection ( injection ). each pack contains 1 ,3 or 5 via
giotrif is a medicine containing the active substance afatinib . it acts on egfr [ epidermal growth factor receptor 2 [ eggfr ]) proteins called erbb1 , her2 [ erbeb2 ] and her2[ erfb3 ]). these proteins help cancer cells grow and multiply . by blocking their action , this medicine can kill cancer cells . this medicine is used to treat cancer of the lung ( non - small cell lung cancer ). giotrictrif may be used as your first treatment if you have received prior chemotherapy treatment for patients of the squamous type or who have not received prior cancer treatment .
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - for low body weight ( less than 50 kg ) warnings and precautions talk to your doctor or pharmacist before taking giotricf : - patients with kidney problems as some may have side effects . - lung inflammation ( interstitial lung disease ). - people with liver problems as these may affect the results of some liver tests . tell your doctor if any of these apply to you . take special care with gioTRIf , you should tell your doctors if : you have a severe liver disease . you have eye problems , such as severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the front of the lens . your doctor may want to check
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet per day . you should take this medication at least one hour before or one hour after food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if your doctor tells you to take more giotrif than you should , you may be given this medicine at least 1 hour before . take the tablet at least 3 hours after food to start with . this medicine should be taken at the same time each day , so it is easier to take it at the next scheduled time . taking this medicine you can take the tablets with or without food , but you must take this tablet at the right time every day ; - swallow the tablets whole with water ; do not split , crush or split the tablet as
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may occur with giotrictric : treatment of diarrhoea has been associated with very common ( more than 1 in 10 patients ) diarhoéa in patients 2 years and older . severe diarration with fluid loss has been reported commonly ( more about 1 in 100 patients ). low blood potassium and worsening kidney function have also been reported . if you experience diarrehooeal , contact your doctor immediately . your doctor will decide if appropriate antidiarrhóeal treatment should be started prior to gioTRIf . it is important that you receive appropriate antidiarrheal treatment including antid diarryneal medicine . in addition , your doctor may recommend a lower dose of antidis
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; and hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( 6000 ). what gitrif looks like and contents of the pack giotrice 20 mg film  coated tablets are presented as white to off - white , oval tablets with " gsi " debossed on one side and " nvr " on the other side . the tablet is approximately 1 mm long , 2 mm wide and
orkambi contains two active substances : lumacaftor and ivacaftingor . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation in a protein called cbtr ( cystic fistula ) transmembrane conductance regulator ( kftr ). the mutation causes an abnormal ccft receptor protein (  - cdtr protein ) to work properly . lumamacaffetor / iva caftoral work by blocking the abnormal fttr proteins . by blocking their action , lumator & ivacabtor causes abnormal protein to work more normally . this may result in changes in your
do not take orkambi if you are allergic to lumacaftor , ivacaftore , or any of the other ingredients of this medicine ( listed in section 6 ). check with your doctor if this applies to you . warnings and precautions talk to your doctor before taking ork Ambi . orkami must be taken with food . the medicine must not be used if the medicine contains the f508del mutation . this is important because orkacco may cause liver or kidney disease . in this case , your doctor may need to adjust the dose of orkamba . if abnormal blood tests of the liver are performed before and during treatment with orkam , tell your doctor or pharmacist if any of these symptoms appear . tell your physician straight away if your doctor suspects you may have liver problems : pain or discomfort in the upper right stomach (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 6 to 12 years of age the recommended dose of orkambi tablet is one ork Ambi tablet once a day , taken 6 to 11 hours apart . your doctor may adjust your dose , depending on your condition . orkacco comes in different strengths and can be taken with orkamba 100 mg tablets in 2 different strengths . this may be taken as 2 separate doses , which are given 2 to 12 hours apart and as 2 independent doses are available . the recommended dosage of orkaambi is 200 mg tablets , once in the morning and once in 2 hours after a meal . in some cases , your doctor might increase your dose to 200 mg orkami 200 mg tablet , one 2 mg tablet in the evening , in the afternoon and once again in the late
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen in orkambi were similar to those seen in ivacaftor . ork Ambi may cause serious side effects which may be seen in patients taking orkamba : raised levels of liver enzymes in the blood . this may increase the risk of liver injury in patients with pre - existing severe liver disease . it may also be seen as the worsening of liver function in patients receiving orkacco . side effects reported uncommonly ( may affect up to 1 in 100 people ) are : if you experience any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite , tiredness , dizziness . these symptoms generally disappear over time . they usually disappear over a few days
what orkambi contains the active substances are lumacaftor and ivacafting . ork Ambi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg of lumаcaftoor and 250 mg iva caftoral .orkambi 200 mg : each tablet provides a 200 mg dose of lombacaffetor , 125 micrograms of ivacabtor in one ml . the other ingredients are : orkamba 100 mg film coated tablets : 125 milligrams / 1000 millilitres orkacco . 200 mg film coating : either : tablet core : pe / 100 milliliter ( 125 kiu / 1 , 000 kius ) or ivacastor pe . pe - 200 mg tablets - the other ingredient ( 
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). patients with mutations ( changes ) in a gene called brca ( breast cancer gene ) are at risk of developing a certain type of brca . some types of cancer are known as parp inhibitors . deaths of parp inhibitions can lead to death of cancer cells . how lylparza works lyps works by blocking an enzyme that helps to repair dna . what LYnparja is used for lynch is used to treat ovarian cancer in adults with brca and / or mutated ovary cancer . it is used
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) - take special care with this medicine - talk to your doctor , pharmacist or nurse before taking lyndparza ( see section 2 " what you need to know before you take LYnparcia "). warnings and precautions talk to you doctor if : - you have low blood cell counts . your doctor will do blood tests to check for low counts ( red or white blood cells ) and - your doctor may also check for lower platelet counts ( see also section 4 " possible side effects "). - are over 75 years old . the signs and symptoms can include fever , infection , bruising and bleeding . - more serious problems with the bone marrow called ' myelodysplastic syndrome 
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynchorza is two 100 mg capsules twice a day . your doctor may decide to increase your dose to 150 mg twice  a week . depending on how you respond to the doses of LYnparaza capsules , your doctor will decide whether to increase or decrease the dose of tablets taken by mouth . do not break or crush the capsules as they may have harmful effects . children and adolescents do not give a capsule to children less than two years of age because of the risk of side effects , and to reduce the dose to one or two capsules of the same dose . adults and adolescents the recommended starting dose is 8 mg lynce per day taken by oral use . take LYNpar
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these are symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ),: allergic reactions such as hives , difficulty breathing , swallowing , dizziness . signs and symptoms suggestive of hypersensitivity reactions . other side effects reported with lynparza very common side effects ( may impact more than one in 10 ) are : feeling tired rash , redness of the skin and fast heart rate . symptoms suggest a reduction in the amount of red cells in the blood ( anemia ) uncommon ( might affect up to one in 100 persons ) include 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once you have opened the capsule , the capsules should be used immediately . if not used immediately ( within 30 days ), and within 3 hours thereafter , any capsules must be disposed of . discard the capsule after this time period . always use the capsule at the expirid date which has passed before the expir date which was stated on labels and cartons . this medicine does not require any special storage conditions . you must use the packaging after " exp ". the date of opening of the capsule should be noted on the blister and carton . any unused product must be in accordance with local requirements .
what lynparza contains the active substance is olaparib . each capsule contains 50 mg of olarib , as lauroyl macrogol - 32 glycerides . the other ingredients are : capsule content : hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( encoding : 18f ). what LYnparja looks like and contents of the pack the hard capsule is white , opaque , hard capsule with " opadarib 50 mg " imprinted on one side . astrazeneca logo on the other side , lynch close to the capsule and the imprint is " ilh ". lypza is available in packs containing 112 ( 3 packs of 448 ) or 112 hard capsules . not all
this medicine contains the active substance naloxone . nyxoid is used to treat dependence on opioids such as heroin , methadone , fentanyl , the oxycodone , buprenorphine / morphine in adult patients . what nnyxxoidic is used for nnoxoidu is a nasal spray for the emergency treatment of opioid overdose in adults . opioid overdosing has been reported in up to 14 out of the reach of patients whose opioid over dose has resulted in breathing problems and severe sleepiness . in the case of an opioid overdetion , you should immediately contact your doctor , who will advise you on what medical care is needed .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions emergency medical care should be provided for you and your emergency services . an opioid overdose is rare . however , the signs and symptoms of an opioid overload may be greatly reduced . check with your doctor , pharmacist or nurse if any of these apply to you . you should continue using this nasal spray for at least 2 to 3 days after you last used a new nasal spray . do not take this medicine if : you are physically dependent on opioids . opioids include heroin , methadone , fentanyl , anacodone , buprenorphine / morphine . your doctor will tell you how to act if this medicine is safe
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . use in adults the recommended dose is one spray once a day . do not use more than this recommended dose . check with the doctor or nurse if your doctor advises you to use less than 1 . if symptoms occur , stop using the shoulders and ears , breastbone ( sternum ), or inside the ear . remove the fingernail carefully to clear the mouth and nose of any blockages . this is to clear your mouth and nostril of any blocked areas . keep the mouth or nose open at the same time every day , as instructed by your doctor . 1  . breathing is the chest moving . in your chest , you can hear breathing sounds as well as breath on the cheek . avoid overdose 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and seek medical advice straight away if you have any of the following acute withdrawal symptoms , which are very common with opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , particularly violent behaviour a higher or lower blood pressure , nervousness , difficulty concentrating and tremors . these can be signs of serious mental changes such as difficulty focusing on one side of your body , unusual behaviour or emotional distress . tell your doctor straight away or seek urgent medical attention if any of these affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 mg of nnaoxione ( as hydrochloride dihydrate ). - other ingredients are trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochryc acid , sodium hydroxide . - purified water . what a nanyxid looks like and contents of the pack nylon 1 : 1 ml nasal spray is a clear , colourless to pale yellow solution . it is supplied in a pre - filled nasal spray in  a single dose container . the amount of sprinkling of a dose of 0 . 1 g nasal spray that you will need to use is also printed on the carton . one pack of n
ovaleap contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fsh ." ffsha is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , it is necessary for the growth and development of the sacs ( fovaries ) in the ovaries that contain the eggs needed for the production of sperm . ovaleeaper is used : to help produce a mature egg cell that has not mature enough to be viable . to help develop a viable egg , ovale consists of a medicine called " collomifene citrate ". it is used in certain assisted reproductive technology procedures ( procedures that help you to become pregnant ) to produce spermatosis . it will
do not use ovaleap if you are allergic to follitropin alfa or fsh - flu - the other ingredient of ovaleep ( see section 6 , contents of the pack and other information ). if there is a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). large ovaries or sacs of fluids within the odes that contain the womb ( ovarian cysts ) of unknown origin . if this happens , tell your doctor . unexplained vaginal bleeding . warnings and precautions talk to your doctor before using ovalep : if your doctor thinks you may have cancer in your oaries , woomb or breasts . take special care with ovaleam : in case of any condition that normally
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if your period is irregular , you may receive this medicine for the first 7 days of your menstrual cycle . if the medicine is not used during your menopause , your doctor may lower your dose of this medicine to a minimum of 75 mg or 150 mg . your doctor will decide on the dose that is best for you , depending on how well the medicine works for you and for how long you need to keep using this medicine . for 7 to 14 days a weekly dose of 37 . 5 mg is 75 mg injected twice a day . depending on the results your doctor might increase your dose to 225 mg twice yearly . you should not inject this medicine more than once 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . these can be signs of severe allergic reactions , weakness , drop in blood pressure , difficulty breathing , and swelling of the face . 37 very rare ( may affect up to 1 in 10 , 000 people ): if you experience this type of reaction , your ovaleap injection must be stopped immediately . tell your doctor immediately , as you may experience serious side impacts in women lower stomach ache , nausea and vomiting . you should also tell your partner or caregivers that you have the symptoms of ovarian hypersensitivity .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the pen label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a single period of up to 3 months below 25 in its outer carton . if the pen is not used immediately , this medicine can be stored at room temperature for re - use after a maximum of 3 days . once removed from the refrigerator , the cartridge can be used for up to 28 days below 25 , as long as it is protected from light by swabs . when you are not using the pen cap on the ovalleap pen , write down the date you first used it in
what ovaleap contains - the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml : each cartridge contains 300  22 ius ( fl ) foollitropIN alfá in 0. 5 millilitre ( mL ) solution . o ovalep 450 iU / 1 . 75 mla : one cartridge contains 450 international units ( i . excipients ) 33 irradiated ffollitrapin alba in 0- 0, 75 milligrams solution , solution for injection . not all pack sizes may be marketed . the following strengths are available : ovaleak 900 ion / 2 . 5. m : the solution for infusion contains 
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . its use is effective in adults ( adults and children over the age of 2 ) for : invasive aspergillosis ( a type of fungal infection due to aspergollus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida sep . infections when the florus is resistant to fluconazoles ( another antifungals medicine ), seriously fungal infections caused by scedosporium spe , or fusarium ss .. vorigale
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if your condition has worsened or you are taking any other medicines , including herbal medicines . the medicines taken during voricanazole acord treatment should be avoided in the following patients : 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ). also , cisapride ( used in stomach problems ) pimozide ( taken for mental illness ) quinidine ( used if a person with irregular heart beat ) rifampicin ( used against tuberculosis ) warnings and precautions talk to your doctor before taking vorionazole Accord : tell your healthcare professional 
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will calculate your dose based on your weight and the type of infection you have . the usual dose is 40 mg per kg of body weight for the first 24 hours . after that , you will receive 400 mg every 12 hours for the initial 24 hours ( 400 mg per kilogram of bodyweight ) and thereafter 24 hours with 200 mg ( 200 mg per ml ). after the initial 72 hours , your doctor may increase your daily dose to 200 mg or 100 mg ( 400 mmol / kg ) per day . depending on how you respond to treatment , the daily dose may be increased to 300 mg ( 1 . 5 mg / m2 ) once daily . if your doctor considers that you may have mild to moderate cirrhosis , it may be given
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects have been reported with voriconazole accord : - rash , jaundice , changes in blood tests of liver function - pancreatitis . other side effects very common ( may affect more than 1 in 10 people ) - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness ), eye disorder -halo vision ; night blindness and swinging vision . common (may affect up to 1 in every 10 people)  visual impairment including blurring vision  changes in vision detection including double vision - blurred field of vision
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg vorionazole ( as besilate ). voricanazole acord 50 mg film - coated tablets : each tablet contain 200 mg voricole ( As besalate ) - each tablet of voriConazoleaccord 200 mg film- coated tablet contains lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose , titanium dioxide ( e171 ), lactosese monohydrat and triacetin . the film  content contains lactated starch and lactosed starch as well .
mvabea is a vaccine to help protect you against ebola virus disease in the future . it is given to adults and children from 1 year of age against a maximum of 1 year against : eboea virus in a 2 - dose course of vaccinations to protect you from getting eebol , because it protects against the zaire e Bolavirus , which is essentially a type of filovirus . this vaccine will not protect you with filo virus , but will protect you only against the whole ebaya virus . if you are not sure about anything , talk to your doctor or nurse before you are given mvasbea . you will receive two types of vaccination : first , zabdeno vaccine , given 8 weeks later . after the first dose of mvalbea vaccine : you
your doctor will decide if the vaccination course is suitable for you . follow all instructions given to you by your doctor , pharmacist or nurse carefully , even if they differ from the general information contained in this leaflet . read carefully and follow the instructions given in this section . if you have a severe allergic reaction to any of the active substances , tell your doctor or nurse . they will also tell you if there is a risk of a serious allergic reaction with an antibiotic called ' gentamicin ', to the vaccine . warnings and precautions talk to your doctor before you receive mvabea if : you have had a severely allergic reaction after any other vaccine injection you have ever fainted following , or even before , the injection . you have bleeding or bruise easily . your doctor has told you that you currently have , have / are going to have
mvabea is given to you by a doctor or nurse as a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . mvasbea vaccine is used as the second vaccine . your doctor will decide if the vaccine is suitable for you . primary vaccination first vaccination using zaburo red cap vial ( 0 . 5 ml ) second vaccination with the mvbea yellow cap viall ( 00 mbq ) 8 weeks after the first vaccine with zbden . booster vaccination with either zabero or zababdeno is given as an injection . it is important to follow the instructions from the doctor or pharmacist regarding return visits . follow - up doses of zabea if you forget
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with this vaccine : very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ), being sick ( vomiting ) itching where the inject is given uncommon ( may impact up to1 in every 100 people ). redness and skin hardness where the vaccination is given , including generalised itching . tell your doctor or nurse if you notice any of the side effects listed above .
what mvabea contains the active substances are : zaire ebolavirus 29 - like strain : wild type tai forest eboebol nucleoprotein marburg produced on 0 . 7 ml , corresponding to 108 micrograms of chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what v2 means mvasbea looks like and contents of the pack mvbea is a suspension in a single - dose glass vial . the vial is closed with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronates are used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to avoid other bone problems that may need surgery or radiotherapy bondronate can also be prescribed if a raised calcium level in your blood due to - a tumour . the calcium is lost from your bones . as a result , some of your bones become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - when you have , or have ever had low levels of calcium in your blood . do not use this medicine if any of these apply to you . if they are not sure , talk to your doctor or pharmacist before taking bondronate . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronant for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocrostic
how it is given this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is usually given as an infusion into your vein . your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks , as an intofusion in your vein over at least 15 minutes . in addition , a raised calcium level in your blood is usually achieved between 1 mg and 2 mg every 2 weeks . depending on the severity of your illness your doctor might adjust your dose or may give you the medicine as an an infected in your sinus . sometimes a
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( can affect upto 1 in 10 ,000 people ), pain or sore in your mouth or jaw . these may be early signs that you have severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). ear pain . discharge from the ear . this may be a sign of an ear infection . bone damage in the hippocampus ( 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . however , chemical and physical in - use stability has been demonstrated for 24 hours at refrigerated temperature . keep this medicinal product in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . one vial of 2 ml solution for infusion contains 2 mg i bandronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate in the concentrate . what bondruat looks like and contents of the pack bondronate is a clear , colourless solution . it is supplied in packs of 1 or 2 vials , closed with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ) in the body . what ezeposia used for zepositiona is used to treat adults with relapsing remitting multiple sclerosis ( rrms ), a form of active disease that affects the immune system ( the body' s defences ). white blood cell counts are important for the nerves in your brain and spinal cord and for the safety of your nerves . rmms is associated with symptoms such as numbness and difficulty in walking .
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your immune system has been severely weakened . warnings and precautions talk to your doctor before taking zeposa : if any of your close relatives has had a heart attack ( angina ), stroke , mini - stroke / transient ischemic attack ( tia ) or severe heart failure within the last 6 months if , you have had irregular or abnormal heartbeats ( arrhythmia or ta ). if during treatment you have severe infection ( hepatitis ), tuberculosis , cancer , severe liver problems if the family has a history of problems with fertility . if in any of these conditions , your doctor may want to monitor you more closely 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zeposia is based on your heart rate . your doctor will prescribe a ' treatment initiation pack ' with orange capsules containing 0 . 23 mg ozanimod . treatment is started 1 week after the first dose . after 4 weeks of treatment your doctor may increase the dose to 3 times a day ( starting dose ) of 0. 46 mg / kg of ozaimod per day for 5 days , 6 to 7 . from 8 weeks onwards , your doctor might decide to give you a new one . you will be provided with a " maintenance pack " with orange caps containing either 0/ 92 mg , oznimod or regular treatment ( starting two 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection , or blood pressure uncommon ( may effect up to 1 in 100 people ). allergic reaction if the signs are clear or if a rash occurs , tell your nurse or doctor immediately . other side effects talk to your doctor , pharmacist or nurse if they are not sure . the following other side effect is common (may affect up to1 in 10 persons ) infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( laryngeal ), viruses , and a type of white blood cell called lymphocytes common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . please return the pack to its original use only in order to protect from moisture .
what zeposia contains the active substance is ozanimod . zeposa 0 . 23 mg hard capsules each capsule contains 0 ( 2 . 3 mg oznimod ( as hydrochloride ). zepa 00 . 46 mg hardcopies each hard capsule contains approximately 0
what temybric ellipta is the active substances of temmybric collapt , fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids , often just called steroids . umeklidinium brmide , vilantrol belongs to another group of medications called bronchodilators . what TEMybrice ellippa is used for temyerc elipta are used to treat chronic obstructive pulmonary disease ( copd ), a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten .
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temmybric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrice ellippta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temmybric is not meant to relieve a sudden attack of breathlessness or wheezing . to relieve this attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and tell your doctor immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ): temybric ellipta may cause symptoms of a lung infection including fever and chills . increased mucus production , change in mucuses colour , increased cough , and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) - sore throat - rash common sideeffect ( may effect up to1 in 10 , 000 people ). - pneumonia ( infections of the respiratory tract ) common side affects more than 1 in 100 people : - cough - increased breathing problems common side impacts ( may impact up to one in
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate ; 65 microgram ( g ) umeklidinium brmide equivalent to 55 microgram(  g ] umeclinium and 22 microgram [ G ] vilantrol ] trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temmybric is for oral use ') and magnesium stearate . what timybrice ellipinta looks like and contents of the pack the ellipida inhaler consists of a
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinForo is used to treat infections of the skin or the tissues below the skin . this is when you have an infection of the lungs called : ' pneumonia ', which is more severe . how zinfordo works zinfo works by killing certain bacteria , it can help prevent serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to other cephalosporin antibiotics . - had previous severe allergic reactions to other antibiotics ( e . excipients , penicillin or carbapenem ). warnings and precautions talk to your doctor before taking zinForo . take special care with zin foro : if your doctor thinks you may be at risk of developing kidney problems . please tell your doctor if during treatment you have ever had seizures ( convulsions ). you should tell your doctors if any of these apply to you . talk to you doctor before you take  Zinforo and if : you have had any non - severe allergic reaction to other bacteria , such as penicillin
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 12 heures . this helps to reduce the risk of some infections . it may be possible for your doctor to increase your dosage to 8 mg once a day . if you are sick ( vomiting ) or have sick ( exhausted ) children less than 12 months of age , your doctor can give you an increased dose . usually , treatment will continue for 5 to 14 days . for skin infections your doctor will give you a starting dose of 5 to 7 days in a row until you get pneumonia . patients with kidney problems if your doctor thinks you may have kidney problems your doctor might reduce your dose of the zinforceo in order to protect your body from being damaged by your kidneys . you will be given zinForo every two weeks for as long as your doctor keeps giving you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ). diarrhoea , stool or blood or mucus . during or after treatment with zinforo , you may be given medicines to help slow bowel movement . this is common ( may affect up to 1 in 10 people ). you will need a blood test , called a ' coombs test ', before you start taking your first antibiotic . if this test is needed , tell your nurse or doctor as soon as possible . your doctor will advise
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine , water for injections and fruit juice . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central nuropathic pain : pregabalin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral necrolysis , such as diabetes or shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing ; sharp , cramping , anaching , and tingling . the effects may last for several months or years .
do not take pregabalin pfizer : if you are allergic to pregabALin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabaltin . some patients taking pregalin pifizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabalinanism may cause dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , take special care with pregabaliin fizer as you may experience blurring or loss of vision , or other changes in eyesight , any changes in your vision
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder take the number of capsules as instructed by your doctor and will usually be between 150 mg and 600 mg each day . you should swallow the capsules whole with water . how much to take pregabralin fizer should be taken once a day , in the morning and once in the evening . for general use , your doctor may prescribe a different dose based on your general condition ; if your dose is lower , you may take pregalin piscesces twice aday , once inthe morning
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , such as clumsiness and memory impairment . loss of memory , the ability to speak english is also increased , especially in the early stages of tremor . difficulty with speaking , feeling jittery . uncommon : might affect upto 1 in 100 people increased sex drive . abnormal dreams . tingling , vertigo , panic attack , loss of consciousness , difficulty with thinking , change in perception of self ,
what pregabalin pfizer contains the active substance is pregabALin . each hard capsule contains either 25 mg , 50 mg / 100 mg ; 150 mg  200 mg — 225 mg ? each capsule contains 300 mg of pregabralin — the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink ( containing shellac ; black iron oxide ( i . e ., propylene glycol , potassium hydroxide )) 75 mg . 100 mg and 200 mg are divided into equal doses . the calculated daily dose is 225 milligrams / ml . not all pack sizes may be marketed 
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine that your brain produces , and helps to move . this newfound ability is important for your brain to work properly . xdagot is used to treat parkinson ' s disease in adults . when this happens , sudden shakes occur and people not being able to move for a long time or have difficulties moving . the medicine is usually taken with levodopa or other medicines used to help treat park inson  s Disease .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not use the following medicines : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine ; isocarboxazid ; tranylcypromine . warnings and precautions talk to your doctor before starting treatment for parkinson ' s disease and depression - pethidine ( a strong pain killer ). you should wait at least 7 days before starting x ad ago treatment and during treatment with mao inhibitors - such as pethtine . you should also tell your doctor if your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . your doctor may prescribe a lower dose of 100 mg once daily by mouth . you should take x ad a lot every day to help you remember to take it . if your doctor has moderately reduced liver function , the recommended starting dose is 50 milligrams once  a Day . try to take a different dose each day , at the same time each day with a meal . it does not matter whether you take it with or without food . always take the tablet with water and swallow it whole with water . even if the doctor tells you to take the other medicine , if it is a long day : xda
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that can lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( mmms ). the signs may include confusion , sweating , and muscle rigidity ( hyperthermia ). they may also increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). this can also lead to confusion . hypotension ( muscle stiffness ) and hallucinations ( hypotension ). as for any combination of two active substances , it is important to note that some side effects can be serious . if you have parkinson ' s disease when used with safinamide , you may experience more severe reactions to xadago . the most frequently reported side effects are
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafatinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - table coating : poly ( e460 ), hypromellose , macrogol , titanium dioxide ( i ) and iron oxide red ( azure ). what Xad adogo looks like and contents of the pack x az - 50 mg are white , oval , biconcave film - coated tablets of 7 mm diameter with metallic gloss . - one side of tablet debossed with " 
zytiga is a medicine containing abiraterone acetate used to treat prostate cancer that has spread to other parts of the body . zytigea increases the amount of testosterone produced after a period of hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ). it is used in combination with another medicine , prednisone or prednosone , to treat high blood pressure in the body which leads to a build - up of fluid retention in your blood .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - are pregnant warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea . - have severe liver damage . you have prostate cancer that has come back after taking this medicine . your doctor may want to monitor you more closely while you are taking this drug . tell your doctor before taking this medicinal product if any of these apply to you . warnings : talk to you doctor before you take this medicine and if your doctor determines that you have liver problems . talk to them before taking your medicine if : you have high blood pressure or heart failure , or you have low blood potassium . low blood sodium can cause heart rhythm problems , other heart or blood vessel problems e
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . taking this medicine this medicine should be taken by mouth . zytiga can be taken with or without food . take zytigea at least 2 hours before or after food , and at the same time each day . you can take zetiga with or just after food and drink . swallow the tablets whole . do not chew , crush or split the tablets . how long to take ztiga for zymiga for more than one week , it is very important that you continue taking zytaga for as long as your physician tells you , even if it is less than 2 hours until your next dose . when to take take a tablet of zytiva with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you have : muscle weakness or muscle twitches , a pounding heart beat or palpitations , or a feeling that your level of potassium in your blood is low . this is linked to low levels of potassium . other side effects very common ( may affect more than 1 in 10 people ): - an excess of fluid in your legs or feet , which could be a sign of low blood potassium , as shown by liver function test , high blood pressure , urinary tract infection , diarrhoea , abdominal pain , nausea , vomiting , and abdominal pain and discomfort , also known as tummy pain . common ( might affect up to 1 in every 10 people the following side effects have been
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg a Birateron aate . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoses "). what zetiga looks like and contents of the pack - zytaga tablets are white to off - white , oval , debossed with " a " and " b " on one side and " 112 " on the other side . the tablets are packaged in a plastic bottle with a child - resistant closure . one bottle contains 120 tablets 
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatri non - infectious uveitis the active ingredient in heifiyan is recombinant . the active protein adelimumamab is , itself , not a monoclonal antibody . monoclonous antibodies are proteins that attach to a specific target in the body . aad alimlumab attaches to tnf ( tumour necrosis factor ) and is present at increased levels in the inflammatory disorders listed
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). warnings and precautions talk to your doctor , pharmacist or nurse before using heifiyo : if any of these apply to you , or if they apply to your family , friends , co - administration of heficiyya may increase the risk of getting infections , fever , wounds , feeling tired , dental problems ( see also section 4 ). in case of moderate or severe heart failure , you may be having a
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . adults the recommended dose is 40 mg once a day . your doctor may prescribe a lower dose of 20 mg once per day , or 40 mg after a one week rest period . the recommended dosage is 20 mg every other week . you should continue to inject hefiya until your doctor tells you otherwise . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every third day based on body weight as measured by body weight . children ' s doctor will prescribe : age and weight how often and how much heferiyan is given ? note children weighing 10 kg or less 40 mg each week starting two
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may be aware of the possible signs and symptoms of infection such as fever , feeling sick , wounds or dental problems . these may be signs of nerve damage in your hands or feet , which may cause difficulty in breathing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and provide a sufficient amount of room temperature storage , even when you have stored your pre . if you have forgotten to use your pre- filled siringe , it should be used within 14 days or discarded , whichever is earlier . you should record the
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e330 ), sodium hydroxide and water for injections . what HEfiуa looks like and contents of the pack hefieya 20 mg solution for injection ( injection ) in pre  0. 4ml solution for infusion is : a clear to slightly opalescent , colourless to slightly yellowish solution for injecting in a single - use clear type i glass sYring
what ritemvia is ritemevia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabub sticks to its surface , the cell dies . what ritamvia looks like and contents of the pack this medicine is presented in a box . you can get ritemes during the treatment with ritemmvia . your doctor may prescribe ritemillion to treat : a ) non - hodgkin ' s lymphoma this is disease of the lymph tissue ( part of the immune system ) that affects a specific type of whiteblood cell called b- lymphoocytes rifampicin . riteritem
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsuximb . or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor suspects you have a severe active infection or a weak immune system . if this applies to you , tell your doctor immediately . warnings and precautions severe heart failure or severe uncontrolled heart disease with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . check with your doctor or pharmacist before you take rritamvia and if any of these apply to you before you are given ritemevia . you may be at increased risk of developing a hepatitis infection . before you receive riteritemvic , your doctor will check whether you
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritemmvia administration before you are given ritamvia , you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects and monitor your treatment if necessary . non - hodgkin ' s lymphoma if you are having ritetmvia alone ritemorvia will usually be given every 4 weeks . repeated treatment courses with rite ritervia are possible . if your doctor decides you will receive riteritemvic in combination with chemotherapy ritedmvia is given
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , certain patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , unusual tiredness or cough . if you experience any of these symptoms , tell your doctor straight away . other side effects may include : very common ( may affect more than 1 in 10 people ): pain at site of infusion , such as blisters and itching common (may affect up to 1 in 12
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritsuximb , and each ml of concentrate contains 10 mg of the active substance ritzuximabi . other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials , one vial per carton .
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine  Teva contains cape citbine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine tingeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitébine theva is applied to the treatment or prevention of colon cancer after complete removal of the tumour by surgery . Capecitabin t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - in case you previously have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - when you are pregnant or breast - feeding ,- - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ),- have severe liver or kidney problems , and - do not have any activity of the enzyme dihydropyrimeidine dehydrogenase ( dpd ) ( complete dped deficiency ). warnings and precautions
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface space taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface surface area of 1 , 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times per day . a child whose bodies weight are 80 kg and tall is 1. 80 m should have
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhoéa at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : sometimes you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : may cause pain , redness , swelling or sores in your mouth and / or throat . hand - washing : this is usually mild and affects most people . your doctor will tell you how to treat these symptoms . common side effects
what capecitabine teva contains - the active substance is capecitebine . capecitationbine - teeva 150 mg film - coated tablets each film  coated tablet contains 150 mg cape citbine  - capecitébine eeva 500 mg film- coated tablet each film coat contains 500 mg capacitabine * - other ingredients : lactose , microcrystalline cellulose , hypromellose , crohn ' s disease ( e464 ), croscarmellose sodium , magnesium stearate , macrogol 400 , and hypromollose, titanium dioxide ( 8000 ), yellow iron oxide (  300 ), red iron oxide [ e172 ] and red iron dioxide ( see section 2 ). what capacitebine toeva looks like and contents of the pack capecited
what silodosin recordati is silofosine recordatis belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sildodostin recordattai is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siilodnosin recordattei is used for silundosen recordatif is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , even at night .
do not take silodosin recordati if you are allergic to silofoshin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sildodsin recordingi : if your doctor recommends it , he / she will make sure that you are properly hydrated . if there is a risk of cloudiness of the lens ( cataract surgery ), the risk of having an untreated eye 26 in patients treated with silundosine recordatin . this is because some patients treated well with this type of medicine experienced a loss of muscle tone in the iris ( the coloured circular part of the eye ). if this happens during a surgery , your doctor will take appropriate precautions . when taking medicine and surgical techniques , you should not take the tablets
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of silodosin recordati is 8 mg once a day . patients with kidney problems if your doctor has moderate kidney problems the dose of this medicine is 4 mg . if the effect of siladoosine recordatis is too strong or too weak , talk to your doctor as soon as possible . you may feel dizzy or feel weak when taking silloodostin recordattai , and later the same day if taken with a glass of water , take the next dose at the usual time . do not take a double dose to make up for a forgotten capsule . just take the following day , with food , at the same time each day : if it is
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions such as swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives have been reported as a common side effect of taking silodosin recordati . dizziness , including dizziity when standing up , and occasionally fainting . when standing or walking , you may feel weak or dizzy . the symptoms of dizzinity and fainting can occur during or after a stay in bed . if this happens to you , do not take sillodesin recordingi and talk to your doctor straight away . it is important that you tell your doctor if you are having complications from a cataract surgery ( eye surgery ), including dental lobes , which may require hospitalisation .
what silodosin recordati contains sillodosesin recordingi 8 mg hard capsules : each capsule contains sillodnosin equivalent to 8 mg sil lodosesin . the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide (  e171 ). sildodsin replayati 4 mg hardcopies , each capsule consists of siloudostani , equivalent to 4 mg of siladostenin , mannita ( е42121 ) and magnesium sterarate in the tablet core ; sodium laursulfates . - the other excipients are - gelatin, titanium oxide ( i 172 ), yellow iron
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzonzalmonio blocks the effect of angio Tensin II so that the blood vessels relax , and your blood Pressure is lowered . what kinzialmona is used for kinzzalmoni is used to treat essential hypertension ( high blood pressure at rest ) in adults . the high blood tension , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you think you may be more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) - have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - suffer from diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . do not stop taking kinezalmony if any of the above applies to you . you must not take the medicine if your doctor determines that you are not sure . warnings and precautions talk to your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably at the beginning of the day ). the tablets should be swallowed with some water or other non - alcoholic drink . it is important that you take kinzyalmona every day until your doctor tells you otherwise . if your doctor thinks that you may have taken more kinzialmony than he should , contact your doctor immediately . for treatment of high blood pressure , the usual dose of the kinzealmonator for most patients is 40 mg once a night to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of one 20 mg tablet daily .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see also section " warnings and precautions "). some side impacts could be serious : while using kinzalmono common side effects ( may effect up to1 in 10 people ), low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects (1 may affect less
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused tablets should be discarded .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmeisartran . - other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets . they have the bayer cross on one side and the number " 94 " on the other side . the tablets are packaged in blister packs of 14 , 28 , 56 or 98 tablets , but these may not all be available in your country .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . aofstуla is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ). factor ii is necessary for blood cloting . to cloat it is necessary in people who have an increased tendency to bleed . the active ingredient in a fsyla enables the blood to coagulate . factor  vii is also necessary for haemic adults to re - clobinate . your doctor has prescribed a form of factor vii for you . how aemoglobin works in patients who do not have enough factor v1 , it is
do not take afstyla - if you have ever had an allergic reaction to adstryla . - are allergic to hamster proteins 46 warnings and precautions talk to your doctor or pharmacist before taking aestlyla , particularly if : - you know that you have been allergic to mouse or hammer proteins 46 - your doctor may ask you to change your dose , the batch number and the type of treatment diary ( see section 4 ). if any of these apply to you , do not use a fssyla without your doctor ' s advice . allergic ( hypersensitivity ) reactions a dose of aaftyl may need to be delayed until symptoms of allergic reactions appear . early signs of allergic reaction may include hives , generalised skin rash , tightness of the chest
your treatment should be initiated under the supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . dose the recommended dose of fstyla is one vial per day . your doctor will determine the dose of one vially per day and will adjust the dose during treatment based on your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) provided in the vial to achieve the best results for your health . aseptic conditions , afsyla must not be mixed in the same way as with other medicines and solvents . see section 6 . the solution should be clear or slightly opalescent . if it is not used immediately , it should be filtered through the eye
like all medicines , afstyla can cause side effects , although not everybody gets them . you should see your doctor immediately if you experience symptoms of allergic reactions . allergic reactions may occur in any of the following symptoms : hives ; generalised urticaria ( itchy rash ); tightness of the chest ; difficulty in breathing ; wheezing ; low blood pressure ; dizziness ; anaphylaxis ( bleeding ). in children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is uncommon . if this happens you should contact your doctor .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . use the afstyla powder immediately or store below 25 for a single period of up to 3 days . once the vially has been stored at room temperature it must either be used within the refrigerator or disposed of . record the date from when you start to store the product in the refrigerator at 2 8 and use it within this period . never freeze , the product may not be used again . please record the end of the 3 month period when you keep the product out of refrigeration . discard the reconstituted product .
afstyla 250 micrograms solution for injection in vials the solution contains 100 microgram ( 0 . 5 ml ) of lonoctocog alfa . after reconstitution with 2 . 50 mL of water for injections the solutions contains 200 microgram( 0
what praxbind is praxxbind contains the active substance idarucizumab . i darucizumаb is a reverse agent . dabigatran ( pradaxa ) is  a blood thinner medicine used in the treatment of blood clot formation . how prawbind works pracbind can rapidly trap dabigaratran in the blood . what ppraxb is used for praXbind is used in combination with pradoxa in emergency surgery or urgent procedures to prevent uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . if your doctor has told you that you have a genetic disease called hereditary fructose intolerance to the substance sorbitol . warnings and precautions talk to your doctor before taking this medicine , as there have been reports of serious adverse reactions . take special care with praxxbind check with your doctor if any of these apply to you . this medicine is not used to treat dabigatran ( a substance present in other medicines which prevent blood clots ). dabigajitran is a protein produced by the body to help prevent blood from clottings . your doctor may ask you to take medicines to prevent blood blood coagulations , depending on your medical condition . talk to a doctor 
praxbind will be given to you in a hospital or clinic under the supervision of an experienced doctor . the recommended dose is 5 mg , given once a day . your doctor will decide the dose that is right for you . this is calculated from the weight of your body . you will receive 2 . 5 mg of dabigatran each day , for a total of 24 hours . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . do not take this medicine for longer than one month . it is important that you take this medication exactly as your doctor has told you , so that it is clear what you need to do .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get medical help immediately if you get any side effects or get any additional information . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , ( e330 ), sorbitol (  e420 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution for injection in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the initial phase of temotter is followed by radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ). - for children 3 years and older and adult patients with malignant gliomema , such as gliboblastomemum multiforma or anaplastic astrocytoma all . all three phases of mdma are treated with temmomedаc as standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - are breast - feeding . some patients taking temmedaca have had the number of blood cells severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before you begin treatment . warnings and precautions talk to your doctor , pharmacist or nurse before taking
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) while you are taking temottec , to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor has decided that you need treatment he or she may decide to interrupt treatment . initially , treatment will be followed by radiotherapy ( concomitant phase ) followed by temomemedab ( monotherapy phase ). during the concommitant phase the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells that can cause fever ) and reduced resistance to infections . the reduction in blood cell counts may also cause anaeemia ( anaesthesia ). contact your physician if your doctor notices any of these . side effects are listed below : very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package . use within 30 days after first opening . tell your pharmacist if you notice any change in the appearance of the capsules . this medicine does not require any special storage conditions . keep the capsule tightly closed in order to protect from moisture .
what temomedac contains the active substance is temozolomide . temonac 5 mg : each tablet contains 5 mg of temizolomide the other ingredient is : temokac 20 mg . each tablet provides 20 mg of the active ingredient temazolomide each time . one tablet of TEMomedаc 100 mg contains 100 mg of this active substance temozalomide one tablet in the tablet core . another tablet of the same substance is used temac 140 mg , which provides 140 mg of total fat . the other ingredients of temomed ac 180 mg / 180 mg tablets : one tablet contains 180 mg of cemozolomides one tablet is given once a day . two tablets of the même substance are used at the same time , each tablet of this medicine contains 250 mg of temelomide two tablets
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , e rect penis suitable for sexual activity . cialiis will help you to get a tough eer penis that is suitable for date and night . how cialize works cialIS contains the active substance tadalafil , which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , it allows cialist to relax the blood vessels in your penis , helping it to get more blood from your peni . the result of this is improved ecg ( a measure of egg ) and improve edile function . you should take cialic as long as your doctor tells you . for further information on the use
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking any form of organic nitrate . - do not share this medicine with other nitric oxide donors . ask your doctor or pharmacist for advice . do not use amyl nitărite . this is a substance used in medicines (" nitsrates ") to treat angina pectoris (" chest pain ") in adult patients . warnings and precautions talk to your doctor before taking cialIS if any of these medicines contains natrate , or if your doctor thinks any of them may apply to you . take special care with cialiis : - you have serious heart disease or recently had a heart attack within the last 90 days - recently had or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with some water . you can take the tablets with or without food . this is a total of 5 mg once a week . your doctor may increase your dose to 2 . 5 mg if necessary . do not take more ciali than your doctor tells you to . how long to take cialist keep taking cialisk until your doctor told you to stop . when to take the tablet , take the bottle with you , with or shortly after a meal . it will help you to get an erection , at any time point during the 24 hours of your cycle . taking ciais is  a medicine for erectile
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : allergic reactions such as rashes ( frequency uncommon ). chest pain has been reported in men taking nitrates ( frequency rare ). priapsim may also cause a prolonged and possibly painful erection after taking cialis . if you have such an er elation as early as possible ( see section 4 ) you must contact a doctor immediately . also tell your doctor if your child has sudden loss of vision ( frequency not known ). other side effects have been reported . common ( may affect up to 1 in 10 people ) headache and back pain have also been reported after taking the medicine . uncommon ( may effect up to 2 in 100 people ). headache and lower back pain has also been experienced by some people taking zolis 
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of t ad alafil ( as besilate ). - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate , magnesium stearate . film - coat : laurose homohydrate ; hypromellose , triacetin , titanium dioxide , iron oxide yellow , ferre red , and talc . what ciais looks like and contents of the pack ciali 2 , 5 mg tablets are light pink , round tablets with " t2 " marked on one side . they are marked
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid can help to control type 2 diabetics in general . treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . in addition , eninessglid may be given with metformin , another medicine for diabetes .
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking enYglid ( see " other medicines and enzyglid " below ). in case you have a severe liver disease . in particular , you should tell your doctor that you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). this is particularly important : if there is a history of liver problems . there is also a need to change the dose of repanlinide ( see also " other medicine and  Enyglide " in section 2 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , or up until about 4 hours before each major meal if your daily dose is less than 30 mg . your doctor may increase your dose to 16 mg once a day if necessary to control your blood sugar . if this dose is too high , enyglid can be taken with or without food . to help you remember to take enYglid , you may find it easier to take it at the same times every day . do not take a hypo on one side . take your tablet with : - one half a cup of water . you may eat a meal or a
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect is hypoglcaemia which may affect up to 1 in 10 people . in general , hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypoglecaem unconsciousness or coma . if this happens , please contact your doctor . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating may be signs of anaphylactic reaction . other side effects are common ( may effect up to1 in 10 ,000 people ): stomach pain is usually mild , but may occur in very rare cases . it may also occur in patients on low blood sugar . very common ( affect
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide the other ingredients are : microcrystalline cellulose ( e460 ); calcium hydrogen phosphate , anhydrous ; croscarmellose sodium ; povidone k25 ; greek yogurt ; gelatine ; magnesium stearate ; meglumine ; polyviscosal ; yellow iron oxide (  e172 ) only in the 1 mg tablets and red iron oxide( e 172 ). the 2 mg tablets are yellow , round and biconvex with bevelled edges . the 1ml tablets are pale brown - yellow . biconvingx . not all pack sizes may be marketed .
what azacitidine mylan is azaCitidine Mylan is an anti - cancer agent . what a aza Citidine miner is ? azaсitidine what zacitine mylan and its active substance are ? the active substance in aza citidine myLAN is a substance that is normally made in the body . the active ingredient in zaсitide mylan belongs to the group of substances called cytokines . What azacecitide Mylan used for aza citrine mylan may be used in adults who are unable to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelosomonocytic leukaemia ( cmml ) or acute myeloid leukemia ( aml ). these are
do not take azacitidine mylan - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking azacitacitide mylan: - had decreased counts of platelets , red or white blood cells . your doctor may need to monitor you more closely . you have kidney disease . in some patients with liver disease , you have ever had a heart condition , heart attack or have lung disease ; - your doctor will check you for any signs of blood test . blood tests before you start treatment with aza citidine myLAN , your doctor and pharmacist will check that you have enough blood cells and that your liver and kidneys are working properly . talk to you doctor
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacecitine mylan every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you feel better . if you have been given more azacriidine myLAN than you should this medicine will be administered to you as an injection under the skin ( subcutaneously ) by  a doctor or another healthcare professional . it may be given under the dermatology on your thigh , tummy or upper arm . any further questions on the use of this
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - changing . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , and reduced appetite . the signs may include confusion , restlessness , fatigue and symptoms of kidney failure . contact your doctor or hospital straight away if your kidneys are not working properly . your doctor may decide to keep you under closer observation or change your dose . side effects may include : common ( may affect up to 1 in 10 people 
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once the suspension has been prepared it should be administered within 1 hour . if the aza citidine myLAN suspension is prepared by adding water for injections , the suspension must be administered at least 8 hours after it has been made and kept refrigerated for up to 8 hours . when the zacitine mylan suspension is made using water for injecting ( unopened ) it should not be administered more than 8 hours before it is prepared and kept in the refrigerator ( 2 8 ). if this is the case , it should only be administered up to 22 hours after preparation . however ,
what azacitidine mylan contains - the active substance is azaCitidine . one vial of powder contains 100 mg aza Citidine ( as mesilate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL aza citide . -the other ingredient is mannitol ( e421 ). what a azacecitine mylan looks like and contents of the pack azaсitidine melan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionidine  . each pack contains 1 vial or 7 vials .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprosth is a prostaglandin analogue that is produced by the eye . the other ingredient , inotersen , is titmololl which is  a beta blocker . it reduces the amount of fluid within the eye and increases pressure within the edge . duototrav drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotartar . if this applies to you , tell your doctor immediately . you may be at increased risk of respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease . in particular , you may experience wheeziness , difficulty in breathing , short - standing cough , as these may be signs of breathing problems . tell your physician immediately if your doctor notices you have severe hay fever . have a slow heartbeat , heart failure or a disorder of heart rhythm
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use one drop in the eye or eyes , once a day in the evening . use duotrav only for your eyes . if your doctor tells you to use more duotar than you should , wash your eyes with water . do not put more than the recommended amount of duotorav in your eyes after you have used duotra . you can use duotrotrav with or without food . to help you remember to use it , you can put it in the morning before going to bed . how to use duoftrav - use eye drops at the same time each day . 1 2 3 4 get a bottle and then use it at the usual time . it is best to use the bottle at the following time :
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor or pharmacist before taking duotrav . very common side effects ( may affect more than 1 in 10 people ) effects in the eye eye redness . common side effect ( may effect up to 1 in every 10 people in the population ) affects the eyeeye eye surface inflammation with or without surface damage . uncommon side effects may affect up to1 in every 1 , 000 people : effects in and outside the eye pain , blurred vision , abnormal vision . dry eye , itchy eye ; eye discomfort . signs and symptoms of eye irritation ( such as burning or stinging ). uncommon side effect : affects less than 1 per 10 people not known ( frequency cannot be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening to prevent infections . write the date of opening on the bottle and carton label in the space provided .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg of travaprosth and 5 mg of it ( as titmololl ). the other ingredients are tilmolole maleate , polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . what duoftrav looks like and contents of the pack duotrav is a white , off - white - yellow solution . the 40 mg tablets also contain boric acid , sodium chloride , water for injections , and sodium hydroxide / hydrochloric acid . it is supplied in a purified water vial containing sodium hydrooxide and hydrochoral acid ; these are used to keep acidity levels
nplate ' s active ingredient , romiplostim , is a protein used to treat low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is inherited itp ( a disease in which your body 's immune system produces too few platelets ). platelets are cells of your blood that help to form blood clots . very low platelets counts can cause bruising and serious bleeding . it can affect the way your spleen is removed . n plate can be used to help prevent itp in patients who have previously had corticosteroids or immunoglobulins , and who have not previously been treated with npla .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy to other medicines that contain escherichia coli ( e . coli ). warnings and precautions before you start using n plate , tell your doctor if : - your doctor has told you that you have a low blood platelet count ( thrombocytopenia ). you may need to take n Plate to check your platelet counts regularly . blood clots if your blood coagulation is low , or blood clumps can be difficult to clotting . talk to your doctor before taking n plates if any of these apply to you . you may be at increased risk of blood  clotes , especially if it is not controlled with
your doctor will give you nplate as an injection under the skin ( subcutaneous ). adults , children and adolescents ( from 1 month to 17 years ) - the recommended dose is one vial of n plate . n Plate must be injected once every month , preferably at the same time each day . your doctor or nurse will decide on the correct dose . for adults : npla is given as an injectable dose , usually under the surface of the skin . children : the recommended starting dose is 1 vial ( 0 . 5 ml ) of nage . before you receive nplatte , your doctor may check your platelet counts regularly . you will need to take regular blood samples to check yourplatelets . this is to check that your platelets are working properly and to adjust the dose if your plate platelet count is too low . the table
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate : very common ( may affect more than 1 in 10 people ): headache , allergic reaction upper respiratory tract infection common ( might affect up to 1 in every 10 people): bone marrow disorder ( increased bone mmarrow fibres ) trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia , migraine ), redness ofthe skin , flushing , headache . uncommon ( may effect up to one in every 100 people ). allergic reaction , upper respiratory trace infection . rare ( may impact up to1 in every 1 , 000 people ), bone mercantiase ( infection of the lungs ), septic shock , nausea , vomiting , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection each vial contains 230 mg romoploslim . each vially contains 125 ml romimiplostime . one vial of 125 micrograms contains romaplost . the deliverable amount of 0 . 25 mL solution contains a deliverable quantity of 124 mg / m3 of romigastim per 500 m n plates containing 250 microgram ( corresponding to a volume of 375 mg ) romicoplostig . every 250 mml vial is a vial containing romromiptim , and each via a deliveryable amount ( 0. 5 mmol solution ) contains 250 mg riplostattim ;
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what to vanor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanour breezehaler ( see section " tovanoral breezihaler contains sodium "). - patients with kidney problems . - patient with an eye problem called narrow - angle glaucoma . tell your doctor if your patient has difficulty passing urine . during treatment with tovanlor brezhaler stop using this medicine and tell your physician immediately if the patient develops tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor  Breezhalers ( bronchospasm ). if any of these applies to you , tell your healthcare provider . difficulties in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to inhale the usual dose is to inhahale your capsules every day at the same time of day . you only need to inhales the content once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly you can use this medicinal product for up to 24 hours at the usual time . if your doctor has told your doctor that you are 75 years of age or older , you should use this product every day , as long as your physician tells your doctor and do not stop . when to use this medical advice , please read the " instructions for use " at the end of this leaflet when you first use this Medicine 
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum bromide ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) of glyco Pyronium ( 11 microgram inhalation powder ). - other ingredients of the powder are lactose monohydrate and magnesium stearate . what to vanor brewing product looks like and contents of the pack tovano breezehaler 44 microlitres inhalations powder , hard capsules consist of a white powder . they are packaged in a device called an inhalers together with capsules in blisters . the following pack sizes are available : 6 and 10 hard capsule sizes
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . adesuve increases the levels of a substance in your brain called dopamine . this increases the level of serotonin , a chemical in the brain involved in calming effects and relieving aggressive behaviour . it is used to treat acute symptoms of mild - to - moderate agitation , in adults with schizophrenia or bipolar disorder , diseases characterised by symptoms such as schizophrenia  hearing things that are not true , mistaken beliefs , becoming withdrawn , an incoherent speech and behaviour and emotional flatness . people with addasuVE may feel depressed , guilty , anxious , or tense . the treatment of bipolar disorders is for adults , adolescents and children .
do not take adasuve if you are allergic to loxapine , amoxapin , or any of the other ingredients of adsuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking aadosuve and if any of these apply to you : if your doctor experiences symptoms such as wheezing and shortness of breath . if this happens , tell your doctor immediately . this could be a sign of lung problems like asthma or chronic obstructive pulmonary disease ( copd ), which is associated with narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shorten of breath 25 if the patient experiences neuroleptic malignant syndrome ( nms ) if symptoms start earlier than usual 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily , up to 4 . 5 mg once per day depending on your condition . how to use adasuve is for injection in the hand - held device ( see " instructions for use " in section 2 ). if the device works well , it may cause the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements that are unusual . if your doctor thinks that the effect of adave is too strong or too weak , talk to your doctor immediately . contact your doctor right away 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse immediately if you notice any of the following side effects you may need medical attention : - any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or irritating your airways ( asthma , copd ) - light - headedness , fainting - increases in your blood pressure - worsening agitation , confusion , fever and muscle stiffness . this may be a sign of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10 people ):  headache  cough  shortness or tightness ( which may be more common in asthma and copd patients ) feeling sick ( nausea )*  fainting
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the pouch and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pouch in the outer carton in order to protect from light . accidental ingestion or opening of a pustule may cause physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxaine and delivers 4 . 5 mg lox apinе . what  adsuve looks like and contents of the pack adesuve 4 : 5 mg inhalation in a single  use disposable white plastic inhalers contains loxamine . - each inhalator is packaged in : a sealed foil pouch . the pack of aadosuve 4.5 . 4 mg inhaled inhalations is available in packs containing 1 or 5 inhalateurs . not all pack sizes may be marketed .
what azacitidine betapharm is azaCitidine betatapharm an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azaсitidine baetapharm contains the active substance ' aza citidine ', which is produced by biotechnology . it belongs to the group of more active substances called cytokines . what a azacecitide betaphar is used for aza citine betapham is used in adults who are unable to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelosomonocytic leukaemia ( cmml ). acute myeloid leukemia ( aml ) these are diseases which affect the bone marrow and can
do not take azacitidine betapharm - if you are allergic to azaсitidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . - are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking azacitacitine betaphar : - you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor may need to adjust your dose . tell your doctor about any of these . have or have had liver disease , or you have ever had a heart condition , heart attack or have lung disease  . blood test you will have blood tests before you start treatment with azaciacitide betaphazard and during treatment , called a ' cycle ', to make sure that you have enough blood
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacecitine betaphar every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , until you no longer feel better . it is recommended that you take this medicine under the skin ( subcutaneously ) by examining your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - changing . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , and reduced appetite . the signs may include confusion , restlessness , fatigue and symptoms of low blood sugar . contact your doctor or hospital straight away if your doctor notices any of these signs or symptoms , or seek medical advice . side effects may include : common ( may affect up to 1 in 10 people ):  feeling sick
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . any unused azaсitidine betatapharm will be stored in the original carton in order to protect from light . this medicine is for single use only . once the suspension has been prepared it should be administered within 45 minutes . when using later on if the azaciacitiza betaphar suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 1 to 8 ) immediately after it is prepared and kept refrigered for up to a maximum of 8 hours . if not used immediately ,
what azacitidine betapharm contains - the active substance is azaсitidine . one vial contains 100 mg azaCitidine ( as mesilate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL aza Citidine as memoglobin . -the other ingredient is mannitol ( e421 ). what a azacecitine betaphar looks like and contents of the pack azacita betaph is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of aza citidine , which is very strong and is very potent .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher syndrome type 1 is an inherited condition in which the body cannot break down certain substances ( called glucosylceramide ), such as the spleen , liver and bones . eglustat works by blocking the effects of glukylcerami on your affected organs . this means that you will not be able to take this medicine for as long as your doctor prescribes it for you . you will need to take it for as many times over a long period of time . it is important that you continue to take cerdlgа for as longtemps as your body is at slow speed and with poor metabolisms , even when you are taking cerdeslg . your doctor will perform a simple laboratory test to make
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ). you should take a minimum of 31 moderate yp3a inhibitors , e. ., erythromycin or itraconazole . taking these medicines will reduce your body ' s ability to perform tasks . do not increase the dose of cerdeslg if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before taking cer delgа : - medicines that have a poor metaboliser such as medicines that contain strong ccype3a inhibit
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . - the recommended dose is one tablet twice a day . the dose is the same as for metaboliser . you must take the tablet at about the same time each day , preferably at the same times each day ( morning and evening ). - swallow the tablet whole with a glass of water . do not crush or chew the tablet . how to take cerdelga you can take the tablets with or without food . take the blister / wallet and the sleeve in the morning with your thumb and finger . pull the blister/ wallet out of the pocket just before you take your tablet , and then take your next dose at the usual time . this will help you get to your next meal . to open the skeleton you can use cerdes
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia and vomiting ), feeling sick ( nausea ), diarrhoea constipation abdominal pain , stomach ache ( upper abdominal pain at the site of infusion ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( stomach ) not known ( frequency cannot be estimated from the available data ) low blood sugar ( hypoglycaemia ) common ( will affect up to 1 in10 people ). reporting of side effects 23 if you get any side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from light and moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of eglustat ( as besilate ). - other ingredients are : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delg  contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( a dark yellow ) and indigotine ( oblong - shaped ) printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgea looks like and contents of the pack cerdeslgaga capsules are a pearl blue 
the active substance in zoledronic acid hospira is zolеdronic acids , which belongs to a group of substances called bisphosphonates . zoleledronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . for e. fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult patient where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolledronic Acid hospria : - if you are allergic ( hypersensitive ) to zolеdronic acids or another bisphosphonate ( the group of substances to which zolzoledraic acid belongs ). - tell your doctor before you are given zedrontic acid houpira . warnings and precautions talk to your doctor or pharmacist before you receive zolaic acid hospiran if : you have or have had a kidney problem . tell your dentist if your doctor thinks you have pain , swelling or numbness of the jaw , a feeling of heaviness in the
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . ( iv ) administration should be started under the supervision of a healthcare professional . your doctor will decide how much zolledronic Acid hospria you receive , and how often . this leaflet is intended for you to help prevent dehydration . how much is given - the usual recommended dose is 4 mg . but if you have a kidney problem , your doctor may decide to give you a lower dose depending on the severity of your kidney problem and how serious it is . the dose of zolеdronic acids hospra that you will be given will be calculated by your doctor according to the severity and location of the bone complications due to bone metastases
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ).- pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , or numbness or a feeling of heaviness in the jaw . - loosening of a tooth . these could be signs of bone damage in the cheek ( osteonecrosis ). tell
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). after first opening , zolledronic acids hospria is a clear and colourless solution .
what zoledronic acid hospira contains the active substance of zoleric acid is zolechloric acid ( 24 mg ). one vial contains 4 mg zolеdronic acids ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedrontic acid houpira looks like and contents of the pack zolledronic Acid hospria is supplied as a liquid concentrate for solution for infusion ' and a ' sterile concentrate ' in a vial containing 4 mg of zledrontic acids . each pack contains one vially of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain . this can cause vomiting , which can make you feel sick or be sick . rolapatant can help to kill these nerve cells and reduce nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking varubies . if your doctor prescribes an herbal medicine containing st john ' s wort ( hypericum performatum ) for depression and difficulty sleeping . ( see section 2 ' what varubY contains '). warnings and precautions talk to your doctor or pharmacist before taking this medicine : 27 if there is a possibility that you may be at increased risk of severe liver or kidney problems . you should be taking certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ). it is recommended that varubamazepine ( used for epilepsy and nerve pain ). the prescribing
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one tablet of 180 mg taken once daily . your doctor may reduce your dose to 90 mg once daily or start you on a different dose . swallow the tablet whole with water , with or without food . you can take varuby with or immediately after your chemotherapy cycle . do not take va ruby more than once a day . chemotherapy can cause sickness and can make sickness worse . taking this medicine together with chemotherapy is not a substitute for another chemotherapy cycle because feeling sick or being sick can affect your ability to take chemotherapy . if your doctor thinks you may have taken more varubies than he / she should , tell your doctor straight away . take this tablet with food , preferably a light meal . it is important
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been observed : side effects reported rarely ( may affect up to 1 in 1 , 000 people ): if you experience symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and / or faster heartbeats , tell your doctor immediately . your doctor will treat you promptly for appropriate treatment . other side effects include : common ( may effect up to1 in 10 people ]: headache , constipation and feeling tired . common ( can affect upto 1 in 10 children ) headache . constipations and feeling exhausted . uncommon ( may impact up to 2 in 100 people ), diarrhoea , nausea , vomiting 
what varuby contains - the active substance is rolapitant . each tablet contains 90 milligrams of rolaapitant ( as mesilate ). - other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coat : polyvinyl alcohol , titanium dioxide ; macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varubry is a colourless to pale blue , round shaped , 100 micrograms , packed in a polyvinyere / polychlorotrifluor
what enerzair breezhaler is energetics contains two active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrratium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the bronchitis . when they are taken regularly , they help the small intestines to remain open . momethason furoates belongs to  a family of medicines known as corticosteroids ( or steroids ). corticotrotics reduce the swelling and irritation ( inflammation ) in the smallairways in your lungs and so gradually ease breathing problems .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enezair and tell your pharmacist . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enenerzerzair brazoshamed tablets : - you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . talk to you doctor about any medical conditions you have ever had diabetes or high blood sugar . tell your family and friends about seizures . not known : severe kidney problems 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much enerzair breezhaler to inhale the usual dose is to inhale the content of one capsule each day . you only need to use the medicine once a day , so you only get the best results and reduce your symptoms . when to inhhale enErzair brezhalers online you can use the following to help you breathe more easily throughout the day and night . this will help you to remember to use enezair broezhale when you need to inhume the medicine . the inhaler and capsules contain the medicine in a single inhalation . only use the capsules with the inhaled version of the inhaler provided in this pack . if the capsule is inhayed 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include the following listed below . if these side effects become severe , please tell your doctor or pharmacist . very common , may affect more than 1 in 10 people common - sore throat - runny nose - sudden difficulty breathing and feeling of throat and feeling very tired - headache - joint pain - muscle pain , joint pain uncommon - may affect less than 1in every 10 children -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from moisture and light . once the blister has been opened , the capsules should be used immediately .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( As accetate ) 63 microgram ( corresponding to 63  microgram ) glycopyronicum bromidе , equivalent to 50 microgram of glycopyronnaum and 160 microgram( corresponding )) of mometesone furobiate , respectively . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 114 microgram indаcaterol( as apothecary ), 58 microgram [ corresponding in glycopyroniaum bromoism ]), 46 microgram[ correspondingly
clopidogrel acino pharma gmbh contains the active ingredient cloclopidotter which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called Thrombosis ). clolombogrell acini pharma grbh is taken to prevent blood  clots ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosia , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clop
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to cloclopidottel or any of the other ingredients of clodogrell aco pharma or any other gmar pharma products if your doctor has a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain if the patient has severe liver disease . if any of these apply to you , or if they are not sure , contact your doctor before taking clopogreL acan pharma mgmbhhh . take special care with clopinogre acina pharma the following are reasons why cloponitol pharma grbh may not be suitable for you : if there is a risk of bleeding such a  medical condition which puts you at risk of
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of cloclopidonogrell aco pharma mg g mbH per day to be taken orally with or without food , and at the same time each day . if your doctor decides that you should take a larger dose of  Clopidogresl аcino  Pharma g mgbh , contact your doctor at the nearest hospital emergency department because of the increased risk of bleeding . take your tablet straightaway and then take your next tablet at the usual time . do not take if any of the above apply to you , or if someone else or a child takes your tablet , you should contact your pharmacist for advice .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to10 users in 1 , 000 ) rare (affecting only 1 to 15 users in 10 and more than 10 users per 10 ,000 ) very rare ( affect less than1 user in10 , 500 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaund
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . please return unused cloclopidagrel alacino pharmacy gmpbh to your pharmacist . product should not be used if you notice any visible sign of damage of blister or film - coated tablets . medicines should not disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is cloclopidorl . each tablet contains 75 mg of clopionogrell ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( 6000e462 ) titanium dioxide (  e 171 ) what clapidogral аcino  Pharma gbh looks like and contents of the pack cloponogreel apothecae g mgbh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard carton
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. they include doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , another nucleolar analogue reverse transcriptastase inhibitor ( ngrtis ), tenofovir disoproxil , also known as a nucleotroside analog reverse transcriptavese inhibitor [ nrto ]) what deltrigo used for delrtrgo is intended for use in adults 18 years of age and older . hiv is the virus that causes aids (' acquired immune deficiencies syndrome '). the virus causes aid to develop
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not use delStrigo after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . warnings and precautions talk to your doctor or pharmacist before taking delsestrigo do not exceed the expirience date if any of these apply to you and are not sure . check with your doctor , pharmacist or nurse before taking this medicine if : you are taking any of following medicines : carbamazepine ; oxcarbazepine or phenobarbital
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe a complete regimen for you , which will include a single tablet for hiv infection and at least 1 year . if your doctor prescribes certain medicines , such as doravirine , it is not recommended to take medicines that are taken with or without food . taking this medicine swallow the tablet whole with water . do not crush or chew the tablet . take this medication with food it is best to take delstrigo at the same time each day . you should take delustrigo every day for as long as your doctors tell you ; do not stop taking dellstricgo without your doctor ' s advice . how long to take take dellstrigot for 12 weeks , then continue your treatment at the usual time . it
like all medicines , this medicine can cause side effects , although not everybody gets them . this medicine may cause side effect , which are very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough and nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ), feeling tired ( fatigue ), cough , nasal symptoms ( nasal symptoms may include feeling tired ), nausea , and diarration , including stomach pain and vomiting ), wind ( flu ) and hair loss hair loss not known ( frequency cannot be estimated from the available data ) rash muscular symptoms ( such as pain or rigidity ), not known : frequency cannot been estimated from available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the medicine in the bottle in order to protect from moisture . delstrigo does not contain any animal products . any unused medicine should be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine 300 mg lamivudine 245 mg tenofovir disoproxil ( as fumarate ) croscarmellose sodium e468 ; hypromellose acetate succinate ; magnesium stearate in the core ; microcrystalline cellulose e460 ; silica , colloidal anhydrous ; sodium stearyl fumarat in the coating material : carnauba wax e903 ; ink containing hypromollose ( e 464 ); iron oxide yellow ( i . e ., lactose monohydrate ; titanium dioxide e171 ; triacetin ). film - coat : 776 pfizer - resistant film . car
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it is used to help alleviate the symptoms of depression that often include feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have previously taken another antidepressant , you should speak to your doctor . read section 2 of this leaflet about some of your favourite activities and their uses .
do not take spravato if you are allergic to esketamine ( also called ketamine ) used for anaesthesia or any of the other ingredients of this medicine ( listed in section 6 ). if there is a gap in an aneurysm ( a weak spot in a blood vessel wall ) that bulges out , or bleeding in the brain . if it has recently had a heart attack within 6 weeks . this may cause a temporary increase in blood pressure . however , there are no serious complications in these conditions . warnings and precautions talk to your doctor before taking s Pravato and before taking this medicine : if your doctor thinks you may have a serious heart problem , such as poor blood flow to the blood vessels .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . use the spravato nasal spray for instructions on how to use the nasal spray device . the recommended dose is 1 spray ( 2 ml ), 2 sprays ( 3 nasal spray devices ), and one nasal spray ( 4 mcg / m2 ) once a day . do not use more than 4 sprays of s Pravato per day , or 2 spray ( 3 mbq / min ). use this product at the same time each day ; this will help to prevent nausea and vomiting . if treatment is interrupted , you should contact your doctor . it is recommended that you use 30 minutes after using this medicine . nasal sprays should be avoided , and you should avoid exposure to steroid and decongestant medicines 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from your everyday life and feeling and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity , mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people the following effects ) being extremely happy ( euphoria ) not feeling agitated feeling jittery . not known ( frequency cannot be estimated from the available data ): trembling , feeling confused , difficulty concentrating , changes in sense or sex drive feeling disorientated , lack of motivation , being less able to sleep , increased sensitivity to light , irritated 
what spravato contains - the active substance is esketamine . each nasal spray device contains eeskeamine hydrochloride equivalent to 28 mg esesketamine in one spray . - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s proxy looks like and contents of the pack s Pravato is a nasal spray solution . this medicine is essentially white to off - white and colourless solution for injection in a single - use nasal spray handset . the colour may vary from colourless to pale yellow . one sprinkling of sprivato may contain either 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . this is a type of cancer where the gene that causes a change ( mutation ) in a gene called ' melamine ' is changed . zelmoraf targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zelmoraf and if any of those following apply to you : - have symptoms of allergic reactions such as swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation when taking zboraF . - experience allergic reactions allergic reactions are possible . you should stop taking zeborafic and tell your doctor straight away if : you have any symptoms of an allergic reaction such as : swelling ofthe face  , lips or tongue with difficulty breathing ( rash ) or faintness sensation and severe , rapid breathing . children and adolescents the safety and efficacy of zelbo
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose is 4 capsules twice a day ( a total of 8 capsules a night ). your doctor may increase your dose to 4 capsule twice  a week if your dose is well controlled , or if side effects occur , your doctor will adjust your dose and interrupt your treatment . if necessary , you can take zelboraf on an empty stomach . swallow the capsules whole with water . do not crush or chew the capsule . take zborafic with food that contains protein . it is important that you take zeborafat every day , as instructed by your doctor to avoid overdose . taking zelbaf if a child swallows some tablets , contact your doctor
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions : signs include swelling of the face , lips or tongue or difficulty breathing rash fainting may occur when zeloraf is administered to you or your child , and may progress to radiation treatment . tell your doctor immediately if you or the child experience any of the following side effects which may be signs of radiation . zelbaf treatment can emit radioactivity , which is very common with zelmoraf . these include : - the most common radiation affecting the skin , isophagus , bladder , liver , rectal , or lungs . notify your doctor or nurse immediately : any of these symptoms : skin rash ( including blistering , peeling and discoloration ) of the skin shortness of breath or cough with or
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any suspension left in a bottle more than four weeks after it was first opened , you should not use it again . ask your pharmacist how to throw away the bottle . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafengib ( as a co - precipititate of VEmuraFenibe ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose , magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , the talc and titanium dioxide (  e171 ). what zeboraF looks like and contents of the pack zeloraf 240 milligrams film  coated tablets are pinkish white to orange white , round shaped ,
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it helps to relax and protect the blood vessels . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duo plavin is taken to prevent blood  clots from forming in hardened arteries , a process known as atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed duoplacevin because you have read the package leaflets of all your medicines .
do not use duoplavin if you are allergic to clopidogrel or acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic , or if he / she is allergic to other products , including non - steroidal anti - in inflammatory products if they are used to treat painful and / or inflammatory conditions of muscles or joints if there is a medical condition such as asthma , nasal discharge , runny nose , polyps ( type of growth ) in or around the nose if any of these apply to you , tell your doctor before you are given duolavin . warnings and precautions talk to your doctor , pharmacist or nurse before using duoplacevin : if the patient has 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take duoplavin around the same time every day , taking your medicine at the same times every day ( for example , one tablet in the morning and one tablet at night ). you can take duotropine with or without food . swallow the tablet whole . you may take duplavin with or just after food , and at the usual times . if there is a risk of a heart attack , you should take duclopine during the day and night , but you should not take more than the prescribed dose . contact your doctor , pharmacist , or the nearest hospital emergency department because of the increased risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . do not
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , abdominal pain , diar
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must be used immediately after first opening . tell your pharmacist if you notice any visible sign of deterioration . does not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duopalavin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopidogrell ( as hydrogen sulphate ) and 75 mg acetoylSalicyLIC acid . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch ; hydrogenated castor oil . see section 2 ' duo plavin contains hydrogenated castingor oil'.
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolame belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medicine called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrINza is used to improve the control of pressure in the eyes in adults ( older than 18 years old ) with eye conditions such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes , infections or diuretics ( water tablets ) or to a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ) and certain antidepressants . tell your doctor if any of these apply to you . warnings and precautions talk to your doctor before taking simbrinerza : if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ) for less than 2 weeks . children and adolescents this medicine should not be used in children
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use it in the morning . do not use simbrinza in the afternoon . wash your hands before you go to bed . how to use wash your feet before you start . step 1 : turn the bottle upside down . twist off the cap . if the tamper evident snap collar is loose , remove before using the medicine . hold the bottle , pointing down , between your fingers . pull the bottle open . tilt your thumb or fingers back . turn the cap of the bottle one last time you are using the product . continue to tilt your head back , pull down your eyelid , with a clean finger 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - a reaction to the medicine ( frequency not known ) may be serious - an allergic reaction may be life - changing . - severe skin reactions ( rash , redness , or itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . tell your doctors immediately - extreme tired and dizzily reporting of side effects after taking simbrinza , you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine and other medicines you are taking .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening : once opened , simbrinza is stable for up to 4 weeks . to prevent infections , use a new bottle . keep the bottle tightly closed in order to protect from moisture .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolamine and 2 mg of brimoniidine tartratrate equivalent to 1 . 3 mg briMONidine . -the other ingredient is benzalkonium chloride ( see section 2 " simbr inza contains benzonzoate and benzalikonium chlorine "). - components of the tablet core : propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients are sodium chloride , tolbutamide , and tyloxapol , hydrochloric acid and sodium hydroxide .
what filgrastim ratiopharm is filgrasentharm contains the active substance filgrastistim . filgraştim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrastime stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . what filGrastim rapportpharm looks like and contents of the pack filgrastorm ratiopham is mainly made up of white blood cells which are very important in helping your body make more white blood cell . you
do not use filgrastim ratiopharm if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgrasent . warnings and precautions talk to your doctor , pharmacist or nurse before using filgratim ratioppharm : if any of these apply to you , tell your doctor before you are given filgraştim ratiompharm . if your partner or caregiver experiences a cough , fever and difficulty breathing , this may be a sign of a pulmonary disorder , which may be associated with side effects . in sickle cell disease 57 if , for example , you get left upper abdominal pain or pain at the tip of your shoulder , as this may relate to a so - called spleen disorder . these side effects are not known . you will need regular blood tests to make sure that filgraștim
what filgrastim ratiopharm is filgrasentry . you should take filgraştim ratioposarm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much filgratim ratioperm to take your doctor will tell you how many days of filgrastorstim ratiopharm to take . duration of filgranstim ratepharm treatment the usual starting dose of filGrastim rapportpharm to use in combination with chemotherapy is 0 . 5 million iu per kg of body weight , given once a week for 60 days . your doctor may decide to give you a lower starting dose up to 30 million , depending on how you respond to your treatment . this may take up to 14 days , but in some disease types , longer treatment lasting up to about one month . filgraStim ratioppharm to be used
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if yew - tree needles get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). it is important that you have regular blood tests before and during treatment with filgraStim ratioppharm to check the number of neutrophils and other types of white blood cells in your blood . this will tell your doctor how well the treatment is working and will also indicate if treatment needs to be continued . other medicines and filgraştim ratiompharm tell your family , friends or carer notices that you are using , have recently used or might use any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgratim ratioppharm should be used immediately , as it is not known how it will be stored . if the solution is cloudy , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgratim - filgrasent - ratioph 30 miu 30 miU / 0 . 5 mL : each vial contains 30 million international unit [ miU [ miUI ]) of filmgrast in 0 5 . 4 m mbq . filgrastat ratiopham 48 miu in a vial : one mmol ( 48 million international [ miù ]), one kilojoux 0 mg / kg : the other ingredients are : sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 , water for injections .
what riluzole zentiva is rilsuzola contains the active substance riocigus . rilluzolе zentivea acts on the nervous system . what reiluzuzole Zentiva used for r Iluzolé zentapa is used in patients with amyotrophic lateral sclerosis ( als ). als is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to muscles are not working properly . this can lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . when rileuzol zentaba uses this glutamat , it stimulates the nerve cell to work more effectively . als is
do not take riluzole zentiva - if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ); -if you have any liver disease ; - increased blood levels of some enzymes of the liver ( transaminases ); ( it is also better to avoid riodopa if your partner is pregnant ). warnings and precautions talk to your doctor before taking rilluzolе zentivea : - any liver problems , such as yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - problems with your kidneys , or fever ; or - you have a low number of white blood cells which can cause infection ; children and adolescents rifampicin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . take the tablets by mouth , every 12 hours , at the same time of the day each day , for example one in the morning and one in a late morning . if your doctor advises you to take more riluzole zentiva than you should if a child swallows some tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . for further information , see section " rifuzola zentivea contains sodium ". - if someone else accidentally takes your tablets / tablets : - do not take a double dose to make up for a forgotten tablet . you should take this tablet every day unless your doctor tells you otherwise . do
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor may want to take a blood sample to check the number white blood cell counts and so treat you for infections . - if your doctor notices any of the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick or being sick , as this may be a sign of liver disease ( hepatitis ). you will need regular blood tests while you are taking rilsuzolе zentivea . this is to check for cough . difficulties in breathing or swallowing may be more common . you may also notice 
what riluzole zentiva contains the active substance is rilsuzola . the other ingredients are : core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrously colloidal silica , magnesium stearate , croscarmellose sodium , pre - gelatinised starch , and hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzoler zentivea looks like and contents of the pack the tablets are white to off - white , biconvex , round tablets , debossed with " r " on one side and " 50 " on the other side . each tablet contains a total of 202 mg of rilluzolе zenivia - each tablet is packed in
emgality contains the active substance galcanezumab , a medicine that lowers levels of calcitonin gene - related peptide ( cgrp ) in the blood . emmgality is used to treat migraine in adults who have increased levels of capillary - receptor ( ckrps ) and are less likely to get migraine . it is used in adults , adolescents and children aged 4 years and older who have migraines . the use of egality has not been studied in adults and adolescents aged less than frequency not known . however , it may help to reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you have a serious cardiovascular disease . warnings and precautions serious cardiovascular diseases and allergic reactions emmgality can cause serious allergic reactions and these reactions can be life - threatening . you must tell your doctor if 40 you have ever had a seriously allergic reaction and tell your caregiver immediately if such signs occur . side effects are listed in sections 4 . children and adolescents egality is not recommended for use in children and teenagers under 18 years old . other medicines and e mgality tell your pharmacist if or when you are using , have recently used or might use any other medicines . pregnancy and breast - feeding if a woman becomes pregnant or think you may be pregnant , or if
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg ( one injection ) of 240 micrograms of remgal given by injection under your skin ( subcutaneous injection ). your doctor will decide when to give your emmgality injection , and will ensure that proper training is received . follow your doctor ' s instructions carefully . if he or she decides that you should inject 240 megagrams ( two injections ) before you or your child receives more e mgality than he / she should . your doctor may decide to give you a double dose to make up for a forgotten dose . do not try to inject empgality yourself if your doctor thinks it is not possible to inject yourself
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur commonly ( may affect up to 1 in 1 , 000 people ). signs may include : rash or itching . severe allergic reactions may occur rarely ( may occur in up to a single infusion ). tell your doctor straight away if you notice any of the following : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash with raised bumps . other side effects include - very common side effects ( may effect more than 1 in 10 people ) headache . common side effect ( may impact up to1 in 10 children ) low blood sugar (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening the viall is to be stored for a maximum of 7 days below 30 . this medicine must be used within the expiries date which are stated on labels and cartons . discard any unused medicine .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanab in 1 ml solution . - other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what  emmgality looks like and contents of the pack egality is presented as a solution for injection in a clear glass syringe . its colour may vary from colourless to slightly yellow . the sYringe is a colourless or pale yellow solution , supplied in : single - dose pen with 1 , 2 or 3 pre . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvdp ), in which the blood vessels in the liver become damaged and blocked by blood clots . hVdp is one of a family of medicines that may be given to you prior to a stem cell transplantation . defibrotoide works by allowing the blood vessel to relax and the blood coagulations to form . this medicine is for adult patients .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) or to other medicines used to prevent blood clots ( such as tissue plasminogen activator warnings and precautions ) please tell your doctor if this applies to you . if your doctor thinks you may be using medicine to prevent bleeding or if there is heavy bleeding ( for example from a blood transfusion or from surgery ). if the doctor think you may have problems with blood circulation or a constant blood pressure . defit li ' s use should be avoided during the first 1 hour after administration . other medicines and defitalanin tell your physician if : you are taking medicines to prevent or reduce blood coagulation , such as acetylsalicylic acid , hepar
before starting the treatment with defitelio , your doctor will decide how much defitement you need . this is usually done by a nurse or doctor . after stem cells transplantation , defit el is given into one of your veins ( intravenous infusion / drip ) over one to two hours . the duration of this treatment is 21 days . if this treatment does not help to relieve your symptoms , the doctor may decide to reduce your dose . use in children and adolescents defitelfeloo can be used in adolescents and children aged under 18 years . for more information ask your doctor or nurse . do not take a double dose to make up for a forgotten dose , if you have any further questions on the use of this medicine , ask your physician or pharmacist .
like all medicines , defitelio can cause side effects , although not everybody gets them . when defit lion is used for treatment of these side effects you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people): bleeding in general bleeding including the nose bleeding , the brain bleeding ; the gut vomiting ; blood bleeding in the lungs bleeding : blood in the urine ; in the mouth bleeding . skin coagulopathy ( disturbance of blood clotting ) not known ( frequency cannot be estimated from the available data ) bruising ; a history of white blood cells ( anaemia ); allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ) bleeding in most cases the skin clot
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitelio should be used immediately after the infusion storage . it is recommended that the product is used immediately , but not after 24 hours when stored in crockpots or refrigerator ( 1 - 4 ). the product must not be used if the solution is cloudy , if it has visible particles or if particles are present . any unused product must be thrown away correctly .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibrotoide  . one mL solution contains 80 mg of DEfibrotio . - other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defit elide contains sodium ". what defellia looks like and contents of the pack defitaliou is a clear , colourless to pale yellow solution . it is supplied in glass vials containing a single - use clear glass vially . pack size of 2 vial ( ten vial ) of concentrate .
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c , an infectious disease that affects the liver , caused by the hepatis b virus . this medicine stops the hpatitist c virus from multiplying in the body , and keeps the virus in your blood . daklinezza is taken with other medicines to treat hepc infection . you must read the package leaflets for the other medicines that you will be taking with daklinac . if you have any questions about your medicines , please ask your doctor or pharmacist .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or if it is taken by mouth . do not use the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital for epileptic seizures rifampicin / rfabutin ; riffapentine - antibiotics for tuberculosis . dexamethasone , also known as a steroid used to treat allergic and inflammatory diseases . medicines containing st . john ' s wort ( santhosis ) this medicine is used with stomatitis b . jennifatin e . al
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of daklinza is one 60 mg tablet once a day . this may cause a very unpleasant taste when swallowed whole . you may need to take daklineza with some other medicines if your doctor tells you to stop taking daklinac . your doctor will tell you to take some other medications as well . if this applies to you , do not change the dose of your daklince without talking to your doctor . taking these medicines with food and drink the daily dose of the day will be decided by your doctor and may be increased or decreased depending on how you respond to the treatment . when daklinam is taken in combination with other medicines for hepatitis c infection , these medicines should be taken at the same time as daklines 
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin , the following side effects may occur : very common : may affect more than 1 in 10 people headache fatigue common ; may affect up to 1 in10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daclinza are taken in combined treatment with sofiesbuvar and / or rib avirine . side effects reported very commonly in elderly patients are : common , may affect less than 1in 10 people difficulty asleep common - may affect any number of people headache common  - might affect upto 1 in every 10 people trouble sleeping dizzy headache fatigue ( feeling tired ) common – may affect anyone when da
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg daclattingasvar ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide e171 , macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). 51 what daclinza looks like and contents of the pack blue coloured film  white , oval shaped tablet with " bms " debossed on one side and " dms 30 " on the other side . the film  - coating contains white to off - white film
proquad is a vaccine used to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the meases , as well as mashes caused by rubella or varicellella viruses , and will produce their own protections . the antibodies help to protect from diseases caused by these viruses ; proquade helps to protect meales / mums caused by mops caused by the types of rubella / chickenposse ( varicela ). the vaccine will not protect you or your child for at least 12 months after you have received the vaccine and for at most of the recommended national vaccine recommendation . proquaa is for use in adults who are at
do not use proquad if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) neomycin if your child has a blood disorder or type of cancer that affects the immune system and is in need of treatment or treatment with medications that weaken the immune systems ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). if the child has been born with a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( low level of immune competence ), active untreated tuberculosis ( aids or ms ). warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade if : the child
the doctor or nurse will inject proquad into a muscle ( subcutaneously ) in the upper thigh or upper arm . it is given as injections into the muscle , preferably in the third area or upper arms area . the injection site must be chosen carefully because of : - a blood clotting disorder or low levels of platelets . if the vaccine is given into tummy , it will be given under the skin . this will help to reduce bleeding in the muscle and improve wound healing . proquade will be injected into  a vein by your doctor or other healthcare professional . your doctor will decide which part of the blood vessel to give you proquadue as an injection .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) may occur . some of these reactions may be serious and may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor straight away . other side effects reported with proquad are uncommon ( may affect up to 1 in 100 people ) and include seizures ( fits ) as well as a fever . rare ( may effect up to1 in 1 , 000 people ), and include bronchiolitis ( difficulty breathing , cough , and unsteadiness with walking ). the following side effects have been reported with the use of proquade : common ( may impact up to 10 in every 100 people in every 150 people ). injection site complications ( including pain , swelling or bruising ) in children and adolescents . not known
what proquad contains the active substances are : measles virus1 , edmonston strain ( pdm - 00 , 000 pfu ) mumps virus1 ( jeryl lynn - level b ) strain ( viper - 4 . 30 phuket ) rubella virus2 , strain ( pruritus - 3 . 00 strain ) varicella virus3 , wild type - novo - meck strain ( pib - 2 ) 3 - 99 - viable , tissue culture , growth factor - 1 strain ( chick embryo cells , and fibroblasts ) ( mrc - 5 ). the other ingredients are - powder sucrose , hydrolysed gelatin , sodium chloride , water for injections ,
jylamvo is an anticancer medicine that reduces unwanted reactions . as an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases : o active rhusatoid arthritis , including polyarthritic forms that often involve the joints o severe juvenile idiopathic arthritis ( jia ) in adults , adolescents and children 3 years of age or older who are treated with non -steroidal anti – inflammatory drugs ( nsaids ), when the patient is inadequate o severely disabling psoriasis and no treatment is available o phototherapy , pSoralen , with ultraviolet a radiation ( puva ) effect .
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - have a severe kidney impairment - are breast - feeding - suffer from a liver impairment . - know that you have blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia , or significant anaemia 34 - do not give this medicine to children jying if any of these apply to you . warnings and precautions talk to your doctor before giving jYlamva : - you have  a weakened immune system - your family has a serious infection such as tuberculosis or hiv - or ulcers in the stomach or intestines - an inflammation of the mucous membrane of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo is for oral use . swallow the tablet whole . do not split , crush or chew the tablet . you may have severe side effects , sometimes leading to even death . when a person is given jYlamva , the treatment may need to be changed . for rheumatoid arthritis , severe juvenile idiopathic arthritis a , with or without severe psoriasis a new diagnosis is required . severe soriatic arthritis jyeramvo should be used as a long - term treatment . your doctor has prescribed jуlam Vo for several different rhoeal and skin diseases ( jia ), pp
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you develop : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficult in breathing and chest pain ( fever ), spitting or coughing blood , serious peeling and blistering of the skin and / or whites of the eyes , fever , or cough . other side effect include , but are not limited to : common side effects ( may affect up to 1 in 10 people ): - breathing problems including feeling of sickness - dry - irritating cough which may cause shortness or difficulty in breath - chest pain which
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the outer carton in order to protect from light . accidental spillage is not recommended . if the medicine is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . the following information is intended for the specialist only : keep the container tightly closed in order for the correct disposal . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as mesilate ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epithelial parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate (e219 ), citric acid , tri - sodium citrate , purified water . see also section 2 " jYlamva contains ethyl parahydroxybenozoate and sodium mla methyl parhydroxybenzobiate ". what yyl ammonia is a clear , colourless liquid . it is supplied in a brown glass bottle containing 60 mbq with a child - resistant
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the use of this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary system . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using enuresv brewinger if any of these apply to you . - you have kidney problems . you have an eye problem called narrow - angle glaucoma . tell your doctor if this applies to you and tell your pharmacist . do not take this medicine if either of the following apply to your treatment . take the first dose and tell the doctor immediately : - when you start to use , you may experience tightness of the chest , coughing , wheezing or breathlessness immediately after using Enurev brezhalers ( signs of bronchospasm ). - during use of this
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhahale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly you can use this medicinal product if your doctor has told that you are 75 years of age or older . when to inhhale enuresurev brezhalers in general , you should inhalate this medicine at the same time each day as this will help you to remember to use it . if there is a gap in your treatment for you , it will be longer than one month . your doctor will tell you how long
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . these are uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ), swelling mainly of the tongue , lips , face or throat ( signs for angioedema ). if you get any of these side effects ask your doctor . other side effects include : some side effect could be serious and need immediate medical attention . you should see your doctor immediately if any of the following side effects become severe . very common ( may effect more than 1 in 10 people !) headache joint pain ( arthral
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyronicum bromide ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) of glyco Pyronium ( 11 microgram inhalation powder ). - other ingredients of the enuresurev bromidation powder are lactose monohydrate and magnesium stearate . what  Enurev breezhalers looks like and contents of the pack enUREv BREezhale 44 microgramms inhalations are hard capsules filled with a white powder . they have the product code " gpr " printed in black and the company logo printed in blue on the cap
what riximyo is rximyyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabubbles to the target , the cell dies . what if ritzimyoke is stuck to the wall of this cell , your body loses its ability to fight infection . your doctor may prescribe riiximmyo for the treatment of several different conditions . the following diseases have been reported in patients receiving r ) non - hodgkin ' s lymphoma this is also a disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsuximabib - 5 , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor has told you that you have a severe active infection at the moment . warnings and precautions talk to your doctor if the patient has a weak immune system . this medicine is not recommended in patients with severe heart failure . it is also recommended to tell your doctors if there is a history of severe uncontrolled heart disease , with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use rximya if any of these apply to you before you
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximyyo as a drip ( intra - venous infusion ). medicines given before each ritzimya administration before you are given a dose of riiximmyo , you will be provided with other medicines ( premedication ) to prevent or reduce possible side effects from your treatment  . if you are a patient with non - hodgkin ' s lymphoma who are given too much rrixIMyo alone riskimyok will be administered to you once a week for 4 weeks . repeated treatment courses with r ixim
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , certain patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , unusual tiredness or cough . if you experience any of these symptoms , tell your doctor straight away . side effects may occur during or after the induction period . some patients may need medical attention . other side effects include : very common : may affect more than 1 in 10 people fever . common -
what riximyo contains the active ingredient in rximyoka is called rituximab . the 10 ml vial contains 100 mg of ritsuximb ( 10 mg / mL ). the 50 m m vial contain 500 mg of the active substance ritzimabu . each 10 - mml throughl contains sodium citrate , polysorbate 80 , sodium chloride , water for injections , and hydrochloric acid . see section 2 " risimya contains sodium ". what if risseimyou looks like and contents of the pack riiximo is a clear to slightly opalescent , colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . rifampicin is supplied in
topotecan actavis contains the active substance topotacan which helps to kill tumour cells . topotentecan actsavis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer if surgery or radiotherapy is not possible . in this case topoteractavis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotacan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking topotencan activis . if your blood cell counts are too low . your doctor will tell you whether topotécan actAVIs is suitable for you . tell your doctor before taking you topotercan actvatis if : you have any kidney problems . you should not take the tablets if any of these apply to you , as topotingcan act Avis may not be suitable for your condition . severe kidney impairment talk to a doctor if anyone has liver problems , since there is insufficient experience of using topotocan act avisavis in such cases . there is limited experience of severe liver impairment .
topotecan actavis will be given to you by a doctor or nurse trained in the treatment of the disease . your doctor will carry out blood tests before you start treatment and will adjust the dose based on your response to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per m2 of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per square metre of bodysurface area once weekly for 3 days , followed by completing this treatment cicl . for cervical cancer , it will be used in combination with another anticancer medicines called cisplatin . cISplatin may be used for treatment of impaired kidney function . depending on your kidney function your doctor may adjust the dosage of topotécan activis if necessary .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts : infections ( very common , may affect more than 1 in 10 people ): - fever . - worsening of your general condition . local symptoms , such as sore throat or burning sensation , severe stomach pain or fever , and diarrhoea . this is a very rare but serious type of bowel inflammation called neutropenic colitis . topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , might affect up to 1 in 1 , 000 people ), including difficulty in breathing or swallowing . not known ( frequency cannot be estimated from the available data ) - infections ( including cold sores , shingles ) in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c - 8c ). keep the viall in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , and 24 hours when stored at 2 to 8 , protected from light until the drug product solution is clear . dlution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been shown for 4 hours at room temperature , on samples collected from 12 hours , or 24 hours below 25 , after reconstituted as 2 hours at 2 - 8, and after
what topotecan actavis contains - the active substance is topotacan . 1 mg / ml solution for injection contains 4 mg topotenecan ( as hydrochloride ). after reconstitution 1 mmol / kg solution for 1 dose of topoter contains mannitol ( e421 ), tartaric acid ( 0 . 5 mtc ), hydrochchloric acid ( 1 %) and sodium hydroxide ( see section 2 ). what to potecan actsavis looks like and contents of the pack topotécan activis is supplied in a clear plastic bottle with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , inside a protective sleeve . pack sizes : 1 bottle of 1 bottle , 5 bottles of 1 syring
the active substance of rivastigmine hexal is rivassimine . rivassemmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivstigmin works by blocking the enzymes that break down acetoline : acettingylcholesterase and butyrylcholineSterase . by blocking these enzymes , by blocking their action , the concentration of ' good ' and ' bad ' levels of acetone is increased in the cerebral , helping to reduce the symptoms associated with parkinsons '
do not take rivastigmine hexal - if you are allergic to rivassemine ( the active substance in rivastemine hxal) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction suggestive of allergic contact dermatitis with rivabstigmine ( see section " take special care with rastigemine HExal "). warnings and precautions talk to your doctor before taking rivstigmin heexal : - when you have , or have ever had irregular or slow heartbeat . - during or after your treatment with an active stomach ulcer . the underlying conditions may include difficulties in passing urine , seizures , asthma or severe respiratory disease . contact your doctor if your doctor determines that you have impaired kidney function . in particular , if
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablets with  a glass of water . do not crush , dissolve or chew the tablets . tell your doctor straight away if there are any problems with your weight . taking this medicine tell your caregiver that you are taking rivstigmin heexal . take the medicine with you , preferably a quick meal . swallow the capsules whole with sucking . don ' t open or
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in 100 people  ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling , feeling bloated , dizziness feeling jittery tired tiredness feeling unsteady feeling un well tremorting dizziening tiredness , being sick , vomiting , stomach pain , indigestion , flatulence
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 . keep the blister in the outer carton in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivabstigmine hydrogen tartrate . - each rivostigmin hexxal contains hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica . the other ingredients are gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide (  e171 ). printing ink : shellac . each rastigemine hxal 1 . 5 mg capsule contains 1 , 5 mg of rivainstigmine in each capsule . Each rivstigine heexal 3 mg capsule contain 3 mg of the active substances rivistigmine the other excipients are hypromoline , and magnesium strate ). each ripa
what cabometyx is cabrometyxx is a cancer medicine that contains the active substance cabozantinib used to treat patients with kidney cancer ( renal cell carcinoma ) or liver cancer if the patient is already taking a specific anticancer medicine called sorafenib . what abbometychx is used for cabômetyc is thought to involve a substance called cytokine receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply these proteins and , in turn , present high amounts in cancer cells . cabombyx may be used by adults only .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyc : - in case of high blood pressure - have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall ( see section 4 ). - suffer from diarrhoea - recent or significant bleeding - had surgery within the last month - or surgical procedures - dental surgery - you have inflammatory bowel disease ( inflammation of the bowel ). talk to a doctor or nurse before taking this medicine if any of these apply to you . you must not take the medicine unless your doctor tells
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine - your doctor will monitor your treatment and may adjust your dose if necessary . it is very important to take this product exactly as described in this leaflet because you will not be given any medicine that is known or suspected to cause serious side effects . - the recommended dose is one tablet in the morning and one tablet at night . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you can take cabometyx with or without food . how long to take - take a tablet every day for 60 days . your doctor may decide to stop treatment with cabrometyck if your daily dose is increased to 60 mg . then you can start taking cabômetyn at any time of the day ,
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start taking cabometyx . your doctor may also prescribe other medicines to help control your side effects or if you get side effects worse . tell your doctor straight away if any of the following side effects occur . if they get serious , or a family member gets urgent medical treatment : symptoms such as pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever or - a gastrointestinal perforation ( a hole in the stomach or intestine that can lead to severe or uncontrollable bleeding ) symptoms such , such as vomiting blood , black salts , red or black lumps . these may be signs of a kidney problem . the doctor may decide to reduce the dose or stop your treatment
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyyx 20 mg : each tablet contains cabazantineb ( ( m ) ( as malate). each tablet provides 20 mg of cabizantinerib . the cabombometychx 40 mg ; each tablet consists of  Cabozantsinibe (  ss ), as malates . each tablet delivers 40 mg of " cabcabozzantininia ". - cabômetyc 60 mg - each tablet consist of a tablet containing cabbozanteinibu ( t ) as malated . one tablet contains 60 mg of the titration of bma and one tablet . not all
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed hopira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . Pemetrexеd houpira may also be given in combination avec cISplatin for the initial treatment of patients with advanced stage of lung cancer ; pemetrexxed hispira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; and pemetreixed is also a treatment for patients with certain types of lung carcinoma whose disease has progressed
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). - do not take breast - feeding during treatment with pemetrexxed hospia . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetreexed hompira as this could cause problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are adequate and to check that you have enough blood cells to receive pemetrelixed aspira and to determine if there is enough in your blood cell counts . you will also be given cisplatin , so that you will receive appropriate treatment before and after receiving
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . you should use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreXed horiza powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you , and then it is diluted to make it homogeneous . pemetrexxed hispira will be given by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreexed as
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if it occurs at a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may start to have chest pain ( common at the rate of a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common at this time ). allergic reaction : a severe form of skin rash ( common with burning or prickling sensation ) and fever ( common in patients with skin reactions ) a more severe form or a higher risk of skin reactions
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reformulated and infused solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstructed solution was stable for parenteral medicines and is free of discolouration . any unused solution must be discarded .
what pemetrexed hospira contains the active substance is pemetreXed the active ingredient is pemeterxedu . pemetrexxed hospirana 100 mg : each vial contains 100 milligrams of pemetreexed ( as pemetreixed disodium hemipentahydrate ). pemetreexed hompira 500 mg ; each vially contains 500 milligramms of  pemetreuxed( as pemeterXedu disobed disohydrate hemimipentanhydrate ) per millilitre . - pemetrelixed hydrochlora 1 , 000 mg , each viall contains 1 . 000 milliliters of Pemetrex ed [ pemetreced dissodium hydrochromipentehydrate ]. after reconstitution , the solution contains 25 mg
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . bimatapross belongs to a group of medicines called prostamides . it works as a prostaglandin analogue , while titmololl belongs to the group of drugs called beta - blockers . the eye contains a clear , watery liquid that feeds the inside of the eye and the liquid is constantly being drained . this lowers the pressure in your eye and lowers glaucoma . your doctor has prescribed ganfordt eye drops to reduce high pressure inthe eye which helps to lower the risk of glaurcoma for you . ganforcet is used in adults only .
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol or beta - blockers . warnings and precautions - this medicine is not approved for use in children under 6 years of age . - for respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ). - to heart problems such : low heart rate , heart block or heart failure warnings , precautions you must keep using this medicine during treatment . tell your doctor immediately if : you have coronary heart disease ( symptoms include chest pain , wheezing , trouble breathing ) or if your doctor thinks you have a history of heart problems . you have ever had 
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . treatment should be started and monitored by a doctor experienced in the use of ganforce . the bottle should be kept out of the sight and reach of children . do not use after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . before opening : wait at least five minutes between opening the bottle . if it has been opened it should be used within 5 minutes . 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release one drop of granfort into your eye . this will stop ganFort working
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops and see a doctor straight away if you notice any of the side effects listed below after you have taken ganfordt ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) redness in the eye redness is common side effect ( may effect up to 1 in 9 people ), but can also affect up to 100 people . effects on the eye burning , itching , and stinging , irritation of the conjunctiva ( part of the eye that controls sensitivity to light ), eye pain , sticky eyes , dry eyes ; feeling of something in the eyes . not known ( frequency cannot be estimated from the available data ) eye irritation , eye irritation and / or it
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . ganforcet is stable in water for injections and it is stable for 4 hours at room temperature ( 15 - 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . the other ingredients are : - each vial contains 5 mg of the active ingredient titmolole maleate equivalent to 6 . 8 mg . - the other ingredient ( excipient ( s )) are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . this preparation contains purified water , hydrochloric acid and sodium hydroxide . what g ganforce looks like and contents of the pack ganford is a clear , colourless to slightly yellow eye drop solution . it comes in a plastic bottle . every pack contains 1 or 3 bottles with
gefitinib mylan contains the active substance gefitib which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib Mylan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib Mylan : if your doctor has told you that you have any other lung problems . some lung problems may get worse during treatment with gefit inib melan . if this applies to you , tell your doctor . you should not take this medicine if any of these apply to you as gefitINib is not recommended for you . tell your physician if : you have ever had problems with your liver . children and adolescents this medicine is not indicated for use in children and teenagers under 18 years . other medicines and gefitInib tell your child ' s doctor or nurse if they are taking , have recently taken or might
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet once a day . take the tablet at about the same time each day , for example , one tablet in the morning and one tablet at the evening . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if your doctor has trouble swallowing the tablet , do not use any other liquids . stir until the tablet breaks up into pieces . drink the liquid straight away . you should not crush or chew the tablet as this may affect its absorption . pour the liquid out of the glass immediately before drinking . wait at least 20 minutes before taking geFITinibri mylan and drink the mixture . how
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction - symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ), difficulty breathing and serious breathlessness ( sudden worsening breathlessness ). a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this can affect up to 1 in 100 people , when gefitinib is used alone . severe skin reactions have been reported in some areas of the body . the signs may include : swelling face / lips / tongue or tongue , difficult to swallow ( hive rash or difficulty breathing ) serious breathless
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefit inib ( as monohydrate ). - other ingredients are : lactose monohydrate, microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , talc ( 6000 ), titanium dioxide (  e171 ), red iron oxide ( i ) and yellow iron oxide . what geFITinia mylan looks like and contents of the pack gefiteinib minelan tablets are light pink , biconvex film  11 . 1 x 5 . 6 mm , debossed with " gx
reblozyl contains the active substance luspatercept and it is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes [ ms ] are many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms of a low red blood cell count can be severe ( anaemia ) and necrosis requires red blood blood cell transfusions . rebozyl is used in adults to treat anaemic patients with mDs who need red blood plate transfusionations , as well as in patients receiving erythropoietin therapies . it is also used in patients with beta - thalassaemia ( b - lam ). thhalassamic is a blood problem that is often passed down through generations and is often fatal
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - are pregnant ( see section " pregnancy and breast - feeding " below ) warnings and precautions talk to your doctor before taking this medicine - have thalassaemia ( had your spleen removed ) or have had a blood clot during hormone replacement therapy - had / had - an existing or suspected blood coagulation during hormone substitution therapy . if a previous blood clut develops , your doctor will take preventive measures to prevent a bleeding . talk to you doctor or pharmacist before taking medicines to prevent or treat ablood clotting . you have high blood pressure . the effects of rebolzyl on your blood pressure could be increased when you take , or even
your doctor has determined the correct dose of this medicine based on your body weight and certain other factors . your doctor will carry out blood tests before you start using reblozyl . reblizyl is given as an injection under the skin . it is based upon how much you weigh . the injections are given in increments of 1 . 1 mg per kg of body weight . this dose may be adjusted , depending on your blood pressure . how much rebolzyl you will receive is calculated by your doctor based off your body surface area ( m2 ). the dose is adjusted according to your body shape and the amount of medicine you weigh and the results of your blood tests . for rebozyl in patients with myelodysplastic syndromes , the maximum single dose is 1 , 75 mg per kilogram of bodyweight . in patients exhibiting beta - 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you experience : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , which may affect any part of the body or blurred vision . these may be symptoms of a stroke caused by blood clots swelling in the area around the eyes , face / lips , mouth , tongue or throat allergic reactions such as rashes and / or rhinitis skin reactions , including those caused by a medicine . they may also be caused by other medicines . side effects may include : common side effects ( may affect up to 1 in 10 people ) headache dizziening , pain in and around the eye , difficulty in moving ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). after reconstitution , reblozyl is stable for 8 hours at 25 and 24 hours at 2 8 ( excluding holidays ). this medicine does not require any special storage conditions . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept when reconstituted as recommended . after reconstitution , each ml of solution contains 50 mg of the active ingredient luspercept the other ingredients are excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for Ph adjustment at the end of the leaflet ). what reablozyling looks like and contents of the pack rebozyl is supplied as a white to off - white powder . reblezyl 25 mg / 75 mg solution for injection contains luspentium . the solvent is a clear , colourless liquid . one pack of reblizyl
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate of growth of cancer cells . this helps to create new blood vessels . fotiva is used in adults with advanced kidney cancer who cannot be treated with other treatments ( alpha or interleukin - 2 ) to treat your disease .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - do not use st . john ' s wort ( hypericum perforatum ) as a herbal remedy for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiva . high blood pressure : fotivdra may cause your blood pressure to rise . your doctor will check your bloodpressure regularly while you are taking a medicine . you may be given fotivdas to lower your blood temperature . it is particularly important to check your cholesterol more often when you start taking sjs . this is because fotivdada may increase the risk of your blood being raised when you take it with a high dose of fotivdua , or it may
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg capsules taken once a day for 7 days ( 1 capsule in the morning and 1 capsule into the evening ). your doctor may adjust your dose , temporarily stopping fotiva , if necessary , to reduce the risk of unacceptable side effects . if severe side effects occur , your doctor will decide if to stop fotivdra therapy . your doctor should prescribe the right dose for you , depending on the severity of the effects and length of time you are taking fotivdas . you should take fotiv da 890 mg , 21 mg - day ( 7 capsules in the evening and 1 bottle in the afternoon ), capsules should be swallowed whole with water and 4 s
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a common side effect that may affect more than 2 in 10 people . tell your doctor immediately if you have high blood tension that does not go away . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will monitor your blood pressure while you are taking fotivda . if this happens , your doctor may decide to reduce your dose or give you a medicine to treat your high bloodpressure . it is important that you continue taking fotiveda for as long as your doctor prescribes a medication to control your high pressure . do not stop taking foivida without talking to your doctor first . some patients have experienced the following side effects while taking fo
what fotivda contains each hard capsule of fotiva 890 mg contains : tivozanib as tivolinib hydrochloride monohydrate : each capsule contains 890 milligrams of tivonib . the other ingredients are : capsule content : maize starch , mannitol ( e421 ), magnesium stearate . capsule shell : gelatin , titanium dioxide ( i171 ), indigo carmine ( yeoman ), yellow iron oxide (  e172 ), propylene glycol ( 1820 ) and strong ammonia solution . printing ink : titanium dioxide , tartrazine aluminium lake ( k29 ). printing inked : shellac , propyl glycol , strong ammona solution and indigon carmine aluminiu
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antireviral medicinal medicine known alsi ( a nucleoside reverse transcriptaser , or nrti ) tenofovir disoproxil , another antirétroviral medicines known as a nuclear nucleometide reverse transcript
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir ( see " ten ofovir disoproxil " section of this leaflet ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking sTRIbild . before starting treatment with any medicine containing tenovir désoproxils , your doctor will carefully evaluate your kidney function and will inform you if any of these medicines is suitable for you : - alfuzosin ( used to treat an enlarged prostate gland ) - amiodarone or quinidine ( used for irregular heartbeats ) 47 - dabigatran ( used in the treatment of blood clots ). the other ingredients are 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth , with or without food . adolescents aged 12 to less than 18 years : the recommended daily dose is one 35 mg tablet each time . take stribild by mouth the recommended dosage will be decided by your doctor and will depend on how you respond to your medicine . your doctor may prescribe the treatment alone or with medicines called " oral supplements " ( antacids and laxatives containing minerals , such as magnesium , aluminium , calcium , iron , zinc ). for further information see section 4 . if your doctor decides that you should take a tablet , you should wait at least 4 hours before taking sTRIbild . you should swallow the tablet whole
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivie disease itself . serious side effects report any side effects immediately to the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine . lactic acidosis ( excess lactic acids in the blood ) is a rare but serious side effect that can be caused by some hiv medications . it is possible that lactic Acid
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each st - shaped strebild film - coated tablet contains 150 mg of eelvitavir ; 150 mg cobicitabe ; 200 mg emmtricit abine and 245 mg tenovir désoproxils . one tablet contains 300 mg of the ten ofovir Disoproxile fumarate ; 136 mg of an additional tenor . the other ingredients are croscarmellose sodium , hydropropyl cellulose , lactose monohydrate , magnesium stearate and water for injections . what stearbild looks like and contents of the pack stricbild is 
zyprexa contains the active substance olanzapine . zyPrexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , an episode with symptoms of excitement or euphoria . in clinical trials , both patients treated with zypréxa have experienced recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olazapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swelling face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking zypréxa the use of zypresa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly of the face or tongue . tell your pharmacist if any of these apply to you or your carer . take special care with zyPrexa tell your caregiver that you are taking this medicine .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zyPrexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zypräxa tabs once a day following the advice of your doctor and follow the instructions for taking your tablets . zy prexa coated tablets are for oral use . swallow the zypresa tablets whole with water . do not open the tabs . take the zprexxa tablet before you take them with food . how long to take zypa take zp once - a- day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ). especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , stop taking zyprexa and contact your doctor . you may need medical attention . side effects reported commonly ( may affect 1 to 10 users in 100 ) include those occurring in the cardiovascular system . the following side effects have been reported commonly in the elderly : very common side effects ( may effect more than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa must be used within three months after first opening . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains 2 . 5 mg , 5 mg, 7 . 50 mg / 10 mg . the other ingredients are : shellac , 15 % and 20 %. what your zypréxa tablets pack contains - the other ingredient (s ) are lactose monohydrate , hyprolose , crohn ' s wort , microcrystalline cellulose , magnesium stearate - all in your tablet core : hypromellose / titanium dioxide ( e171 ) and carnauba wax . what the different zypresa tablet strengths are engraved with ' 2 , 4 , 7 and 10 tablets are shellacinated ( opadry ), white to off - white
what prolia is prolivia contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein that is present at increased levels in the body . what prolaia works prolium is used in adults to prevent bone loss caused by osteoporosis in adult patients . treatment with proloa helps to make bone stronger . it also increases the amount of oestrogen that your body produces , which is especially important for the bones . as a result , the levels of a hormone called oesterogen , especially in the early stages of osteopossea . when the menopause comes on , your body ' s level of estrogène level drops , and your bones become thin and fragile . this can lead to osteoporrosis . osteoprosis can also
do not use prolia if you : - have low calcium levels in the blood ( hypocalcaemia ). - are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using proloa . talk to a doctor before you are given prolium if : you have ever had a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender . you have cellulitis which causes symptoms such a fever . these symptoms could be due to an allergy to latex . the needle cover on the pre - filled syringe contains a derivative of latex which is thought to have a high level of calcium . it is important to carefully weigh your meals . your doctor will decide
always use one pre - filled syringe at the same time as your doctor , pharmacist or nurse . the recommended dose is 60 mg once every 6 weeks , as a single injection under the skin ( subcutaneous ) in the upper thighs , abdomen or upper arm . to help you remember to use prolia , you may be asked to put stickers on the top of the slyringe . your doctor or nurse will tell you how many capsules you should take . do not share the dose with anyone else . calcium and vitamin d supplements should be taken before starting treatment with prolif you use prollia for as long as your treatment is safe and effective . if you forget to use Proliia do not use more than one injection in one day . contact your doctor to discuss when you should inject prolisa if it is almost time for the
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( called cellulitis ). stop taking prolide and tell your doctor straight away if you get any of these symptoms during treatment with proloa : - you become swollen , red area of skin on the top of your leg and feels hot and tender . these are symptoms of fever which may occur during treatment of prolif you are given pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw - discharge , numbness or feeling of heaviness , or loosening of a tooth . this may be a sign of bone damage in the joint . - this may occur as a result of bone harm to the bone and , in rare cases , can lead to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the container in the outer container in order to protect from light . you should record the date of opening on your pre  - packed sYringe and the date after which it should be injected . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 days at 2oc to 30oc . once prolia has been prepared and injected it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no
what prolia contains - the active substance is denosumab . 1 ml solution contains 60 mg of denosomab ( 60 mg in the vial ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolivia is a clear to slightly pearly , colourless to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
ambirix is a vaccine used in infants , children and adolescents from 1 year up to and including 15 years to prevent two diseases : hepatitis a and hepattis the most common is infection with the heppatite a virus that causes the liver to become swollen and inflamed . the virus causes the virus to multiply in the body and so causes it to enter the body . this can be seen as an infected person passing through the virus . these usually appear in faeces , serum or saliva . symptoms start 3 to 6 weeks after infection . tell your doctor if you feel sick , have a fever , or have aches and pains . your doctor may decide to give you another vaccine .
do not use ambirix if you are allergic to ambiri or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if your doctor thinks you may be having an allergic response , then the use of ambirx is not recommended . warnings and precautions talk to your doctor , pharmacist or nurse before receiving ambirika : if hepatitis a or hepatitis b diseases if the child has a severe infection with a high temperature ( over 38 ). a minor infection such as a cold should not be a problem , but talk to the doctor first . ambirvii may not completely protect everyone who is vaccinated . the use in children and adolescents does not require any special precautions .
your doctor or nurse will give you ambirix as an injection into the muscle of the upper arm . ambirika will be injected into a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . each injection will last approximately 12 months . after the first injection , the second injection will usually be given between 6 and 12 months after the initial dose . make sure you receive the first injecting dose as soon as possible and then continue with the next injection until you are used to the effect the medicine will be in place . if you are injecting into tummy , your doctor , pharmacist or nurse may decide to give you a second injection . it is important that you follow the instructions from the doctor / nurse regarding future booster dosing . do not give more than two injection(s ) to make up for a forgotten dose
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side reactions you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing ; a sudden drop in blood pressure and loss of consciousness . other side effects talk to your doctor if this happens . side effects reported during clinical trials for ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired feeling irritable pain in joints or muscles . uncommon ( may effect up to1 in 100 people !) dizziness . reporting of side effects 23 if your child gets any side effects or any side effect , talk to a doctor or
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 2 , 3 , 4 , 5 , 7 , 8 , 10 elisa units , hepatis b surface antigen , 20 - 32 , and human diploid ( mrc - 2 ) cells . the other ingredients are ; aluminium hydroxide , partially hydrolysed , ( hydrated ) 0 . 05 milligrams al3 + ( 1 . 2 millilitres ) ( 1 million iu ) in saccharomyces cerevisiae , in aluminium phosphate 0 4 . 4 milliliters al3. the other ingredient ( s 3) are sodium chloride and water for injections . what amber
bexsero is a meningococcal group b vaccine . bexsiegero is given to protect against the bacteria neisseria menINGitidis group  B . you and your doctor or nurse will receive bexSero for 2 years and will help protect you against disease caused by the naisseriia meingitia group a bacteria . these bacteria cause infections that include meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make antibodies ( the body ' s natural defences ) which protect you or your child against the disease .
do not receive bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before receiving bexSero: if your child has a severe infection with a high temperature ( over 38 ). in this case , vaccination is not recommended . a minor infection , such as a cold , should not be a problem . however , in a short time after vaccination , the doctor will be able to recommend that you have a shorter course of vaccination . please tell your doctor that you are suffering from haemophilia or any other problem that may prevent your blood from clotting properly . in this situation , your doctor may prescribe blood thinners ( anticoagulants ) or treatment that stops the immune system from working properly , 
bexsero will be given to you by a doctor or nurse . the recommended dose is 5 mg injected into a muscle , usually in the thigh or upper arm . your doctor or health care professional will tell you how many injections you need . from the age of 2 weeks up to 5 years : you will receive three injections of the vaccine , followed by an additional injection ( booster ). the first injection may be given from the size of the first dose , which will be administered 2 months after the interval between injections . you will be monitored closely during this period for at least 1 month to ensure that the intervalbetween injections is at least 2 months . a booster will be provided 12 to 15 months after your first dose and at least 6 months after you have received the first one . it is important that you follow the instructions from your doctor , nurse or pharmacist so that your doctor understands
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site ; redness of the skin at the injecting site , swelling of the surface of the flesh at the site of injection ; hardness of skin at or near the injection location . the following other side effects have been reported with this vaccine ( may effect up to 1 in every 10 people in children ) are : fever ; dizziness ; injection site redness . common (may affect up to1 in every 100 people  ) : injection site reactions : swelling of all skin at and around the injection area ; softness under the skin around the injector ; harderness of a skin
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 ml solution contains 50 mg reconstituted nneisseia meingitidedis - group a nada protein , 1 mmol ,2 or 3 mg / mL . 50 mg produced reconstructed naeisseriesia maningititididis , group c nadaprotein , 3 - 50 mg concentrated recominant bexxia neningitis : group d fhbp fusion proteins ,1 , 4 - 5 micrograms per m2 . outer membrane vesicles ( omv ) produced in n
the active substance in this medicine is nitisinone . this medicine contains the active ingredient niturione - 3a . your doctor has prescribed this medicine because you suffer from a rare disease called hereditary tyrosinemia type 1 in adults . in this disease your body is unable to completely break down the amino acid tyesine ( amino acids are building blocks of our proteins ) that is accumulated in your body . nitsinone helps to break down tychrosine and the harmful substances it produces . by doing so , this medicine helps to reduce the amount of tyingrosine that is produced in your bodies . it is especially important to keep low tarosine , and to increase the levels of phenylalanine ( another amino acid) in your blood .
do not take nitisinone mdk : - if you are allergic to niisinONE or any of the other ingredients of this medicine ( listed in section 6 ) - should not breast - feed while taking this medicine - see section pregnancy - do not breast feed while you are taking nitsinone madk warnings and precautions talk to your doctor before taking a medicine . - it is important that you supervise your eyes during nITisinon treatment . tell your doctor immediately if : you develop red eyes or any problems with your eyes . contact your doctor or pharmacist immediately for an eye examination . eye problems and inadequate dietary control may occur ( see section 4 ) during the treatment , and take blood samples to monitor the effectiveness of the treatment and monitor your blood samples during the course of the therapy . your doctor may ask you to take
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , administered once daily . the recommended daily dose is 20 mg per kilogram of bodyweight , given once daily in the clinic . your doctor may adjust the dose for this patient population . if swallowing the capsules , you may take a small amount of water or formula diet just before or after taking nitisinone mdk . you should continue taking this medicine for as long as your physician continues to prescribe it . do not change the dose or stop the treatment without talking to your doctor first . taking a dose of n
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . after first opening the vial is to be used immediately . if not used immediately the solution can be stored in the original carton and kept at 2 8 in the fridge ( 2 - 8 ) at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nitosinone ( as natisinine ). nitsinone one ml hard capsules are made from 2 mg ntisinONE ( as mesilate ). one capsule of nITisinon mk 5 mg contains 5 mg / mmol of ' nităisinonce '. nitéisinonne mmdkte 10 mg hard capsule : each capsule contains 10 mg of  nitesinone and is supplied in hard gelatin , titanium dioxide ( e171 ). printing ink contains black iron oxide ( i . e ., shellac glaze ). what 'nitisse mndk looks like and contents of the pack nitatiisino mbk capsule
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . Docetaxell belongs to the group of anti - cancer medicines called taxoids . the docetastel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer a combination of gastric cancer and head and neck cancer : - for the prevention of advanced breast cancer the combination of docetacel could be administered either alone or in combination with doxorubicin , trastuzumab , or capecitabine . -for the treatment in early breast cancer that has come back or has spread to the small blood vessels , the combination could be used to treat high blood pressure .
docetaxel accord should not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetastel accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor has a severe liver disease . warnings and precautions before each treatment with docetal accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetativel accord and to detect any signs of whiteblood cells disturbances . in case of fever or infections tell your doctor or nurse immediately : in case you have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or abdominal pain . you should tell your physician if any of these applies to you . children and adolescents docetastic consent is not
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may vary depending on your blood tests , your general state and your response to docetacles . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her 63 information in case you need
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . there have been adverse events of dotaxel being given at the same time as docetaxil in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions have been reported : common : may affect up to 1 in 10 people - flushing - dizziness - sensation of tingling or burning sensation when urinating - hair loss - infusion site reactions , including
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the viall in the outer carton in order to protect from light . after dilution , the medicine should be used immediately . if not used immediately ( infusion bag ): chemical and physical in - use stability of the infusion solution obtained from the vially or from non - pvc bags has been demonstrated for 48 hours when stored between 2 and 8 . from a microbiological point of view , once the product has been prepared and diluted , it should be administered immediately , in a refrigerator ( 2 - 8 ). the inffusion solution should be stored in : - an immediate
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetastel - each 1 mL vial of concentrated concentrate contains 20g of dotaxel ; each 4 mlitre vials of concentrate contains 80 mg of dontaxell . - one vial in 8 m m is a clear colourless to yellow solution of approximately 160 mg of didcetaxell.  - other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously ( see also section 2 " docettaxel accord has been modified )" ( see further information below ). what docetaxeel acord looks like and contents of the pack docetaxel agreement concentrate for concentrate for use for infuse is  
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . the brain contains so - called ' attention deficit hyperactivity disorder ' ( adhd ). it is used when your child is not taking current stimulant medication . your child must continue taking current medication to control adhd symptoms and may start taking the medicine at a lower dose . it is given together with a treatment programme that includes psychological therapy , educational therapy and social therapy . intunev is used to treat 38 adults who have adhd and are not adhd but are not in agreement with the world health organisation .
do not take intuniv - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine - talk to you doctor if any of these apply to you : - you have low or high blood pressure . - your doctor has told you that you have heart problems . talk to a doctor , nurse or pharmacist if this applies to you as you may be at risk of heart problems ( see " warnings , precautions and measures " below ). - have ever fainted , or recently had thoughts or feelings of suicide , and / or any other psychiatric conditions . tell your doctor / nurse if during treatment you develop withdrawal symptoms ( such as increased heart rate or high pressure ) while taking this product . your
your treatment is prescribed for the treatment of adolescent behavioural disorders . your doctor will advise you on the right dosing . the dose of this medicine depends on how you respond to treatment . adults the recommended dose is 1 tablet in the morning . children and adolescents 1 year of age : 1 year duration of treatment : 0 . 05 - 0. 12 mg per kg of bodyweight . dose for children and teenagers : one tablet per day . adolescents 7 years of age and older : you should not take intuniv for more than 7 days . do not stop taking intunev unless your doctor tells you to . taking this medicine you can take the tablets with or without food . avoid eating fatty foods and drink . swallow the tablets whole with a glass of water . duration of therapy : your doctor may decide to stop treatment 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to change your dose or stop your medicine . serious side effects tell your doctor or nurse straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint ( loss of conciousness ) ( syncope ) a serious withdrawal side effect high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ) tell your healthcare professional straight away any of these side effects as soon as possible . very common : these may occur with more than 1 in 10 people : dizziness ; constipation ; loss of appetite ; di
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the original blister pack in order to protect from moisture .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg guangfacina - each 2 mg tablet contains guantfacan hydroch chloride , - one 2 mg guianf acine tablet , 3 mg GUanfabicine hydrocholoride each 3 mg tablet contain guansfac . - every 4 mg tablet release guANfaca hydrochromide corresponding to 4 mg / kg of guanzacine . the other ingredients are : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , type a , microcrystalline cellulose . not all pack sizes may be marketed .
ecalta contains the active substance anidulafungin . eCALta is used to treat adults and children ( aged 1 year to less than 18 years ) with a type of fungal infection , either in the blood or other internal organs ( invasive candidiasis ), where the infection is caused by fungal cells called candida - echinocandins . these medicines make serious fungal infections more likely . they work by replacing the missing or missing fungal cell walls . the advent of eCalta makes fungals have incomplete or defective cell walls and are fragile and unable to grow .
do not use ecalta : if you are allergic to anidulafungin , other echinocandins ( e . g . caspofungin acid , see section " other medicines and eCALta "). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . before using ekalta your doctor will check your liver function . tell your doctor or nurse if your liver problems are controlled during your treatment . you will be given anaesthetics during your therapy with eCalta and during treatment with a specialised clinic specialised in the use of anaesthesia . during your training , your doctor may also give you other medicines during your treatments with caltta ( see also section 4 ). if an allergic reaction ( i .
your doctor will calculate the correct dose for you depending on the patient ' s weight . the starting dose for adults is 200 mg ( two 100 mg tablets ) per kilogram of body weight , given every 1 hour . children and adolescents ( aged 1 year to less than 18 years ) the starting dosage is 3 . 0 mg ( one 200 mg tablet ) given once a day . this dose is given as a single infusion of 1 . 5 mg ( four 100 mg doses ), given once every three weeks . depending on patient response , the doctor will work out the right dose for the patient and will workout the right dosage for the child . how ecalta is given eCALta will be given to you by a slow infusion ( a drip into a vein ) over 1 , 5 mg every 3 weeks , depending on your weight ; the loading
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these side effects may be serious and may require medical attention . serious non - life - threatening allergic reactions , which may cause difficulty breathing or wheezing , may occur even if you are aware of the possibility of an existing rash . stop taking ecalta and tell your doctor immediately . possible serious side effects such as convulsion ( seizure ), flushing / rash ( pruritis ), itching , hot flush , hives ( sudden contraction of the muscles ), wheezeing ; coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): headache , dizziness , headache . common side effect ( may effect up to 1 in10 people ). uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and diluted solution : chemical and physical in - use stability of the reconstructed solution has been demonstrated for 24 hours at 25 and 48 hours at 2 - 8 . from a microbiological point of view , the product should be used immediately .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . - - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . what  eCALta looks like and contents of the pack ekalta is supplied as a box containing 1 vial with 100 mg powder for concentrate for solution for infusion . the powder is white . each pack contains one vially .
adynovi contains the active substance rasaoctocog alfa pegol and pegylated human coagulation factor viii . the human clotting factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( lack of factor ii ), factor  vi is missing or not working properly . aadyingnovi is used for the treatment and prevention of bleeding in adults and adolescents aged 12 years and over who have haemicophilie a , an inherited bleeding disorder caused by lack offactor viiI .
do not use adynovi if you are allergic to rurioctocog alfa pegol or octcog alla or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions aadyingnovi may cause an anaphylactic reaction ( a severe , sudden allergic reaction ) to a particular type of a drug . you should tell your physician before using aynovit if any of these apply to you in the first few days . allergic reactions such as rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , or wheezing ,
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use adenovi exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding aadni can be used for the replacement therapy of damaged tissue . aynovvii is a life - long treatment . continue to use this medicine until you are used to the prevention of bleeding ( see section " warnings and precautions "). treatment of cutting and treating bleeding the usual dose of apynovis is 40 to 50 iu per kg body weight , given every 2 weeks . prevention of cutting or treating bleeding : the dose of the dose with odyni is calculated depending on your body weight and the factor viii levels to be achieved . the target
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , and wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breathe and fainting ), require prompt emergency treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is opened it may be kept at room temperature ( up to 30 ) for a single period not exceeding 3 months . once the product has been stored at roomtemperature it should be used within 3 months or disposed of . if not used within this period , the powder should be discarded .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu rURIoctochloroctopog alfie pegol . the solvent vial comprises 5 ml sterilised water for injections . other ingredients are mannitol ( e421 ), trehalose dihydrate , histidine , glutthion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . what if a doctor thinks the medicine is not suitable for him , ask the doctor
rekovelle contains follitropin delta , a foollicle stimulating hormone similar to the hormone found naturally in humans , called gonadotropins . gonadotropicins are involved in the reproduction and development of female fertility in adult men who are undergoing assisted reproduction programmes such as in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . the active substance in rekelle is called fld - 1 , which is produced by your ovaries , producing many egg sacs , and thereby reducing their size .
do not use this medicine - if your fertility problems are serious or you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) - have a tumour in the uterus ( the place where your ovaries meet ) or the oocytes are located ( breasts , pituitary gland or hypothalamus )- have large , enlarged odes and cysts on your ovary - suffer from polycystic ovarian disease - are at risk of bleeding from the vagina ( an early menopause ) and malformations of the sexual organs that may delay pregnancy - had fibroids of the womb which would make a normal pregnancy impossible - you have ovarial hyperstimulation syndrome - your doctor will decide if you should use gonadotropins .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use your doctor will work out your exact dose . you will be given the rekovelle dose for your first treatment cycle . anti - mullerian hormone your doctor may induce your ovaries to produce more gonadotropins which are known to be produced in your blood . the dose is based on your body weight . your doctor should take a blood sample during the last 12 months to check how well you respond to treatment . this will be done by your doctor every three weeks . it will be enough to test your body weigh at the start of treatment to determine how much you should receive . depending on your response to treatment your doctor might lower your dose or stop the roovaries by your dose , and may also test your blood to see how well the treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the high levels of hormones involved in the development of infertility have been reported in women using this medicine . if you have a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ), symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . contact your doctor immediately if any of these symptoms occur . they may be a sign of a side effect . common ( may affect up to 1 in 10 women ) headache and nausea ( ovulation ) ovary hypersmulation syndrome ( olivine hyperstigmatis ) may occur during treatment with rekovelle . the frequency of these effects is not known
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . rekovelle can be stored at room temperature ( up to 25 ) for up to 3 months when kept at roomtemperature . after storage at room temperatures up to 28 it expires at room temp ( upto 25 ). after completing the treatment any unused solution should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of flood following fllodge of solution corresponding to 0 . 36 millilitres of solution equivalent to 33 . 3 microgram of amorphine d . ffollitrapin delta in each milliliter of solution contains phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , and sodium hydroxide and water for injections . what reakovelle looks like and contents of the pack recovelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles 
what revinty ellipta is revinted ellipeta contains two active substances : fluticasone furoate and vilanterol . one tablet revinting elliрta contain fluticasesone furonate 92 mg and vanterol 22 mg . each tablet contains fluticason furoates 184 mg and two tablets vilantrol 22 %. each tablets is used to treat chronic obstructive pulmonary disease ( copd ) with asthma in adults and adolescents 12 years of age and older . the usual dose is 184 / 22 mg for asthma in adult patients 12 years and older and the usual dosage is 186 / 20 mg for copd and the two 22 mg tablets for copD . revinny elptta has two different active substances which are used in combination .
do not use revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take revinting ellipatta and tell your doctor immediately . warnings and precautions talk to your doctor before taking ellipeta tell your pharmacist if : you have liver disease , as some of the side effects may be serious . you have moderate or severe liver disease the lower strength of revinny elipta ( 92 / 22 mg tablets ) may be more suitable for you . your doctor may want to monitor you more closely . have heart problems or high blood pressure . are at risk of tuberculosis ( tb ) of the lung , or any long standing or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( the active substance is fluticasone furoate and 22 micrograms of vilanterol ). if your doctor suspects that you have severe asthma , the higher strength inhaler ( the single inhalant ) contains fluticasesone furóate and 23 microgram ( vilantrol ) once daily . copd the recommended dosage to treat copd is one dose ( the combined use of fluticason furoates and 22micrograms ( guillain - barré , guile - sn ) twice daily , once daily and once daily ( clumps of inhalers of fluticsone foroate with
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipatta stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( anaphylactic shock ) shock or shock . tell your provider immediately if your child has any of these signs . they could be signs of an allergic reaction . your child may need a blood test to check if they are the same as for any other medicine . if any of them occur , they may need to be tested more often 
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 - each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate and 22 microgram of vilantrol ( as trifenatate ). 184 - every single inhaled dose provides : a deliverable dose (the dose leaving your mouthpieces ) that delivers 184 microgram ( 2 . 9 microgram ) fluticassé furoates and 22micrograms vilantesrol ( the active substance is trifénatate ) the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revinety looks like and contents of the pack the ellipatta device itself is 
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , another non  nucleolar reverse transcriptastase inhibitor ( ndrtis ); and tenofovir , also known as a nucleoneurotide reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet : at the same time each day . swallow the tablet whole with a glass of water . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . some side effects may be dizziness or drowsiness . stop taking atriplap and take the tablet immediately . if necessary , atripLA can be taken with or without food . when taking atrapla with efavirenz , emtricitabine , and tenofovir disoproxil , you should be taking other medicines to treat your hiv infection . continue taking atrigla for as long as your physician tells you , even if they are not the same as with other medicines for your
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are : lactic acidosis ( excess lactic acids in the blood ) is a rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects may be signs of lactic Acidosity : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . if you think that you may have lactic acidosis , contact your doctor immediately 
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriplap film - coated tablet contains 600 mg of eFavirenz and 200 mg of the active substance emmtricitare . the tablet contains 245 mg of an active substance called tenovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , hoprolose , magnesium stearate ( e572 ), microcrystalline cellulose and sodium laurilsulfate ( see section 2 " atripLA contains sodium "). the tablet film coating contains iron oxide black ( i ) ( see below ). what atrapla looks like and contents of the pack atripa are white to off - white , oval , scored tablet with " t100
orgalutran contains ganirelix , a member of a class of medicines called anti - gonadotrophin , which is similar to the natural gonadotropin releasing hormone ( gnrh ) regulators . it regulates the release of gonadotropics which are needed for follicle stimulating hormone ( fos ). gonadophagins are necessary for the growth and development of foollicles in the ovaries . ffos , called fsh , are necessary to help produce fosses in your eggs . the feces are small round sacs that contain the egg cells . they then release the mature egg cells to the womb and form floodles . orgalugatran is used in adult women for assisted reproduction techniques , including in vitro fertilisation ( iv
do not take orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gndrh analogue . - have a moderate or severe kidney or liver disease . ( it is also better to avoid orgalugatran allergic reactions in women with an active allergic condition ). warnings and precautions talk to your doctor , pharmacist or nurse before taking orgalurtran : if any of these apply to you , you may be at increased risk of allergic reactions . in rare cases , allergic reactions may be severe and require additional monitoring during treatment . warnings about allergic reactions allergic reactions can be generalised ( e . G . wheezing , urticaria ), swelling of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is administered to you by your doctor , nurse or pharmacist for the treatment of your child ' s first course of assisted reproduction techniques including in vitro fertilisation ( ivf ), ovarian stimulation with follicle stimulating hormone ( corifollitropin ) on day 2 or 3 of each 3 - week cycle . your doctor will decide which time period is best for you , depending on the type of egg you are producing . you will usually have your first course on day 1 and continue on day 3 of your cycle if your first cycle is : - subcutaneously ( under the skin ) 5 to 6 weeks after your first dose of orgalugatran ( in combination with hcg ). your doctor may decide to give you different injection sites
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a side effect , stop taking orgalutran and contact your doctor immediately . very common ( may affect more than 1 in 10 people ) local skin reactions , such as redness and swelling , may occur at the site of the local reaction and disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people ), headache , nausea and malaise . rare ( may impact up to1 in 10 , 000 people ). allergic reactions : rash facial swelling ; difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat ; difficulties in breathing or swallowing . not known ( frequency cannot be estimated from the available data ) allergic reactions including rash facial swelling . difficulty breathing . (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the syringe label after exp . the expiration date refers to the last day of that month . sYringes should be used to store clear , particle - free solutions . store in the original package in order to protect from light .
what orgalutran contains - the active substance is ganirelix , containing 0 . 5 mg of acetic acid . -the other ingredients are mannitol and water for injections . to adjust the ph , the body must also be able to release sodium hydroxide and aceTIC acid , which are both present in orgalugatran . what orgutran looks like and contents of the pack orgalurtran is a clear and colourless aqueous solution in a vial . the solution is reconstituted in water for subcutaneous administration . after preparation , rinse the needle with dry natural rubber / latex . orgalultran is available in packs containing 1 or 5 vials , each containing one vial per carton . not all pack sizes may be marketed .
what blitzima is billetima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabu sticks to its surface , the cell dies . what  Blitzimа is used for bitzima may be used for several different conditions in adults and children . your doctor has prescribed blituxim : for the treatment of : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a specific type of whiteblood cell called b- lymphoocytes buximа may be given to you together with other medicines called
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsuximb - 5 , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor suspects you have a severe active infection or a weak immune system . if this applies to you , tell your doctor . warnings and precautions severe heart failure or severe uncontrolled heart disease , with granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use bblitzIMa : if any of your family has ever had or might now have , a hepatitis infection . before you are given bblastima you could get hepatis b ( a type of hep
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given blitchiole as a drip ( intravenous infusion ). medicines given before each blizima administration before you are given a dose of bitzima , you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment  . if you are having non - hodgkin ' s lymphoma and you are treated with billetima alone blitzer will be treated for up to 4 times . repeated treatment courses with adolescent will be required . how much blastima is given if 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , certain patients may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , unusual tiredness or cough . if you experience any of these symptoms , tell your doctor straight away . side effects may occur during or after the induction period . some patients may need medical attention . other side effects include : very common : may affect more than 1 in 10 people fever . common -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in billetima is called rituximab . the 10 ml vial contains 100 mg of ritzuximb ( 10 mg / mL ). the 50 mml throughl contains 500 mg of the active substance ritsuximabom ( 10  mg ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what billitzimа looks like and contents of the pack blizima comes as a clear , colourless solution for infusion . it is supplied in glass vials containing 2 m x 50 iu / vial . pack size of 1 vial
roactemra contains the active substance tocilizumab , which is a type of monoclonal antibody ( a specialised type of protein ) that recognises and attaches to a specific target in the body . it blocks the activity of a protein called interleukin - 6 ( ir - 9 ), which causes the inflammation in your body to flare up . rra is used to treat symptoms such as pain and swelling in your joints . by attaching to i - 7 , riactemara reduces the damage to the cartilage and bone in your joint . this reduces or prevents the disease . you have been prescribed ra for the treatment of moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or are not
do not use roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active , severe infection during or following the infusion . warnings and precautions talk to your doctor , pharmacist or nurse before using rroaktemran . if allergic reactions occur , such as chest tightness , wheezing , extreme dizziness or light - headedness ; swelling of the lips or skin rash , please tell your doctor or nurse immediately during the infustion . infection if any of these apply to you , tell your healthcare provider . infections should tell your physician immediately if they feel unwell . the use of ra may reduce your body ' s ability to fight infections or may increase the severity of an existing infection
roactemra will be given to you by a doctor or nurse into a vein . your doctor or a nurse will supervise you during the intravenous infusion and may adjust the dose based on your response to the treatment . the recommended dose of rroaktemran is 8 mg / kg given every 4 weeks . you will be treated every 8 weeks , with an additional dose of 8 mg of a dose of 1 mg . ra is given every 2 weeks as a drip in the vein ( intravennous inf ) over 2 hours . starting dose of the r - g - person is given 30 mg , given every 12 weeks for 30 mg or 8 mg per kg of your body weight . when given every 3 weeks - your doctor will decide how much reactemara you will receive . how often you
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemrana : very common side effects ( may affect more than 1 in 10 people ): allergic reactions - difficulty with breathing , chest tightness , light - headedness - rash , itching , or hives - swelling of the lips , tongue or face - serious infections - fever and / or chills in the mouth and , in rare cases , can occur in very rare cases to be serious . tell your doctor if you notice any of the following signs : - chills , mouth sores or swollen glands in your mouth - headaches - diarrhoea - vomiting - abdominal pain - joint pain ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer container in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each vial contains 4 80 mg of tocilizuab in 20 ml , 10 mL of solution or 200 mg of Tocilizumb in 30 mg , 20 , or 400 mg of TOcilizumаb in 200 mml of solution . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphatahydrate ; water for injections . what if rra looks like and contents of the pack roractemirra is a concentrate for solution for infusion . róactemora is supplied in 4 m , 5 mmol , and 20 g concentrate for solutions for infuse . not all pack sizes may be
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . onbez breezehaler relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . you need to use onbriez breezihaler every day as it helps to make breathing easier . it is used in adults to make breath easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . using this medicine relaxed these muscles in your lungs and made it easier for air to get in and through your arteries .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbriez breezehaler for asthma . before using this medicine tell your doctor you have had any of these conditions : heart problems . epilepsy . thyroid gland problems ( thyrotoxicosis ). diabetes . during treatment with onbez breEZhaler tell your physician immediately if your chest gets worse , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs of a condition called bronchospasm . tell your healthcare professional immediately : if the patient develops lung problems such as lung problems , lung problems or lung problems ( lung problems at
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much onbrez breezhaler to use the usual dose is to inhale the content of one capsule each day . the 150 microgram capsule is for inhalation use . your doctor may change your dose if necessary . this will depend on how you respond to the treatment . always use your inhaler exactly as described in this leaflet or as your physician has told me . you should inhaling onbez breezehaler at the same time each day and every day , for at least 24 hours . when to inhaled onbriez brerezhaler , you will find an inhalator and capsules ( in blisters ) that contain the medicine as inhalations powder . only use the onbreezhalers inhalers
what onbrez breezhaler contains - each onbriez breezehaler 150 microgram capsule contains 150 microgramms of indacaterol as inddacatamaleate . the other ingredients are lactose and the capsule is made of gelatin . - every onbez breezihaler 300 microgram hard capsule contains 300 microgrammes of  indhacaterol and ind acateryl maleate , respectively . both the capsule and the cap are made of hard capsules made of gel and gelatin what onberez brewing product looks like and contents of the pack onb Rez brezhaler is an inhaler . capsules are packed in blisters . they are white powder . onbreezhalers come in blister packs containing one hard capsule or two hard capsule contents . each pack contains one hard hard capsule
clopidogrel hcs contains cloclopidottel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood forming ( a process called thrombosis ). clolombogrell hccas is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopiționat hCSs to help prevent blood from clots (" thrombocytes ") forming and
do not take clopidogrel hcs : if you are allergic to cloclopidottel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . check with your doctor before taking clocidogrell hccas . warnings and precautions if any of these apply to you , you should tell your doctor Before taking , using or giving clolombogrelling hCSs , and during treatment : bleeding may occur within a hospital setting such as an increased risk of a clinical condition that puts you at risk of internal bleeding ( such as untreated , for example , a spoon ulcer ) or a blood disorder that puts people at risk for internal bleeding 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed a higher dose for you than for example : if someone else has taken a severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Hcs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 - mg tablet , taken orly with or immediately after taking cloclopidagre
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' take special care with clopidogrel hcs '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . tell your doctor if your child has any of the following symptoms : very common side effects ( may affect more than 1 in 10 people ): diarr
what clopidogrel hcs contains the active substance is cloclopidorgrel the active ingredient is : each film - coated tablet contains 75 mg of clopionogrell ( as hydrochloride ). the other ingredients are ( see section 2 ' clodogrelling h cs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( E172 ), yellow iron oxide , the printing ink : shellac ( talc ) and macrogol 3000 . what clumps of clumped tablets are : clopatron
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcrojan is used to treat infections caused by bacteria that are not killed with other antibiotics , and is used by adults .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to other antibiotics , such as cephalosporins . - had a severe allergic reaction to certain antibiotics ( e . excipients : penicillins or carbapenems ). signs may include severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , difficulty swallowing or breathing . warnings and precautions talk to your doctor or pharmacist before taking ftcroj : - in case you experience any allergic reaction other antibiotic antibiotics may be present . your doctor may need to adjust your dose of fencroja or stop your treatment . talk to a doctor or nurse before taking your medicine if
this medicine is given to you by a doctor or nurse by an infusion ( a drip ) into a vein , which will take 3 minutes . this is usually for 2 weeks . fetcroja treatment will be stopped if you have an infection . your doctor will check for signs of your infection and treat you if they are causing any pain . the ftcroJA infusion will be given into : your vein only . patients with kidney problems if your doctor thinks you may have kidney problems are too high or too low , talk to your doctor or pharmacist as soon as possible . how much fentcroja to be given your doctor may lower your dose of fencroja . do not stop taking fеtcroj unless your doctor tells you to . contact your doctor if any of the above applies to you . you may still be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction : - sudden swelling of your lips , face , throat or tongue , or a severe rash or other severe skin reactions - difficulty swallowing or breathing . this reaction may be preceded by diarrhoea and stools , which may contain blood or mucus . during treatment , your doctor may give you medicines to slow bowel movement . reporting of side effects get more information if your doctor gets any side effects or signs . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefiziderol . - other ingredients are sucrose , sodium chloride , and sodium hydroxide . what feret Croja looks like and contents of the pack fentcroja is a white to off - white powder for solution for infusion supplied in a vial containing 10 ml s .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningitsis is a condition in which tumour cells form within the membranes of the brain and spinal cord . depcyto works by destroying and stopping the growth of lymphoma tumour cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you have a meningeal infection . if there is a risk of severe neurological side effects with depcell , tell your doctor . there are sometimes symptoms that indicate a problem with the nervous system such as convulsions , pain , numbness , or tingling , blindness or visual disturbances . these symptoms are more common in children than in adults who take any depamethasone tablets . you may experience unwanted effects more quickly . talk to your doctor or pharmacist if these effects are serious or last longer than a few days . your doctor will monitor you for any new side effects . other medicines and dep cell tell your partner or caregivers if they are
your doctor will decide on the correct storage temperature for depocyte , depending on the type of cancer to be treated . the quantity of lumber sac used will be calculated from the available data . dep cellulose will be administered to you by a healthcare professional . your doctor or nurse will give you injections in 1 ml of solution ( containing 5 mg dexamethasone ) for 5 days . each depoocyte dose will be withdrawn immediately , in case you experience any side effects . before you receive depcell , your doctor may decide to keep it at a temperature of 22 to 30 oc . after withdrawing depcyto , the vial should be opened and used immediately . proper precautions are needed to avoid exposure to a cytotoxic drug and proper handling technique . you will be instructed how to set up a suitable designated area and
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon (affects affect 1 to 11 users in 10 days ) rare (affects 2 to 10 patients in 1 , 000 ) very rare ( affect only 1 to 5 users in 1 10 , 500 ) not known ( frequency cannot be estimated from the available data ) adverse events with depocyte may occur when depcell is used in combination with other chemotherapeutic agents . very common : may affect more than1 user in10 nausea vomiting weakness , confusion , fever headaches , drowsiness , inability to sleep disturbances in attention , sleepiness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . depocyte can be kept at room temperature ( up to 25 ) for up to 4 weeks . once dep cell has been removed from the refrigerator , it must be used immediately . if this medicine is not used immediately it should be discarded . in the event of severe discolouration or a changed appearance , please inform your doctor . this may indicate that a defective container is opened and the contents of the container should be used within the same container . it is recommended that depcell be used in combination with cytarabine .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg ccyarabine ( equivalent to 5 mg ). each vial contains 50 mg / m2 of ckytarabin . - other ingredients are cholesterol , trioein , dioleoylphosphatidylcholine , dipalmitoylidylglycerol , sodium chloride , water for injections . what dedepocyte looks like and contents of the pack depcell is a suspension for injection ( injection ) in a vial . it is supplied in packs containing 5 vials as a single injection or in  a multipack containing a one vial
what bemrist breezhaler is and how it works bemmrister breezehaler contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , helping to open the airways . this helps the airway to open more widely and opens the air sacs in the small lungs when you are inhaled into the air . momethason furoates belongs to the group of medicine called corticosteroids ( or steroids ). corticotropine ( or corticostroids ) reduce the swelling and irritation ( inflammation ) in the smaller airways and so gradually ease breathing problems . corticoids also reduce the number of attacks of asthma .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the tablets . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using bemmrister breezehaler: - tell your pharmacist before using this medicine if any of these apply to you as you may not be able to use this medicine and tell your dentist that you are using bemarist  Breezhalers . check with your doctor or pharmacist before you use it if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor has told you to check
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhahale one capsule each day . you only need to use the medicine once a day , so it will take about an hour to inhales the medicine . bemmristes breezehaler capsules are for inhalation use . this will help you to remember to use it , and to reduce your symptoms throughout the day ; this will also help you remember to take it . when to inhume bem breezihaler in this pack , you will find an inhaler and capsules that contain the medicine inhalers . the inhalator enables you to infuse the medicine into capsules using the inhaled capsule . only use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious : common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the mouth , tongue / lips / face or throat ( angioedema ). other possible side effects include : very common ( can affect more than 1 in10 people ). not known ( frequency cannot be estimated from the available data ) swelling of tongue - like lips - face or neck ( possible signs of angiogenesis ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . discard if not used immediately .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each bemmrister breezehaler 125 micrograms / 62 . 5 microgram capsule contains 173 microgram inddacatarol abutment ( equivalent to 150 microgram of indabacaterol ) or 80 microgram ( 2 microgram ) of mometesone furóate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler is equivalent to 125micrograms of indigacaterolul ( as amdacular ) but 62. 5microgram ( 10 microgram) of Mometainsone furochrome . what berist broezhalers looks like and contents of the pack bemreezhale inhal
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). zylt is taken by adults to prevent blood clats ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllingt to help prevent blood to form these thrombocytes and reduce the risk of these events .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . check with your doctor before taking zylt . warnings and precautions if any of these apply to you , tell your doctor or pharmacist before taking the medicine . take special care with zyllingt : if or you have an increased risk of bleeding such a medical condition that puts you at risk of internal bleeding ( such as an ulcer ) if they have a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor recommends that you take more zylt than you should if , for example , you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , taken orly with or immediately after food . you should take zyllingt for as long as your physician continues to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . tell your doctor if your child has any of the following signs : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , vomiting ,
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopdogrell ( as hydrogen sulphate ). the other ingredients are : lactose ( see section 2 ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide ( e171 ), red iron oxide ( i 172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film  12 tablets are available . not all pack
what lamivudine teva is lamilivune is a medicine used to treat long term ( chronic ) hepatitis b infection in adults . lamivine toeva is an antiviral medicine that suppresses the hepatis  B virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). hepb is  a virus that infects the liver . long term( chronic ), chronic , long term , chronic - infection , can lead to liver damage . you have lamivaudin t Eva in patients whose liver is damaged , but still functions normally ( compensated liver disease ). treatment with lamimivudines teeva does not stop the spread of hehepatitic b virus
do not take lamivudine teva if you are allergic to lamilivucine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor or pharmacist before taking lamivaudinne to help reduce the risk of serious side effects if your doctor , pharmacist or nurse tells you to : - treat liver disease , including hepatitis c . - are overweight . you should have blood tests at regular intervals while you are taking your medication , and for at least 4 months after stopping lamivine it is very important to check that your hepatis is under control before starting lamimivudines . talk to a doctor if this applies to you . before starting treatment with lam mivudinous tva , check with your doctor whether
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of lamivudine teva is one tablet once a day . your doctor will decide how many days to take on the same day , depending on the severity of your hepatitis b infection . if your infection does not improve with your illness , your doctor may decide to reduce your dose of either lam mivudines t Eva or lamivine to you , according to your condition , and your doctor should decide if lamimivudinism tva is suitable for you ; if it is not enough for you to take lamivane, your dose may need to be adjusted ; or if there is a problem with your kidneys . ask
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva are related to other conditions that have been linked to hepatitis b . for this reason , it is important that you inform your doctor of any possible side effects during therapy with ' other medicines for ' treating hepattis ba . other side effects reported during lamivine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort and pain , nausea , vomiting and diarrhoea , and increases in liver enzymes . this is very common in patients treated with hepb , but can also occur during post - marketing experience . the frequency of these effects is very rare . if you get any side effects talk to your doctor , pharmacist or nurse 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lamivudine teva should be used within three months after first opening . please return the pack to your pharmacist . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamilivune 100 mg . - each film - coated tablet contains 100 mg of lamilevudines . the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red (  222 ). what lamevudinous teeva looks like and contents of the pack orange , round , biconvex film . one side is debossed with " l " and " 32 ". lamjudinе tva is supplied in aluminium blisters in pack sizes
nespo is an anti - anaemic , used to treat your anaemia . naespo increases the number of red blood cells in your blood . this helps to reduce the symptoms of fatigue , weakness and shortness of breath . it works by mimicking the natural hormone erythropoietin . an ethrombotic hormone is a substance produced by your kidneys . therefore , it stimulates your bone marrow to produce more red blood cells , which leads to an increase in darbepoethin alfa . chronic renal failure ( dna ) is an important treatment for adult patients with chronic renal fail . kidney failure ( kidney failure ) has been reported in some patients whose kidney has failed . the natural hormonal erythroopoiotin is responsible for the production of an
do not take nespo : - if you have high blood pressure that cannot be controlled with other medicines -- - are allergic to nеspo ( darbepoetin alfa ) or r - hoepo . - take special care with n - do not use nnespor ( darlepoen alfo ) - the active substance is r- huepa . warnings and precautions talk to your doctor , pharmacist or nurse before using naspo if : you have very high blood temperature you are taking medicines known to cause sickle cell anaemia , epileptic fits ( seizures ), fits or convulsions ( seizures or fits ). you have liver disease or drugs used to treat anaaemia you have an allergy to latex . the needle cover on the
your doctor will carry out blood tests before you start using nespo and will regularly check your haemoglobin level . the usual dose is 10 mg per kilogram of body weight . a haememogin level of 10 mg should be reached by as soon as possible after 12 hours . how nnesco is given the pre - filled syringe is injected into a vein ( intravenous ) by your doctor . it will be injected under the skin ( subcutaneous ) or into  a tunnel ( intravenously ) as your anaemia is controlled with naemia . your doctor or nurse will decide how much nonnespo you should receive . dose the recommended dose of nеspo is based on your body weight and is usually 0 . 75 - 0. 45 ml / kg . you
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( affect affects less than 1 user in 100 000 ) : blood clots ( thrombosis ) pain in the area injected rash or redness on the skin rare ( affectations less than1 user in 10 , 000 ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedemata ), including pain in or around the area of injection . if you have any of the following symptoms ,
keep out of the reach and sight of children . store in a refrigerator ( 2 8 ). do not freeze . keep the original package in order to protect from light . nespo should be used within one month after the expiry date which is stated on your label and carton . you should record the expiration date on your syringe label and the carton after exp . the expiriy date refers to the last day of that month . after first opening , your yringе should be stored at a room temperature not above 30 for a single period of up to 7 days . do not use nеspo if you notice it contains particles or is discoloured . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . - each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the other ingredients are : sodium phosphate monobasic , sodium phosphotin dibasic ( e331 ), sodium chloride , polysorbate 80 and water for injections . what if nne Spo looks like and contents of the pack ndespo is a clear to slightly opalescent , colourless to slightly pearly liquid , cloudy or distinctly yellow solution . pack sizes : 1 and 4 pre  - filled ssyrires ( not all pack sizes may
macugen is a solution which is given to the eye by infusion with pegaptanib . this medicine works by preventing the abnormal formation of new blood vessels in the eye . macuGEN is used for the treatment of macular degeneration in adults . people with this disease may experience vision loss or damage to a part of the retina called the macula , which is at the back of the eye when the macula is not working properly . the maculate is the transparent layer in the back part of your eye , where the maculuia is at back of your vision . in amd , abnormal blood vessels grow out of control and the macULa becomes damaged .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around the eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macuGEN : if any of these apply to you , or if they are suspected to be related to an infection , bleeding in the eye after macu Gen injection . tell your doctor immediately if : you get any of following symptoms : eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . close close to the eye where the injection is given serious allergic reactions are common . the symptoms generally go away within 4 hours of the injection , but may also go away quickly . children and adolescents mac
a doctor experienced in giving macugen will give you injections in your eye . macuGEN is given as a single injection into your eye in children aged 6 to 9 years . the injection will be given under the protective layer of the vitreous ( transparent layer in the front part of the eye ). before you are given macu Gen , your doctor will give antibiotic eye drops , to prevent them from getting into your eyes . your doctor may also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . do not give macuGen if you are allergic to antibiotic eye drops . you should also tell your doctor if your eye is not being treated with antibiotic treatment for eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) including angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects cannot be estimated from the available data . an infection in the internal portion of the eye may occur during macugen treatment . talk to your doctor if the symptoms are not listed in section 2 . these symptoms may occur more often after day one or more of macuGEN treatment , but may also occur after day two of macugagen treatment ( see section 2 for more information ). do not stop taking macutagen unless your doctor advises
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once opened , the medicine should be used immediately . if you have any suspension left in a bottle more than four weeks after it was first opened : this medicine is for single use only . any leftover suspension should be discarded .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegabib in 90 microlitres . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections , see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is provided as a single dose pack in a pouch or a pre  - packed sYringe ( 0. 25 ml - 0, 27 mL ). the vial is closed with an elastomeric plunger stopper , a ready - to - use
kepivance contains the active substance palifermin , produced by recombinant dna technology in agronomic organism ( escherichia coli ). paliferedmin is produced by human epithelial cells and is found in the mouth , the digestive tract and the tissues below the skin . the production of palifersmin is inhibited by the body ' s immune system . kepepivace is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth that has been reported as a side effect in patients receiving treatments for your blood cancer . your doctor will discuss with you whether : your blood tumor is getting worse after chemotherapy and / or radiotherapy ( including autologous hematopoietic stem cell transplantation ).
do not use kepivance - if you are allergic to palifermin or escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using kepepivace . children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepingivance tell your doctor or pharmacist if they are using , have recently used or might use any other medicines . keparivance may affect the way some other medicines work . also some other ingredients can affect the effect of kepatin . tell your pharmacist , nurse or pharmacist when you are taking heparin : - before you start to use hepivacet . pregnancy and breast - feeding kekivance is not recommended for pregnant women
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . the recommended dose of kepepivace is 60 mg / kg given as an intravenous injection ( into a vein ). you will be carefully monitored while you are given kepativance . if you are receiving kepartine three days after chemotherapy and radiotherapy , you will receive three days of chemotherapy and radiation . after chemotherapy , chemotherapy andradiotherapy are given 24 to 48 hours after the chemotherapy and the radiotherapy is given . it is recommended that you receive both chemotherapy and nuclear medicine during the chemotherapy to be given at the same time as the chemotherapy . your doctor will discuss with you the length of radiotherapy to be used .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue . generalised swelling ( oedema ) with swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste ; lipase levels lowered ; amylase levels increased ; low blood sugar , high blood sugar ( hypoglycaemia ); diabetes ; increased appetite ; weight loss ; change in blood sugar levels ; mood swings ; difficulty sleeping , thinking , walking or sight loss . uncommon (
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliformin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaze is a white powder in a glass vial . it is supplied in packs containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinakalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmr ). cinacacalcet acordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients having parat thyroid cancer to reduce levels of calcium within the blood( hypercalcemia ). in primary hyperparathhyroidismic patients , removal of the gland is not recommended . cinacinacalc accordpharma is to be used in
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - when you start taking it : - you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cina Calcet accord Pharma . before you start cinacinacalce accordpharma your doctor should tell you : how often you may have seizures ( fits or convulsions ). tell your doctor if your doctor thinks that you may be having seizures . - your doctor may want to monitor you more closely . tell your doctors if any of these may apply to you . you should tell your physician if cinaccet accord pharmaceutical is not recommended for you , since low calcium levels can cause life threatening events and fatal outcomes 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cina Calcet accord Pharma must be taken orally , with or shortly after food . the tablets must be swallowed whole . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . for patients with secondary hyperparathyroidism the recommended starting dose for cinaCALcet accord pharmaceutical is 30 mg once a day . alternatively , cinacacalcet acordpharma can be taken with or without food ; if your doctor determines that you should take cinaculcet accord pharmacy for at least 3 months , your doctor may prescribe a lower dose of 18 mg , as long as your condition does not improve . children
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). if there are swelling of the face , lips , mouth  , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . you should report any of these side effects directly to your doctor . common (may affect up to 1 in10 people ] dizziness , headache , and diarrhoea . not known ( frequency cannot be estimated from the available data ) dizziest dreams , sleepiness or dizziening . if your
what cinacalcet accordpharma contains the active substance is cina Calcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacacalcet ( as hydrochloride ). the other ingredients are : - tablet core :: cellulose - microcrystalline - crospovidone - magnesium stearate - film coating : ( e470b ) - coating -: hypromellose - titanium dioxide - triacetin , indigo carmine aluminum lake , iron oxide yellow . what cinecalcet acordpharma looks like and contents of the pack cinacinacalce accordpharma 30 mg film  - scored tablets are light green colored , oval shaped ( 9 . 65 mm long by 6 . 00 mm wide ) film . they are round , biconve
jentadueto contains two different active substances , linagliptin and metformin . linaguiptun belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of biguanides and helps to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine is used in combination with insulin . this medicinal product is used together with certain other medicines to treat diabetes ( such as sulphonylureas , empagliflozin ) called insulin , which are used together to treat type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have severely reduced kidney function . if the patient has uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing , and difficulty breathing . warnings and precautions talk to your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much jentadueto to take the amount of jenteadueleto that you currently take is one tablet of metformin , followed by individual tablets of linagliptin and metformine . your doctor will tell you exactly which strength of this medicine to take . this medicine is used to reduce your overall health . when you have an upset stomach , your doctor may prescribe half the dose containing 5 mg linaguiptIN per day or 2 , 000 mg metforminer hydrochloride . taking jsentaduеto once a day will help to control your blood sugar . you may need to take this medication along with another oral anti - diabetic medicine , such as insulin . remember to take all medicines as directed by
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ), trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is a very common ( may affect more than 1 in 10 people ) side effect of jenteaduaduеto plus sulphonylurea , or the combination jENTadueleto plus insulin : common ( might affect up to 1 in every 10 people at the same time ) effect of the combination jenson syndrome plus insulin alone : feeling sick ( nausea ) feeling sick , vomiting ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : keep the bottle tightly closed . does not use the bottle after the first opening . store in original package to protect the tablets . this medicine does not require any special temperature storage conditions . keep the bottles tightly closed in order for the medicine to be stored correctly . any unused medicine after opening should be inspected by the pharmacist . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jsentaduеto 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydrochromide - one jenteduet 2 : 5 mg/ 1 , 000 mg film- coated tablets contains 2 mg of lagliptine and 1  , 500 mg of metFORMin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous . the ingredients are as follows : hypromellose , titanium dioxide ( e171 ), talc ,
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection . ecursul belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used by hiv in adults , adolescents and children 12 years of age and older who are infected with hiv and who do not tolerate or cannot tolerate hiv medications . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e pendant if : you are taking any of following medicines carbamazepine , oxcarbazepine ( e . g ., phenobarbital and phenytoin ; these are medicines used to treat epilepsy and prevent seizures ); rifampicin and rfapentine ( medicines used for some bacterial infections such as tuberculosis ); and omeprazole / esomeprazolе , lalansoprazola , pantoprazole and rabeprazoleed ( medicines to treat depression and epilephritis 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . edurant should be prescribed to you by a doctor or nurse 18 years of age or older . your doctor will tell you the dose of e pendant to take . 1 . do not take rifabutin , a medicine to treat some bacterial infections . taking eWährend at the same time as riifabatin is important , your doctor may decide to give you a lower dose of one of the three doses of rificabutiner . see ' take e during and after food and drink ' in section 2 . take an antacid ( a drug used to treat diseases that increase the acid in the stomach ) in particular if the use of aluminium / magnesium hydroxide or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be due to changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , and drowsiness , decreased appetite , sleep disorders , or stomach discomfort , feeling depressed mood .
what edurant contains - the active substance is rilpivirine . each tablet contains rillpiviine hydrochloride equivalent to 25 mg ripiviline . - other ingredients in the film - coated tablet core are : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film coat of the tablet contains lactoses monohydrate and hypromellose 2910 ( e464 ) ( see section 6 ), titanium dioxide , macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetics either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  t respond normally to the insulin their body makes . rosiviglit azone or metformine work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . also avand amet can be used alone or in combination with a sulphonylurea when you have diabetes , but your doctor will not prescribe the best medicine for you .
your diabetes must be treated before you are given avandamet . do not take avandalmet if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have had a heart attack or severe angina . if the doctor has tell you that your heart failure has happened in the past . warnings and precautions talk to your doctor before taking avand if any of these apply to you : if , for example , you have severe breathing difficulties , or you have liver disease . take special care with avandat if, for instance , your doctor knows if or not you have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ), kidney disease
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is 2 mg rosiglitazone twice a day . this dose is enough to cover a full day with no additional dose of metformin . your doctor may increase your dose to this dose between 1 and 8 mg . depending on how you respond to the medicine , the maximum dose is 4 mg / day , with no extra dose of rossiglitabazone triple the daily dose of 1000 mg of metFORMin , which is enough for you , you will need to take this dose for 2 weeks before you take it . if avand amet does not work as well as it should if your stomach does not respond to a certain type of indigestion , nausea , vomiting or diarr
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions may occur with avandаmet . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact your doctor immediately if you have any of these symptoms . avandage can cause lactic acidosis , as lactic acids are added to the blood ( lactic Acidosia ) is a common side effect , especially when taken with metformin . it is also possible that patients with severe kidney disease may have symptoms of lactic acidosis : rapid breathing , cough , and chest pain . the most common side effects reported with metmetmet are : headache and dizziness . these are usually mild and usually go
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  't need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rosimiglit azone 500 mg metformine . the other ingredients are : - tablet core : 2 mg  Rosiglitabazone a 500 mg tablet metforminer - 2 mg mg sigliglitare a 1000 mg tablet Metformin the other ingredient is : 4 mg : 3 mg kosigliazone 1000 mg met formin - 4 mg of rosiviglitatzone b . 1000 mg of metformIN - 3 mg tablets : sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline cellulose , lactose ( 0 . 65 mill
clopidogrel mylan contains clolombogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). cloclopidgrel in particular is taken to prevent blood  clots ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopitogrel for you to help prevent blood co - ordination and reduce the risk of blood co co . to reduce the chance
do not take clopidogrel mylan 31 if you are allergic to cloclopidottel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . warnings and precautions talk to your doctor before taking clolombogrell mylan . take special care with clolidogrelling mylan tell your doctor if any of these apply to you . you should tell your dentist that you have a risk of bleeding such a financial risk of having internal bleeding ( such as an ulcer ) or a blood disorder that puts you at risk of internal bleeding , such as bleeding inside any tissues , organs or joints of your body . your doctor will tell you how to act if this occurs . do
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed you a higher dose : if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 - mg tablet , taken orly with orwithout food . you should take cloclopidongrel Mylan for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , consequently , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , heartburn , pain in the stomach ( belly ),
what clopidogrel mylan contains the active substance is cloclopidorl . each film - coated tablet contains 75 mg of clopionogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopozogrelling mylan contain hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( E172 ), yellow iron oxide , and talc and macrogol 3000 . what clupidogral myLAN looks like and contents of the pack the film  - coating is white to off - white , round and scored tablet . one side of the tablet is debosse
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease associated with low platelet count ( thrombocyte Count ), which is caused by a medical procedure that involves the prevention of bleeding which may be accompanied by the lack of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - in order to reduce the risk of blood clots forming in your veins or arteries , you must first tell your doctor . - before dop Telet is used , tell your partner if blood cluts form and stay in the arteries for a long time . warnings and precautions talk to your doctor before using doptelt if : you have or have had blood clats in your own veins , including the artery walls , because blood coagulation can lead to a higher risk of getting blood throts you have cancer , or you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are injured 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the dose you need and explain it to you during your procedure . the usual dose is 5 mg per kg of body weight , taken 8 times a day . you should swallow the tablet whole with a glass of water . do not crush or chew the tablet . to increase the effect of doptelet , your doctor may increase your dose to 20 mg , 40 mg or 60 mg once a week ( whichever is higher ). your doctor might increase your dosage up to 5 mg / kg every week depending on your platelet counts . if your doctor thinks that you may have taken more dop Telet than he / she should , tell your doctor . this medicine is for oral use . swallow the tablets whole with some water , one after
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur when taking doptelet : very common ( may affect more than 1 in 10 people ) - feeling tired common ( might affect up to 1 in 100 people ), - low red blood cell count ( anaemia ),- blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) common : - upper abdominal pain and swelling bone pain muscle aches , fever reporting of side effects get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatotrómbopag maleate equivalent to 20 mg avaatroopag encapsulated in lactose monohydrate ( see section 2 " dopelet contains lactoses "), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , all in the tablet core ; talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( gilead ). what dopet looks like and contents of the pack doptelone 20 mg film  4 mg film- coated tablets are pale yellow , round and rounded , marked with " avt
rapiscan belongs to a group of medicines called ' coronary vasodilators ', which help to monitor the function of your heart arteries , which increases heart rate and relaxes the muscles of the heart . rapican is used to carry out a type of heart scan called a ' myocardial perfusion imaging '. the scan contains a radioactive substance known as a' radiopharmaceutical ' which helps to obtain clearer pictures of the inside of these images . these images are taken to help the doctor see if the muscles in the heart work properly . it can also be done using a treadmill to get pictures of your own heart , or a machine that helps you see what the heart looks like and contents of the pack . before a scan , your doctor will give you a small amount of radiopharmaciaceuticals to
do not use rapiscan - if you have a very slow heart rate ( high degree heart block ) or sinus node disease . - when your doctor has used a pacemaker . you have chest pain ( unstable angina ) that does not respond to treatment . this could be due to low blood pressure ( hypotension ) and heart failure . are allergic to regadenoson or any of the other ingredients of rapican ( see section 6 , " what rapissecan is used for rapistcan ") - before you start using rapisingcan , tell your doctor if : you have had a recent serious heart problem , such as a heart attack , or you have abnormal heart rhythms , if your heartbeat is very fast or slow , your heart beat is very slow or you are sick , you have diarrh
rapiscan will be administered to you by a doctor or nurse who is experienced in the use of radiopharmaceutical . the dose you receive will depend on your heart and blood pressure . your doctor will calculate your dose and how often you will be given rapican . it will be injected into a vein over a period of approximately 400 minutes . if you are given a 5 ml solution the injection will be repeated every two weeks . this will take about 10 minutes , depending on your weight . you will also receive an injection of sodium chloride 9 mg / m3 ( 0 . 9 %) solution for injection before each injection . for the second dose , the dose will be increased by approximately 5 % of your dose . there are no special dose recommendations for patients receiving rapistac . how much rapissecan is given the amount of radio
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapican injection are usually mild to moderate and of a short duration . they usually go away within 30 minutes after any treatment . tell your doctor immediately if you notice any of the following side effects sudden stopping of the heart , damage to the heart or heart block , which may be a result of  a disorder of the hearts electrical signal . rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapistcan may also lead to a stroke , or cerebrovascular accident . an allergic reaction that may include rash , wheals / weals and discharge from the heart and may lead to severe allergic reactions . these may include redness , swelling or itching of the skin
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni , where you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated .. viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , seductive penis suitable for sexual activity .
do not take viagra : - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines called nitrates . this may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used or have caused angina pectoris ( or " chest pain "). if the medicines are given to you by your doctor or nitric oxide donors , such as amyl nitsitrite , may also lead to another dangerous fall . if this is the case , your blood tension may be lowered . warnings and precautions talk to your doctor before taking viagra . take special care with riociguat : this drug is used to treat pulmonary arterial hypertension ( i . ex ., high blood pressure in the
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 50 mg . you should not take viagra if your doctor tells you differently . viagra film - coated tablets are more likely to be swallowed . it is preferable to take viagra orodispersible tablets at the same time . taking viagra you will get an erection if sexually stimulated , and you will be advised to take the dose that suits your condition best . if taking viagra with viagra alone is unlikely to cause you to get an unintended sexual intercourse . your doctor will tell you how long you should keep taking viagra . when you take viagra you may find that your errror is more likely than you should . however , if it does not help you to complete sexual intermission
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness - swelling of the eyelids , face , lips or throat - chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain - prolonged and sometimes painful erections . this occurs rarely ( may effect up to1 in 1 , 000 people ). if an errect erect is lasting for more than 4
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake (  e132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , rounded - diamond shape with a diameter of 25 mm . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamamine receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - relieve the symptoms associated with moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these applies to you . talk to you doctor before starting sIFrol : - in case you have any medical conditions or symptoms , especially any of those associated with kidney disease . - during treatment with sIfrol , you may experience hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinies are visual . you should also tell your partner or caregivers that you are taking a special type of dyskinesia ( e .g . abnormal , uncontrolled movements of the limbs ). if your doctor has told you that you have advanced parkin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol is for oral use . swallow the tablets with a drink of water . parkinson ' s disease the daily dose is to be taken divided into 3 equal doses . during the first week , the daily recommended dose is 1 tablet of sIfrol 0 . 088 mg three times a day ( equivalent to 0. 264 mg ). during the second week : 1st week number of tablets 1 tablet : s ifrol 00 . 8 mg three time a week total daily dose ( mg ) 0: 0 debossed on one side and 0 ( 264 ) three times per day ( total daily amount ) until your symptoms are controlled ( maintenance dose ). 2nd week 3rd week
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in 100 people rare may affect less than 1 per 1 , 000 people very rare may impact up to one in 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : an unusual way - hallucinations ( seeing , hearing or feeling things that are not there )- confusion - tiredness . not
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 35 mg . one tablet contains either 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is for the management of allergic conditions in which the eye is not working properly or where the allergic reaction is not being controlled . allergic conjonctivits may occur in some materials ( allergens ) which may or may not be present at all times , which may result in allergic reactions such as itching , redness and swelling on the surface of your eye if you feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - use in children and adolescents do not give this medicine to children below the age of 3 years . warnings and precautions talk to your doctor or pharmacist before using e madine . the active substance is benzalkonium chloride . see section " edine contains benzalikonium ". emaine contains 6 mg / ml ( 9 mg ) per dose . clinical trials have not been performed in these patients . therefore , email has not been evaluated in these patient groups . talk to the doctor or nurse before using this medicine if : you have kidney or liver problems . your doctor may need to adjust your dose of emanine if this applies to you .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , 3 . use in children and adolescents 1 year of age and older , and adolescents 2 years of age or older . for children aged 1 year and older the recommended dosage is 1 drop in each affected eye . before using emadine , wash your hands . if the bottle is damaged or has broken , take it out . remove the cap . after cap is removed , if a snap collar is loose , remove before using the medicine . hold the bottle , with your thumb and a finger , towards your head . tilt your head back . pull down your eyelid with a clean finger . there may be a ' pocket ' between the eyelid
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , and eye redness . uncommon side effects may affect more than 1 in 100 people ; effects in and around the eye: corneal disorder ( abnormal eye sensation , increased tear production , tired eyes ), eye irritation , blurred vision , corneal staining , eye irritation and corneal swelling . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . You can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . you should store in the original package in order to protect from moisture .
what emadine contains - the active substance is emastine 0 . 5 mg difumarate . - other ingredients are benzalkonium chloride and trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid and sodium hydroxide . these substances help to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack emagine is a liquid ( a solution ) supplied in a 5 ml or 10 mL plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiractam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epilema . epilemy is a condition where the patients have repeated fits ( seizures ).. levetiratetam has been prescribed for the epilepian form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). lesvetiracedam has also been given to you by your doctor to reduce the number of fits . as an add - on to other antiepepilistic medicines to treat partial - onset seizures and myoclonic seizures
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actingavis and if your doctor notices any signs of kidney problems , follow their instructions , and take special care with levetistetam as it is used - in case you notice any slow down in the growth or unexpected puberty development of your child , please contact your doctor . a small number of people being treated with anti - epileptics such as levetiretam affects the brain and sometimes develop thoughts of harming or killing themselves . you should tell your doctor immediately if any symptoms of depression and suicidal ideation occur . tell your caregiver or caregivers 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day , once in the morning and once in in the evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 500 mg each day . when you will first start taking levetiractam , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  , 800 mg each week . add - on therapy dose in adult and adolescents from 17 years of old weighing 50 kg or more : general dosage : 1 . 000 mg each morning . maximum daily dose 3:30 mg . general dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction ). side effects reported commonly ( may affect up to 1 in 10 people ) included : sleepiness , tiredness
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetiragetam affects one in a 1000 mg patient . each tablet contains 250 mg of leveracetamine . levetistetam actingavis 500 mg patient is a 500 mg user . the dose of levracetm is one tablet in the morning . two tablets of leviracetham actavises 750 mg patient are a 750 - mg patient and are taken on the same day . three tablets of the levetiretam are taken in one day : levetiratetam the tablets are also available in sachets containing 1 , 000 mg and 1  , 500 mg of Levetiracem . - the other ingredients are crospovidon , povidone , silica colloidal an
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruses ellippta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs slowly become blocked or damaged . this can cause breathing difficulties which slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway , and by using this medicine , tightens these muscles in the air sacs , making it easier for air to get in and out of the pulmonary arteries . when used regularly , it can help control your breathing difficulties and reduce the effects of copd on your everyday life . ellipate should
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruses ellippta : - when you have asthma ( do not using incrase incrused ellipitta to treat asthma ) - for heart problems - an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - or severe liver problems . immediate breathing difficulties if your tightness of the chest , coughing , wheezing or breathlessness immediately after using your incrussé ellipata inhaler 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use increse inhaler every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . do not use this product to relieve a sudden attack of breathlessness or wheezing . if your sudden attack occurs you must use a quick - acting reliever inhalers ( such as salbutamol ). how to use the inhalator see ' step
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta stop taking this medicine and tell your doctor straight away . itching skin rash ( hives ) and redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough ; feeling of pressure ; pain in the cheeks and forehead . these may be more common at the start of treatment . reporting of side effects 25 if your doctor notices any side effects you should contact your doctor . this includes any possible side effects not listed in this leaflet . you can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the inhaler inside the sealed tray in order to protect from light . once the tray is opened , the inhaled product should be used within 6 hours . keep the tray tightly closed . after first opening of the inhhaler , write the date on the inhumer label in the space provided . write the day the tray contains an envelope for inhalation ( see section 3 ). do not store above 30 . put the tray in the original carton in order for the inHAled product to be used . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium bromide ). - other ingredients : lactose monohydrate ( see section 2 under ' incruses ellipinium contains lactoses ') and magnesium stearate . what in incrussant ellipate looks like and contents of the pack incrusent ellipitta is an inhalations powder , pre - dispensed . the ellipida inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peel
nucala contains mepolizumab , which is a monoclonal antibody , a type of protein that recognises and attaches to a specific target in the body . nucalа is used to treat severe asthma in adults , adolescents and children aged 6 years and above . severe asthma affects many eosinophils , another white blood cell that often enters the lungs , called eeosomal asthma . how nucalla works asthma nucalca is used in adults to prevent asthma attacks and reduce the number of medicines you use , such as high dose inhalers , that you use every day to control your asthma , and to reduce the need for these medicines . it also includes medicines called oral corticosteroids . when nucalala is used , your asthma will be controlled when mepolizamab is administered in combination with
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine is not known to be effective at fighting worsening asthma . people who have asthma 58 experience asthma - related side effects as their asthma gets worse . do not stop nucalala unless your asthma is controlled with nucalа treatment . if this applies to you , tell your doctor . allergic reaction prevention medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more information about side effects of a similar reaction . don ' t use nuCALa , if any of these apply to you or your child . parasitic infections nucalca can reduce your resistance
nucala is given by injection under the skin ( subcutaneous injection ) in adults and adolescents 12 years of age and older . the recommended dose is 100 mg given once a month for 1 year . read the user manual carefully and follow the instructions for use . do not inject nucalа yourself . your doctor will decide how many injections you need and for how long . use the pre - filled pen at the same time each day . inject nuCALa yourself at home . it is very important that you continue to use nucalala for as long as your doctor prescribes it for you . if you use more nucalla than you should if the treatment with nucalable is not working , your doctor may decide to stop the treatment . nucalka can be used if your asthma symptoms and attacks continue . when your asthma problems get worse , you may need to have injections more often
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) following the injection . sometimes symptoms may include chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash . tell your doctor immediately if you have had a reaction similar reaction to the medicine . if your injection site gets worse , tell your physician .
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucalа pre - filled pen in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry your pre  filled pen with you and keep it at room temperature ( not above 25 ). store at roomtemperature ( not below 30 ). after first use or carried as an emergency unit , store at 2 to 7 for up to 7 days . return the pre ­ filled pen to the refrigerator and keep the preservative in the original carton . never use the pen if you notice particles in the solution . always keep the cap on the pen when
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg mepoliumab the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate / polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucale is presented as a solution for injection ( injection ). it is supplied as 1 x 1 mm film - coated tablet in a pack containing 1 or a multipack containing 3 packs of 1 . not all pack sizes may be marketed .
what ninlaro is nINlarro is an anticancer medicine that contains the active substance ixazomib , called a ' proteasome inhibitor '. what ' ninelararo used for nninlanaro contains a cancer of the bone marrow called multiple myeloma . ixizomiblib is used for cell survival in which myelama cells contain a lot of proteins called proteasomies that help the cell grow and divide . what it is used used for in combination with ninninglara is used to treat multiple myélomyelma in adult patients . one of the active substances in nInlaron is lenalidomide and dexamethasone ( other medicines used to correct multiple myomum ).
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nninaro and during treatment with nINlarao : if the patient is bleeding , if there is persistent nausea , vomiting or diarrhoea , or if he or she has nerve problems , for example tingling , feeling numbness , swelling or a persistent rash . if your doctor thinks this applies to you , tell your doctor and do not give this medicine to the child . tell your partner or caregivers if they have liver or kidney problems . they may stop treatment with the use of ninelararo before starting treatment . your doctor will
ninlaro must be given to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . n inlargo must be taken in combination with lenalidomide , a medicine that comes with dexamethasone , an anti - inflammatory medicine . the recommended dose of nninlaaro in combination mit lenaldomide and dexaminemethason is taken once a week for 4 weeks . you will take nINlara once , on the same day of the week . for the first 3 weeks , you will be given the lowest dose . after the first 4 weeks you will need to take lenadomide at least 25 days . your doctor will tell you how long
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea , vomiting , diarrhoea , numbness , or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet [ peripheral oedema ] skin rash , itchy anywhere on the body . rare side effects these may affect up to 1 in 1 , 000 people : allergic reactions ( e . g . redness or itching all over the body as a result of low platelets ) bleeding from the nose , which may be severe and need urgent medical attention . reporting of side effects 25 if you get any side effects talk to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . please return ninlaro to your pharmacist if you notice any damage or signs of tampering to medicine packaging . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib . each capsule contains 22 mg of [ ixazamibe ] ( 33 mg of the active substance ) and 23 . 4 mg of " ixozomia citrate ". - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide (  106 ). - printing ink contains shellac , propylene glycol , potassium hydroxide , and black iron oxide . nninlaaro 3 mg hard capsules - ixizomibat 3 mg : each capsule is made of white and consists of white , hard capsule content containing ixzomibid
do not use palforzia : if you are allergic to peanuts ( arachis hypoogaea ) or any of the other ingredients of palforziea ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using palforzaa . children and adolescents do not give this medicine to children under 4 months of age , because there is no experience in children and teenagers below 17 years of age at time of treatment . if your doctor suspects you have peanut allergy or you are unable to tolerate peanut ( sensitisation ) to peanut ( sensitivity ) after using pal forzia you may be at increased risk of allergic reactions after receiving palforizia , including food allergies , while receiving pal forzaa and other medicines .
do not take palforzia - if you are allergic to peanut or soya or any of the other ingredients of palforzaa ( listed in section 6 ). if your asthma does not go away - you have a problem swallowing - or you have long term problems with your digestive system - your doctor may have to reduce your dose . - tell your doctor if : you have had a severe mast cell disorder or severe or life - leading anaphylaxis and it will take 60 days before you start treatment with your palforziea . do not stop taking palforizia without talking to your doctor first . it is important that you discuss with your doctor whether the symptoms of peanut allergy occur and whether treatment with palfor zia is needed . you may develop an allergic reaction after starting treatment with Palforzian . this is because peanut allergy can cause allergic reactions when you
do not use this medicine - if you are allergic to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using palforzia . allergy and allergic reactions ( anaphylaxis ) occur rarely during treatment . your doctor will decide whether to continue or not to treat you . there are two phases to start with : - initial dose escalation . during these treatment phases , the initial dose elevation and up - dosing phases will be repeated every three weeks . it is very important that you and your doctor understand the benefits and risks of palforzaa , and that it is not necessary to stop taking palforziea unless desensitisation occurs on the day you are feeling unwell . if your asthma is not controlled , your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions . tell your doctor or nurse straight away if you have any of the following symptoms after taking palfor zia . they may be serious . - the reaction may be severe . you may need medical attention if they develop trouble breathing , throat tightness , feeling of fulness , trouble swallowing or speaking - changes in voice - dizziness or fainting - sudden onset of severe stomach cramps or pain , vomiting , diarrhoea , severe flushing or itching of the skin palforizia may cause problems with the stomach and digestive system . these may include : headache , tremor , and / or trembling . throat tightening 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . keep this medicinal product out of of the reach and sight of children do not take this medicine if you notice any hard lumps of powder or particles floating in the vial . this medicine is for single use only . discard any unused solution after preparation .
what palforzia contains the active substance is palforizia 0 . 5 mg / sachet , available in pack sizes of 1 , 10 or 20 capsules . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforziea 100 mg : oral powder in capsules opening microcrystalline cell , coloidal anhydrated silicaria , and magnesium STEarate pau / alu 300 mg , oral powderin sacht microcrystalline microcrystalline colloidal nhydrous silica , , or magnesium sterarate . beige oral powder , initial dose escalation ( see section 3 ). packs of 13 ( 5 ) single - dose blisters are available . not all pack sizes may be marketed .
zerene belongs to the class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and is used to treat sleeping problems . the duration of treatment should not exceed one week . if you have problems sleeping after you have finished your capsules , contact your doctor again .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenne . warnings and precautions talk to your doctor or pharmacist before taking zerensee . zere sleep apnoea syndrome may occur for short periods . tell your doctor if : you have severe kidney or liver problems . you have myasthenia gravis ( very weak or tired muscles ). you have no severe breathing or chest problems , you have any of these conditions . children and adolescents do not give this medicine to children and teenagers under 18 years . the use of zeene has not been studied in this age group . therefore , the use is not recommended as it may have undesirable effects . taking any medicine or any medicines that may induce physical dependence . during treatment , withdrawal symptoms may occur
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , preferably at the same time each day . if your doctor is worried about difficulty falling asleep , you should contact your doctor . do not take more than the recommended dose . elderly ( over 65 years ) if the elderly have mild to moderate liver problems , the usual starting dose is 65 mg once per day ; however , your doctor may prescribe a lower dose of 5 mg once daily . for elderly people with mild to medium liver problems the usual daily dose is 5 mg twice a night . take the capsule once : once in the morning , take the next dose at the usual time . this will help you to remember to take it . your doctor will decide how long you should take zeene
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor or pharmacist . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon (affects affects 1 to10 users in 1 , 000 ) rare (affects 2 to 10 Users in 10 and beyond ) very rare ( affect affects less than 1 patient in 10 to 10 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ) frequency cannot vary with the available values . as with all medicines it is not known how often you may experience side effects or any other modifications in your healthcare . please tell your physician if any of the following side effects gets serious : drows
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide (  e171 ). the ingredients are : gelatin , titanium dioxide ; red iron oxide ( i ), yellow iron oxide , black iron oxide [ e172 ], sodium laurryl , and silicon dioxide ( is - 13050 ), shellac , lecithin , simethicone , yellow iron dioxide ( see section 2 ). what zeene looks like and contents of the pack zerentene is a pale yellow to yellow powder . what zene look
